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Abstract
This thesis is initially concerned with the characterization of a molecule purified from 
extract of beef heart on the basis of its ability to support the in vitro survival of 
embryonic chick ciliary neurons (Watters, and Hendry, 1987). The factor is 
characterized as a heparin binding, acidic protein of molecular weight 18kD which 
possesses mitogenic as well as neurotrophic activity. Although blocked to N-terminal 
sequencing, enzymatic fragments revealed 100% homology to the class 1 heparin­
binding proteins (HBGF-1). The molecule is apparently not retrogradely transported by 
its target neurons. A monoclonal antibody capable of blocking the in vitro activity of the 
neurotrophic factor (Watters et al. 1989) was shown to be an IgA subclass which 
recognizes acidic, but not basic, fibroblast growth factor on western blots. Significantly, 
administration of this antibody to neonatal mice disrupts development of the 
parasympathetic nervous system. The ubiquity of class 1 heparin binding growth factors, 
their concentration in target tissues and their lack of retrograde transport are discussed 
with regard to the neurotrophic hypothesis.
The last three chapters are concerned with the interactions of the class 1 heparin binding 
proteins. It has long been considered that the ability of heparin and several other 
glycosaminoglycans to augment the biological activity of HBGF-1 is related to their 
capacity to bind the factor. With this in mind, the ability of native heparin, structurally 
modified heparin and several other glycosaminoglycans to (i) bind to and (ii) potentiate 
the biological activity of heparin-binding growth factor 1 was investigated. It is 
concluded that binding of glycosaminoglycans to HBGF-1 accounts for only part of their 
potentiating activity, and the possibility that these polysaccharides exert a direct effect on 
their target cells is discussed.
Finally an in vitro study of the interaction between retinoic acid and the class-1 heparin­
binding proteins is presented in chapter 6. It was found that retinoic acid potentiates the 
neurotrophic, but not the mitogenic action of HBGF-1. The neurotrophic action of NGF 
was unaffected by the presence of retinoic acid in the culture medium.
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General introduction
2The molecular approach to the study of neuronal development has recently seen 
significant changes. The following is a brief account of the 'traditional approach' to the 
study of neurotrophism which led to the isolation of the molecule characterized in this 
thesis, and which lays the foundation for some of the experiments attempted. Whilst it is 
recognized that several classes of molecules have been implicated in the processes of 
nerve development and regeneration, the emphasis of this thesis is on neuro trophic 
molecules in their true sense (trophikos - Greek, concerned with nutrition, nourishment);
i.e. molecules that regulate cell survival and differentiation.
Neurotrophic theory
The morphogenetic events involved in the formation of vertebrate neural centres have 
been conceptualized as a series of stages (Cowan, 1979):
1. Proliferation of neurons and glial cells
2. cell migration
3. selective aggregation
4. cytodifferentiation e.g. process formation, mode of conduction, transmitter synthesis
5. establishment of afferent and efferent connections
6. neuronal death
7. validation or elimination of connections
Although a somewhat artificial division of a continuous and often overlapping 
developmental process - for example sympathetic neurons differentiate as they migrate 
(Enemar et al. 1965) and proliferation in sensory ganglia continues throughout 
differentiation and cell death (Hamburger et al. 1981) - these stages nonetheless serve as a 
useful frame-work. Historically, it was the investigation of the penultimate stage that led 
to the establishment of the neurotrophic hypothesis; target tissue related control of 
neuronal survival remains the most outstanding example of trophic dependence. It is 
recognized however, that trophic control of neuronal development is not restricted to this 
developmental stage. For example the recent in vitro observations that fibroblast growth 
factor (FGF; Gensburger et al.1987), insulin and the insulin-like growth factors 
(DiCocco-Bloom, and Black, 1988) stimulate proliferation of rat neuroblasts and that 
ciliary neurotrophic factor (CNTF) inhibits division of chick sympathetic neurons 
(Emsberger et al.1989) represent the first reports of growth factor control of the initial 
stage of neuronal development. Moreover, molecules possessing neuronal survival 
activity may not be restricted to this role in vivo; nerve growth factor (NGF) and the 
putative neurotrophic molecules brain-derived growth factor (BDGF) and ciliary
3neurotrophic factor (CNTF) also possess differentiating activity (Paravicini et al. 1975; 
Hofmann, 1988; Kalcheim, and Gendreau, 1988; discussed below).
Neuronal death
Investigations carried out since the turn of the century established that the number of 
neurons surviving to maturity is in some way related to the extent of the available 
peripheral field of innervation. For example extirpation or expansion of target regions 
early in development results in a corresponding increase or decrease in the number of 
motor (Shorey, 1909; Hamburger, 1934; Hamburger, 1975; Chu-Wang, and 
Oppenheim, 1978; Hollyday, and Hamburger, 1976), sensory (Shorey, 1909; Detwiler, 
1920; Hamburger, and Yip, 1984), ciliary (Landmesser, and Pilar, 1974b; Hamburger, 
1934), trochlear (Cowan, and Wenger, 1967) and isthmo-optic neurons (ION; Cowan, 
and Wenger, 1968). It was later recognized that neuronal degeneration is not limited to 
neuronal centres lacking normal peripheral fields (Hamburger, and Levi-Montalcini, 
1949), but is a normal developmental phenomenon in almost every neuronal centre 
examined (Jacobson, 1978; Cowan, 1979); indeed exceptions are rare (Cowan et 
al.1984).
Although developmental or histogenetic neuronal death has been related to refinement of 
errors of projection (see eg Clark, and Cowan, 1976) the extent of cell loss cannot be 
explained by such errors in all cases. The most extensive study of the interaction between 
the target tissue and developing neuronal centre has been carried out on the chick ciliary 
ganglion (Landmesser, and Pilar, 1974a; Landmesser, and Pilar, 1974b; Landmesser, 
and Pilar, 1978; Pilar et al.1980). Cell proliferation continues until stage 25 when axonal 
outgrowth toward the myoblast target cells is initiated. Electrical, biochemical and 
morphological indices of differentiation show an autonomous sequence; the neurons 
conduct action potentials, are electrically excitable, synthesize and transport 
acetylcholine, choline acetyl-transferase (CAT) and acetyl cholinesterase and will 
respond to externally applied acetylcholine. Shortly afterwards (stage 31) all ganglion 
cells can be activated via afferent synapses. Early removal (stage 16-20) of the optic 
vesicle does not alter this developmental sequence in any detectable way. However at 
stage 34, when the outgrowing axons are forming functional synapses, a phase of target 
dependence ensues. Peripherally deprived ganglion cells fail to exhibit normal 
morphological differentiaton and subsequently die over a critical period between stages 
34 and 40. Cells of control ganglia also decrease in number over the same period (from 
6500 to 3200 cells per ganglia i.e. normal histogenetic cell death) although all cells can 
be retrogradely labelled by injection of horse-radish peroxidase into the target region,
4exhibit various indices of differentiation and receive afferent synapses. Such 
observations argue against histogenetic cell death as either loss defective neurons or as a 
preprogrammed sequence. The increase in neuronal survival seen in the 9-13 day chick 
ciliary ganglion following grafting of an additional optic vesicle at stage 11 (Narayanan, 
and Narayanan, 1978) further supports this contention.
Similar developmental sequences have been described for the chick motomeurons of the 
ventral horn (Hamburger, 1975; Chu-Wang, and Oppenheim, 1978) and brainstem 
(Cowan, and Wenger, 1967; Cowan, and Wenger, 1968) confirming that cell death 
occurs at a time when most axons have reached their target and are forming initial 
synaptic contacts. It is worth noting however that sensory ganglia do not follow such a 
defined developmental sequence. Proliferation in the ventrolateral population of the chick 
dorsal root ganglia (DRG) continues through the stages of differentiation and cell death 
which begin well before all fibers have exited the developing ganglion (Hamburger et 
al. 1981).
There is considerable evidence that, during the stage of target dependence, neuronal 
processes compete at the site of the target organ. Increasing the size of the field of 
peripheral innervation allows survival of neurons that would otherwise die (Narayanan, 
and Narayanan, 1978; Hollyday, and Hamburger, 1976). Reduction of the number of 
competing axons by axotomy of two of the three branches of the ciliary nerve increases 
the number of surviving cells sending axons out the remaining branch (Pilar et al.1980); 
the field of innervation of the remaining branch is correspondingly increased. 
Conversely,- increasing the number of competing axons decreases neuronal survival. 
This has been achieved by early removal of the chick eye resulting in increased ipsilateral 
projection from the ION (Clark, and Cowan, 1976). Competition at the level of the target 
tissue ( in this case the amacrine and displaced ganglion cells) is suggested by increased 
developmental cell loss in the contralateral ION. With development the ipsilateral 
pathway regresses and their soma degenerate leaving a reduced contralateral nucleus.
The precise nature of this competitive interaction remains uncharacterized; most theories 
have as their basis the failure o f unsuccessful cells to receive adequate trophic support in 
the form  o f target tissue derived trophic molecules (after Prestige, 1967; Prestige, 1970; 
Hamburger et al. 1981). It should be noted that in the case of the developing chick 
sensory system the proposed source of trophic support is the somitic and subcutaneous 
mesenchyme over which the axons traverse (Hamburger et al. 1981).
5Historically it is this competition for survival by neurons during a critical period in their 
developmental history that has formed the basis for modern neurotrophic theory. 
However the role of trophism has been extended by Purves to include the regulation of 
neuronal form (Purves, 1988; see also Cowan et al.1984). In his elegant treatise, Purves 
drew on experimental data from a variety of animal species to argue that control of 
neuronal number per se represents an "incomplete solution". Neuronal number is 
established early in development, and thus it is changes in neuronal form - i.e. branching 
of both the axonal and dendritic processes and the pattern of their connections - that 
account for the ongoing ability of the nervous system to adapt to a changing organism 
(both ontogenetic and phylogenetic changes are considered). Trophism, broadly defined 
as the " long term dependencies between neurons and cells they innervate" (Purves, 1988 
p.2), is hypothesized to account for adaptive changes in neuronal form and nature of 
synaptic contacts. As described for neuronal survival, patterns of neuronal branching are 
hypothesized to be established by competetive interactions for limited trophic resources. 
Whilst the theory does not address several specific aspects, for example the mode of 
delivery of the trophic factor and the specificity of the synaptogenesis, it does have far 
reaching implications. It is suggested as the basis of quantitative matching of pre and 
post synaptic numbers and the establishment of appropriate degrees of convergent and 
divergent innervation such that accurate neuronal maps are represented in the nervous 
system and control by motor elements is appropriate.
The NGF Paradigm.
The proposed molecular basis of neurotrophism is epitomized by the known biology of 
nerve growth factor (NGF); it serves as a 'biological standard' by which all newly 
described, putative neurotrophic factors are measured.
NGF was discovered as the mouse sarcoma derived diffusable factor responsible for 
enlargement of the spinal and sympathetic ganglia and visceral hyperinnervation 
following grafting of sarcoma fragments onto the body wall (Levi-Montalcini, and 
Hamburger, 1951) or chorio-allantoic membrane (Levi-Montalcini, 1952; Levi- 
Montalcini, and Hamburger, 1953) of the chick embryo. Coculturing of the sympathetic 
and spinal ganglia in proximity to the sarcoma fragments was found to induce a dramatic 
radial fibre outgrowth from the ganglia (Levi-Montalcini et al.1954); the fibrillar halo 
was to become the basis of a bioassay that enabled characterization and purification of the 
"Nerve Growth Stimulating Factor" (later nerve growth factor, see Cohen et al.1954; 
Cohen, and Levi-Montalcini, 1956). The fortuitous discovery of high levels of NGF in
6the submaxillary gland of the adult male mouse enabled purification of the factor in high 
yield (Cohen, 1960).
NGF would appear to satisfy the requirements of a target tissue derived neurotrophic 
factor. The increased numbers of sympathetic or sensory neurons surviving to maturity 
following systemic administration of NGF, originally thought to indicate a mitogenic 
action (Levi-Montalcini, and Hamburger, 1951; Levi-Montalcini, and Angeletti, 1968), 
are now known to reflect the augmented survival of those neurons which would 
normally die following competitive interaction in the target region (Hendry, 1977; 
Hamburger et al. 1981). Mitotic figures are restricted to reactive proliferation of satellite 
cells in response to the increased size of individual cell soma (Thoenen et al.1979). 
Developmental cell death in the rat superior cervical ganglia, amounting to a 30% loss 
between the 6th and 28th postnatal days is prevented by the daily administration of NGF 
(Hendry, and Campbell, 1976). Neurons are post-mitotic by day 4, NGF administration 
neither enhancing cell division nor reinitiating the mitotic cycle (Hendry, 1977b). A 
reinvestigation of cell death in the chick spinal ganglia (Hamburger et al. 1981) showed 
that the developmental loss of sensory neurons is prevented by the daily injection of 
NGF into the yolk sac. Interestingly both ventrolateral (VL) and dorsomedial (DM) 
populations were rescued.
Effects of anti-NGF
The single most significant piece of evidence imp licating NGF as a biologically relevant 
neurotrophic factor is the destruction of sympathetic and the sensory neurons following 
exposure to NGF antibodies during critical periods of development.
Sympathetic neurons
The term 'immunosympathectomy' refers to the selective and permanent destruction of 
the immature sympathetic neuron by daily injection of NGF antiserum into newborn 
animals (Levi-Montalcini, and Angeletti, 1966); the sympathetic ganglia of newborn 
mice, rats, cats and rabbits exposed to anti-NGF cease differentaition and degenerate 
(Levi-Montalcini, and Booker, 1960; Cohen, 1960; Levi-Montalcini, and Angeletti, 
1968). This is accompanied by a decrease in activity of the enzymes of transmitter 
synthesis (Hendry, and Iversen, 1971; Goedert et al.1978). Similar injection regimens in 
the adult rodent (>30d) result in neuronal atrophy accompanied by a decrease in size and 
fluorescence intensity of the neuronal soma, decreased noradrenalin (NA) content and 
uptake, decreased activity of the enzymes of transmitter synthesis and peripheral fiber
7dropout (Angeletti et al. 1971; Bjerre et al.1975; Goedert et al. 1978). No neuronal 
destruction is observed and all indices return to normal in 4-12 weeks. Prolonged NGF 
deprivation by "auto-immunosympathectomy" has, however, revealed trophic 
dependence of the mature sympathetic neuron. Adult rats or rabbits generating anti­
mouse NGF over several months were found to have markedly atrophic SCGs; neuronal 
number decreased by 35% (rats) and 85% (rabbits) (Johnson et al. 1982; Gorin, and 
Johnson, 1980).
Sensory neurons
Sensory neurons pass through a phase of NGF dependence during intrauterine 
development. DRG numbers in offspring of NGF immunized rats or rabbits are reduced 
70% (Gorin, and Johnson, 1979; Johnson et al.1980; Johnson et al.1982). Guinea pigs 
bom to females with high titers of anti- NGF displayed severe sensory deficits with 
DRG numbers reduced 80-85%, and rarely survived for more then a few days (Johnson 
et al.1983). Adult sensory neurons appear to be less dependent on NGF than their 
sympathetic counterparts. Autoimmune NGF deprivation results in a slight decrease in 
neuronal size (Rich et al.1984) accompanied by a decrease in substance P levels in skin, 
spinal cord and DRG (Schwartz et al.1982). This lack of dependency has been attributed 
to the provision of trophic support by central targets of the sensory neuron and possibly 
an additional peripheral trophic factor (Johnson, and Yip, 1985).
Retrograde axonal transport
Central to the neurotrophic theory has been the demonstration of specific retrograde 
axonal transport of the intact NGF molecule where it exerts biochemical and 
morphological effects. Injection of 12^ i-NGF into the anterior chamber of the eye results 
in the preferential accumulation of radioactivity in the ipsilateral superior cervical 
ganglion (Hendry et al. 1974a; Johnson et al. 1978a). Transport is abolished by 
transection of the post-ganglionic adrenergic fibres or intraocular injection of colchicine 
and is specific for the biologically active molecule (Hendry et al. 1974b; Johnson et 
al. 1978a). Autoradiography showed intense staining in a small number of SCG neurons 
which were 25% larger and found to occupy twice the cell volume when compared to 
unlabelled neurons (Hendry, 1977a). Unilateral injection of NGF into the anterior eye 
chamber increases tyrosine hydroxylase (TOH) activity by 60-70% in the ipsilateral SCG 
(Paravicini et al.1975). Similar studies have demonstrated retrograde transport of NGF 
by sensory neurons of the rat (Stockel et al.1975; Csillik et al.1985) and embryonic 
chick (Brunso-Bechtold, and Hamburger, 1979).
8More recently evidence that the NGF content of the sympathetic ganglia results from 
retrograde transport of the endogenous molecule has been obtained using sensitive 
immunoassays and hybridization assays. Although containing high concentrations of 
endogenous NGF (Korsching, and Thoenen, 1983a), very little message for NGF is 
found in adult SCG (Heumann et al.1984) or the embryonic trigeminal ganglia (Davies et 
al.1987). Furthermore, interruption of axonal transport by 6-hydroxydopamine or 
colchicine results in an increase in NGF content in the target tissue and a corresponding 
decrease in the innervating superior cervical and stellate ganglia (Korsching, and 
Thoenen, 1985b). Using the same immunoassay NGF was found to accumulate on the 
distal side of a ligature applied to the rat sciatic nerve (Korsching, and Thoenen, 1983b).
Pharmacological or surgical interruption of axoplasmic transport during critical periods 
of development results in a massive neuronal loss. Administration of vinblastine to 
neonatal rats results in degeneration of the SCG (Johnson, 1978b); TOH levels fell to 
20% control values and ganglionic volume was decreased by 60-80% (Menesini Chen et 
al.1977). Similarly, developmental cell loss in the SCG is increased to greater than 90% 
following post-ganglionic axotomy at day 6 (Hendry, 1975a). In both cases systemic 
administration of NGF prevents degeneration of the sympathetic neurons . Similarly, 
removal of the chick wing bud at E2.5 results in massive neural degeneration within the 
brachial DRG (Hamburger, and Yip, 1984). Administration of NGF over this critical 
period rescues some 50% of the ventrolateral population and all of the dorsomedial 
neurons.
NGF in target tissues
Inability to reliably detect NGF in the target tissues was, for some considerable time, the 
major stumbing block to wide acceptance of the neurotrophic theory; initial 
inconsistencies are now only of historical interest (see Thoenen, and Barde, 1980). 
Development of reliable immuno-assays capable of detecting picogram quantities of NGF 
(Korsching, and Thoenen, 1983a) have more recently allowed its unequivocal detection 
in target tissues. The concentration of NGF (Korsching, and Thoenen, 1983a) and its 
mRNA (Shelton, and Reichardt, 1984; Heumann et al.1984) show a strong positive 
correlation with the density of sympathetic innervation, adding to the body of established 
evidence suggesting the level of NGF synthesis limits innervation and is therefore 
'subsaturating'. NGF mRNA has been localized to target tissues of the sympathetic and 
sensory nervous systems by in situ hybridization (Bandtlow et al.1987).
9Both the appearance of NGF as detected by enzyme linked immunoassay and initial 
expression of NGFmRNA in target tissue correlate with the time of arrival of the 
innervating nerve fibres (Korsching, and Thoenen, 1988; Davies et al.1987). Moreover, 
neuronal expression of NGF receptors occurs at the stage of fiber contact with the 
peripheral target (Davies et al.1987). Although temporally linked, NGF expression 
occurs independently of the ingrowing nerve fibre; appearance of NGF mRNA in the 
chick hindlimb is unaffected by prior denervation (Rohrer et al. 1988).
Central neurons
Recent attention has focused on NGFs role in the central nervous system. Accumulated 
evidence along lines previously described for peripheral neurons has suggested NGF is a 
target derived survival factor for the cholinergic neurons of the basal forebrain. This 
includes: (i) retrograde axonal transport of NGF by neurons of the basal forebrain from 
their target areas in the hippocampus (Schwab et al.1979) or cortex (Seiler, and Schwab, 
1984); (ii) intraventricular administration of NGF increases CAT activity in the 
hippocampus, septum and cortex of newborn rats (Gnahn et al. 1983); (iii) 
intraventricular injection of NGF rescues neurons of the medial septal nucleus and 
vertical limb of the diagonal band of Broca following fimbrial transection (Hefti, 1986) 
and; (iv) the localization of NGF and its RNA by immunoassay and hybridization assay 
respectively. In particular, high levels of NGF were found in the hippocampus, 
neocortex, and olfactory bulb (i.e. target fields of the basal forebrain cholinergic 
neurons) and the septum, diagonal band of Broca and nucleus basalis ( regions of the cell 
bodies) (Korsching et al. 1985a; Whittemore et al.1986). The hippocampus and cortex 
also contained high levels of NGFmRNA (Korsching et al. 1985a; Shelton, and 
Reichardt, 1986; Whittemore et al.1986), although only very low levels of message were 
detected in the region of the cell bodies. Appearance of NGFmRNA is coincident with 
the development of cholinergic innervation of the hippocampus (Whittemore et al.1986). 
Further analogy with the biology of NGF in the periphery would predict the destruction 
of the NGF responsive neurons following administration of NGF antibodies at the time 
of target innervation. However the local (intraventricular and intracortical) injection of 
anti-NGF was without effect on ChAT activity in the hippocampus, cortex or septum 
(Gnahn et al. 1983). This lack of effect may be the result of poor antibody penetration in 
CNS tissue (Thoenen et al.1987).
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Criteria for a neurotrophic factor.
Several authors have incorporated the biological actions of NGF into criteria that should 
be fulfilled by newly described molecules before their acceptance as a "neurotrophic 
factor".
Hendry et al.(1981) defined a retrogradely transported neuro trophic factor or retrophin 
as a molecule which:
(i) is synthesized and released by target tissues;
(ii) is internalized at the nerve terminal (where it binds to specific receptors);
(iii) is retrogradely transported to the cell body;
(iv) has a neurotrophic effect on the particular neuronal population by which it is 
transported; and
(v) is able to replace the neurotrophic effect of the target tissue after axotomy.
Others (Thoenen, 1988; Barde, 1988; Davies, 1988; Barde, 1989; Walicke, 1989) have 
further emphasized:
(vi) limited distribution throughout the body;
(vii) the putative factor's ability to regulate survival of specific populations of neurons 
during critical periods of development; and, with reference to the competition hypothesis
(viii) limited availability, such that during normal development some neurons fail to attain 
adequate amounts of the factor and degenerate.
The 'traditional' approach
The limited activity of NGF - directed toward sensory and sympathetic neurons as well 
as specific populations of central cholinergic neurons - would suggest the presence, in 
target tissues, of analogous factors possessing similar biological activity for their 
respective innervating neurons. A large amount of effort has been expended over the last 
two decades in identifying and purifying putative neurotrophic molecules from tissue 
extracts or medium conditioned by various cell lines (Berg, 1984; Barde et al.1983; 
Thoenen, and Edgar, 1985).
The approach to isolation of such factors has been to utilize neuronal bioassays, 
originally described for NGF, whereby survival and/or neurite outgrowth by explanted 
whole ganglia or dissociated cells is taken to indicate the presence of a trophic molecule 
in the culture medium (Levi-Montalcini et al.1954; Levi-Montalcini, and Angeletti, 
1963). Such activity could be distinguished from NGF by using neuronal populations
that do not respond to NGF or incorporating NGF antibodies in the medium. An 
example of the former approach is to use cultures of E8 chick ciliary ganglion. The initial 
observations that parasympathetic neurons can be maintained in:
(i) coculture with target organs (Coughlin, 1975; Nishi, and Berg, 1977; Ebendal, and 
Jacobson, 1977; Ebendal, 1979; Ebendal et al.1980);
(ii) media conditioned over heart (Helfand et al.1976; Collins, 1978a) or skeletal muscle 
(Nishi, and Berg, 1979; Bennett, and Nurcombe, 1979) cells;
(iii) media supplemented with tissue extracts (Nishi, and Berg, 1979; Varon et al.1979; 
Tuttle et al.1980; Ebendal et al.1982; Ebendal et al. 1983; Miki et al. 1981; McLennan, 
and Hendry, 1978; McLennan, and Hendry, 1980; Bonyhady et al.1980; Hill et al. 1981; 
Bonyhady et al. 1983) led to an intensive search for the "ciliary" or "parasympathetic" 
neurotrophic factor. Many of these preparations also possessed activity for chick 
sympathetic or sensory neurons (Manthorpe et al. 1982b; Ebendal et al.1982; Ebendal et 
al. 1983; Bonyhady et al.1983; Belford, and Rush, 1983; see also Riopelle, and 
Cameron, 1981; Lindsay, and Tarbit, 1979) which was not susceptible to the presence of 
anti-NGF in the medium.
The low concentrations of trophic factor present in these preparations, the failure to 
identify rich sources of the factors and the use of time-consuming (and necessarily 
sterile) bioassays has meant these projects are long term and tedious. In terms of 
isolating identified and sequenced molecules it is only recently that some of these 
investigations have come to fruition. Indeed 1989 has been a good year for the sequence 
identification of several molecules thought to be relevant to nervous system biology 
(Leibrock et al.1989; Stockli et al.1989; Lin et al.1989; Yamamori et al.1989), largely 
due to the 'Science 1989 Molecule of the Year', DNA-polymerase (Guyer, and 
Koshland, 1989); cDNA encoding all these molecules was cloned using the polymerase 
chain reaction. The following is a brief account of the neurotrophic molecules 
successfully isolated from either tissue extract or conditioned media (although bioassay 
procedures as outlined above were not used for either purpurin or neuroleukin). It should 
also be recognized that molecules isolated on the basis of unrelated biological activities - 
for example epidermal growth factor, insulin and the insulin-like growth factors - also 
possess in vitro neurotrophic activity (see Snyder, and Kim, 1980; Morrison et al.1987; 
Recio-Pinto et al.1986; Aizenman, and de Vellis, 1987), and may well be relevant to 
neuronal biology in vivo (Walicke, 1989).
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Brain-derived neurotrophic factor (BDNF)
The initial observation that crude homogenate of rat brain possessed neurotrophic activity 
for embryonic chick sensory neurons (Barde et al.1980) led to the purification of a basic 
(pi =10) protein of MW 12.3 kD from pig brain (Barde et al. 1982). The molecule was 
distinguished from NGF by its activity in the presence of NGF antibodies and by its 
spectrum of target neurons. In particular, BDNF supports the in vitro survival of 
peripheral sensory neurons of epidermal placodal origin, including cells of the nodose 
(Lindsay et al. 1985), vestibular, petrosal, geniculate, and ventrolateral trigeminal ganglia 
(Davies et al. 1986); in addition it is neurotrophic for rat and chick retinal ganglion cells 
(Johnson et al. 1986; Rodrigeuz-Tebar et al. 1989). The latter study showed that chick 
retinal ganglion cells depend on BDNF only after the time when their axons have reach 
the tectum (Rodrigeuz-Tebar et al. 1989). Unlike NGF, BDNF fails to support 
sympathetic, and possesses little activity for dorsomedial trigeminal neurons (Lindsay et 
al.1985; Davies et al.1986). The deduced amino-acid sequence of BDNF shows striking 
homology to NGF (Leibrock et al.1989); 51 of the 114 amino acids are shared with 
NGF, raising the possibility of a family of neurotrophic factors. Like NGF, BDNF 
binds two classes of receptors on chick DRG neurons (Rodrigeuz-Tebar, and Barde, 
1988); no BDNF receptors could be identified on sympathetic neurons .
In vivo administration of BDNF to chick embryos from E3 to E7 rescues neurons of the 
DRG and nodose ganglion that normally undergo developmental cell death (Hofer, and 
Barde, 1988). In both cases neuronal numbers at E8 were similar to maximal neuronal 
number before the period of cell death. NGF was without effect on the nodose ganglion. 
BDNF also rescues neurons of the developing neuronal anlage when administered locally 
(Kalcheim et al. 1987). Early postmigratory DRG neurons separated from the neural tube 
by a silastic barrier will degenerate over the next 10 hours. If the silastic barrier is 
pretreated with both laminin and BDNF, DRG cells distal to the silastic barrier are 
maintained. Interestingly, neither BDNF on a collagen substrate nor laminin alone 
exerted the same effect. Moreover NGF/laminin was without effect. BDNF may also 
stimulate differentiation; it has been shown to promote survival and morphological 
differentiation of HNK-1 positive neurons in cultures derived from somitic tissue of 
quail embryos at the stage of neural crest migration (Kalcheim, and Gendreau, 1988).
Together these results suggest that BDNF is a centrally derived neurotrophic factor. This 
interpretation is supported by the observation that DRG neurons respond to BDNF 24 
hours before the earliest NGF response, presumably reflecting the earlier arrival of the
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central process in the spinal cord (Davies et al.1986); BDNF but not NGF 
responsiveness is lost between days E6 to E9 (Emsberger, and Rohrer, 1988). Northern 
blotting (Leibrock et al.1989) reveals a BDNF signal in central neural tissue, but not in 
any peripheral tissue tested.
Thus BDNF is rapidly assuming the status of a target tissue derived neurotrophic factor 
of the same molecular family as NGF. It is present in target tissue in low abundance and 
is effective in supporting specific populations of neurons during the stage of target field 
innervation. Although several of the criteria listed above remain to be fulfilled - for 
example whether the factor is retrogradely transported by responsive neurons and its site 
of synthesis within the nervous system- its recent cloning and expression (Leibrock et 
al.1989) should facilitate answers to these questions. Possible neurotoxic effects of anti- 
BDNF will be of particular interest.
Ciliary neurotrophic factor (CNTF)
Initial characterization of ciliary neurotrophic activity utilized, logically, extracts of 
embryonic chick eye tissue (Manthorpe et al.1980). The in vivo relevance of such 
activity was suggested by its relatively high specific activity in extract of choroid, ciliary 
body and pigment epithelium (Adler et al.1979), along with a developmental increase in 
total and specific activity at the time when ciliary ganglionic neurons are establishing 
functional connections with their targets (Landa et al.1980). Although characterized on 
the basis of its activity for embryonic chick ciliary neurons, the extract also maintained 
both sympathetic and DRG neurons in culture (Manthorpe et al. 1982a).
Pure CNTF was initially isolated from eye extract as an acidic protein of MW 20.5 kD 
(Barbin et al.1984) and later from rat sciatic nerve (MW 24 kD; Manthorpe et al.1986); 
both preparations supported not only ciliary but chick and mouse derived sensory and 
sympathetic neurons. cDNA of rat (Stockli et al.1989) and rabbit (Lin et al.1989) sciatic 
nerve CNTF have recently been cloned and shown to code for acidic proteins of MW 
22.8 and 22.7 kD respectively. The deduced amino acid sequence does not show 
significant homology with any other known protein.
The initial contention that CNTF is a target derived neurotrophic agent (eg Barbin et 
al.1984) has recently been treated with scepticism by some reviewers (Davies, 1988; 
Barde, 1988). Indeed the known biology does not comply with the neurotrophic criteria 
set out above. The molecule does not display significant specificity with regard to 
neuronal type and its abundance in target tissue (a purification factor of only 25,000 is
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required, see Lin et al.(1989) and Manthorpe et al.(1989), compared to 106 for BDNF) 
make it unlikely to be limiting neuronal survival. The absence of a signal peptide and 
glycosylation consensus sequence (Stockli et al. 1989; Lin et al. 1989) are more 
characteristic of a cytosolic rather than a secreted protein. Expression of the CNTF 
cDNA clone in HeLa cells (Stockli et al.1989) or COS-7 cells (Lin et al. 1989) does not 
result in active protein released into the culture medium; in both cases however, cell 
extract contained CNTF activity. Similarly type-1 astrocytes release CNTF activity into 
culture medium only when injured (Raff, 1989). Northern blots reveal a strong CNTF 
signal in sciatic nerve (Stockli et al.1989): the absence of a signal in either muscle or skin 
make it unlikely that the molecule is retrogradely transported. Furthermore CNTF activity 
appears in the sciatic nerve after the time period of cell death.
It is possible CNTF serves other functions in the developing nervous system. CNTF 
inhibits the proliferation of E7 chick sympathetic neurons and induces the expression of 
vaso-active intestinal polypeptide (VIP) immunoreactivity (Emsberger et al.1989). A 
similar instructive action has been demonstrated for E8 chick neural retinal cells; 
dissociated cultures grown in the presence of CNTF were found to express increased 
levels of CAT activity compared to controls (Hofmann, 1988). CNTF has also been 
implicated in glial maturation. Low concentrations (IO'11!'*!) of the molecule mimic the 
effect of optic nerve extract in inducing GFAP expression in 0-2A  progenitor cells 
(Hughes et al.1988). The effect is transient however, and it is probable other factors 
maintain the type-2 astrocyte phenotype.
Purpurin
Purpurin was isolated from embryonic chick retinal cell adherons (see Schubert et 
al.l983a) as a heparan sulfate binding 20kD MW protein (Schubert, and LaCorbiere, 
1985a) - the molecule was named after its purple appearance on silver stained gels. When 
plated out as a substrate purpurin maintains both a subpopulation of E10 chick neural 
retinal cells (Schubert, and LaCorbiere, 1985a) and E8 chick ciliary ganglionic neurons 
(Schubert et al. 1987a) in dissociated cell culture. The molecule also promotes adhesion 
of chick retinal cells to the substratum, an effect inhibited by anti-purpurin antibodies. 
The primary sequence of purpurin (Berman et al. 1987) shows some 50% homology to 
human serum retinol binding protein and is able to bind 3H-retinol. Purpurin mRNA is 
localized to the neural retina of the adult and embryonic chick; no signal was detected in 
brain, heart or liver. In situ hybridization revealed the site of synthesis as the 
pho toreceptor cell layer, although in terestingly  the protein itse lf was
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immunohistochemically localized to the extracellular space between the photoreceptors 
and the pigment epithelium.
The function of purpurin in vivo remains obscure: it has been suggested that it is 
involved in the transport of retinol between cells of the neural retina and pigment 
epithelium. In addition its association with adherons (which can be incorporated into the 
extracellular matrix; Schubert et al. 1983b), and its ability to interact with cell surface 
heparan sulfate proteoglycans ( the putative receptor for adherons, Schubert, and 
LaCorbiere, 1985b), make it a candidate for a matrix adhesion molecule. Adherons in 
their native (in vitro ) form were immunohistochemically localized to the filopodial tips of 
cultured retinal cells and seen as filamentous clusters connecting cell surfaces and the tips 
of the filopodia to the substrate (Tsui et al. 1988). Purpurin's role as a possible in vivo 
neurotrophic agent remains to be investigated. In particular, information regarding 
possible neurotoxic effects of anti-purpurin is, as yet, unavailable.
Neuroleukin
Neuroleukin is a 63kD basic protein that generated considerable interest as a neurotrophic 
factor for sensory and possibly motor neurons (Gurney et al. 1986b), as well as a 
product of stimulated T-cells that directs immunoglobulin secretion by cultured B-cells 
(Gurney et al. 1986a). Its isolation from mouse salivary gland (Gurney et al. 1986b) was 
preceded by evidence that the 56 kD antigen stimulates terminal sprouting of motor 
axons. Polyclonal (Gurney, 1984) and monoclonal (Gurney et al. 1986c) antibodies 
raised against fractions of muscle cell conditioned media were found effective in 
suppressing botulinum toxin induced axon terminal sprouting. All biologically active 
antibodies recognized a 56 kD antigen on immunoblots of the conditioned media. Rats 
developing a high titre against the antigen showed weight loss, muscle wasting and 
motor deficits (Gurney et al. 1986c). Moreover the sera of some patients with motor 
neuron disease was found to inhibit axonal sprouting and contained antibodies that 
recognized the 56 kD antigen
The purified factor supported the in vitro survival of both E8 sensory and E10 spinal 
cord neurons (Gurney et al. 1986b) as well as septal and hippocampal neurons (Gumey, 
1989). Survival activity was blocked by the same monoclonal antibodies effective in 
inhibiting terminal sprouting by motor axons in vivo (see Gumey et al. 1986c).
The deduced amino acid sequence shows some homology to the Human 
Immunodeficiency Virus (HIV) external envelope protein (gpl20) and led to speculation
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on the possible role of neuroleukin in AIDS dementia (Gurney et al. 1986b). Indeed 
detergent disrupted HIV or Simian Immunodeficiency Virus (SIV) was found to be toxic 
for neuroleukin, but not NGF dependent neurons in vitro (Lee et al. 1987). The effect 
was reproduced by addition of purified gpl20 or a bacterially expressed fragment of 
gpl20.
The subsequent identification of neuroleukin as glucose-6-phosphate isomerase (Chaput 
et al. 1988; Faik et al. 1988; Gurney, 1988) has necessitated some reevaluation of its 
neurotrophic role. Interestingly, monoclonal antibodies that block its neurotrophic action 
were without effect on its enzymatic activity (Gurney, 1988). It remains possible that 
different epitopes on neuroleukin subserve distinct functions, although its ubiquity and 
necessary function in the glycolytic pathway ( therefore being subject to the feedback 
controls of intermediary metabolism) make it unlikely to be a neurotrophic factor in the 
classic sense.
Aims of the present study
The remainder of this thesis describes the characterization and identification of a 
neurotrophic molecule present in extract of bovine cardiac muscle (McLennan, and 
Hendry, 1978; McLennan, and Hendry, 1980; Hill et al. 1981; Bonyhady et al.1982) as 
well as an investigation of its possible role in vivo. It is also recognized that neurotrophic 
molecules do not act alone; indeed it is likely their activity in vivo is modulated by a 
variety of soluble and matrix-bound components. Examples include the interaction 
between BDNF and laminin (Lindsay et al. 1985; Kalcheim et al. 1987), NGF and 
laminin (Edgar, 1985), and interleukin-1 and NGF (Lindholm et al.1987); further 
examples are presented in the introductions to chapters 4 - 6. In this context, these last 
three chapters describe the interaction between the beef heart factor and heparin, a variety 
of other glycosaminoglycans and retinoic acid respectively.
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Chapter 2
Identification of the beef heart-derived parasympathetic neurotrophic 
factor
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Introduction
The presence of 'ciliary' neurotrophic activity in crude extract of cardiac muscle was 
initially described some 10 years ago (McLennan, and Hendry, 1978; McLennan, and 
Hendry, 1980; Hill et al.1981). Beef heart derived activity was characterized as an acidic 
protein, the MW varying with ionic strength of the solution (Bonyhady et al.1980; Hill et 
al.1981; Hendry et al. 1983; Bonyhady et al.1982). In 20mM Tris/HCl the factor eluted 
from a gel filtration column with a MW of around 50,000; the presence of EDTA or high 
concentrations of NaCl in the eluting buffer resulted in the appearance of neurotrophic 
activity in the 15-30,000 MW pool. The reversal from low to a high MW complex on 
exposure to low ionic strength was thought to be consistent with a multi-subunit 
structure or presence of a carrier molecule bound to the active 20,000 MW form. The 
physico-chemical characteristics of the heart-derived factor were shared by similar 
activity in chick embryo extract (Ebendal et al.1982; Ebendal et al. 1983; Lindsay, and 
Tarbit, 1979; Riopelle, and Cameron, 1981), a preparation from the chick eye 
(Manthorpe et al.1980; Manthorpe et al. 1982b) and activity present in the extract of a 
chick smooth muscle (Belford, and Rush, 1983).
The application of heparin affinity chromatography to a partially purified beef heart- 
derived factor (see Bonyhady et al.1982) resulted in the isolation of an essentially 
homogeneous neurotrophic preparation (Watters, and Hendry, 1987). The factor eluted 
from heparin with 1.1M NaCl and was characterized as an acidic protein of reported MW 
22-23kD.
The present chapter describes further characterization of this neurotrophic factor and its 
identification as a class 1 heparin binding protein. Concerning the nomenclature used 
here, the term acidic fibroblast growth factor (aFGF) is reserved for the amino-terminally 
truncated form of the molecule purified from bovine brain under acidic conditions (Lobb 
et al. 1986). ß-endothelial cell growth factor was the term originally applied to the full 
length molecule extracted under neutral conditions (Burgess et al.1986); both molecules 
are class 1 heparin-binding growth factors (HBGF-1). Basic fibroblast growth factor 
(bFGF), purified from bovine brain (Gospodarowicz et al.1984), has been classified as a 
class 2 heparin-binding growth factor (HBGF-2; Lobb et al.1986; Burgess, and Maciag, 
1989) and is sometimes referred to as such. Some of the results presented in the current 
chapter are discussed in chapter 3.
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Materials and Methods
Neuronal bioassay
Cultures of E8 chick ciliary neurons were established in collagen coated 96-well 
microtitre plates (Nunc, Copenhagen) as previously described (Bonyhady et al.1980; 
Bonyhady et al. 1982). Ganglia were dissected aseptically, dissociated with trypsin 
(0.08%; Worthington Biochemical Coorporation, NJ) in calcium and magnesium free 
Hanks balanced salt solution and suspended in Dulbecco's modified Eagles medium 
(DMEM; Flow L aborato ries) buffered  to pH 7.4 w ith 0.5M  N-2-
hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES) and containing 1% horse 
serum (Commonwealth Serum Laboratories, Parkville, Victoria). Dissociates were 
routinely preplated to remove non-neuronal cells. Samples to be assayed were diluted in 
the growth medium (DMEM-HEPES /  1% horse serum) and added to the top well in a 
final volume of lOOjil, and a dilution series set up across the plate. Neuronal cell 
suspension (lOOjil; ~ 2,200 neurons) was added to each well and incubated for 24 hours 
at 37°C in a humidified air incubator. Cytosine arabinoside (10’5M) was incorporated 
into some cultures to suppress the proliferation of non-neuronal cells. Neuronal survival 
was assessed by phase contrast microscopy (200 x magnification); the number of phase 
bright adherent cells in four fields (-11% of total area) across the diameter of each well 
was recorded. Dissociated cultures of embryonic chick sensory and sympathetic neurons 
were established in the same manner.
BALB/c3T3 mitogenesis assay
Stock cultures of BALB/c3T3 cells (Commonwealth Serum Laboratories, Parkville, 
Victoria) were maintained in DMEM/HCO3 /10% fetal calf serum (FCS; CSL 
Parkville,Victoria) at 37° (5% CO2 incubator) in 60ml flasks (Coming, N.Y.). Prior to 
confluency, cultures were lightly trypsinized (0.025%, lOmins), resuspended at 15,000 
cells/ml and replated. Experimental cultures were seeded into 96 well plates (Nunc, 
Copenhagen, Denmark) and allowed to reach confluency (4-5 days) at which time the 
medium was replaced by serum-free DMEM/HCO3. After 24 hrs serum deprivation the 
beef heart derived factor was added at various concentrations in the presence and absence 
of 50p.g/ml heparin, and incubated for 24hrs before the addition of ^H-thym idine 
(Amersham, U.K.). After a further 24hrs incubation the cells were frozen and thawed 
twice and harvested onto glass fibre (Enzo Biochem. Inc., N.Y.) using a Titertek 530 
cell harvester (Flow Labs). The fibre discs were placed in scintillation vials (Packard
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Instrument Co., ILL) containing scintillation fluid (2.5mls; 2 parts xylene, 1 part triton X 
114, + diphenyloxazole 0.5%) and counted.
Isolation of factors
Purification of the ciliary neurotrophic factor from bovine heart was routinely undertaken 
according to the method of W atters, and Hendry, (1987), with the following 
modifications: (i) the active fractions from the second gel filtration column (sephadex G- 
100; 0.1M Tris pH 8.0, 0.5M NaCl) were pooled, diluted 1:2 with distilled H2O and 
pumped directly over a heparin-agarose (Biorad, Richmond, CA) column (Pharmacia 
K 16/20) at 2 mis per minute. By reducing the losses associated with concentration over a 
Amicon membrane and the subsequent loading of small volumes onto the heparin 
column, the substitution of this step resulted in a 2-fold increase in yield; 250g of heart 
muscle yielded about lOOfig of purified factor; (ii) the heparin-agarose column was 
washed and eluted with NH4HCO3 instead of NaCl. This allowed immediate 
lyophylization of the pure factor which was stored dessicated at 4°C for several months 
without loss of activity. Purified fractions to be used for reverse phase chromatography 
were eluted from the heparin column with NaCl. Acidic and basic FGF were purified 
from bovine brain according to published procedures (Lobb, and Fett, 1984; Lobb et 
al. 1986). All preparations were routinely checked for purity by SDS-PAGE.
Heparin binding proteins present in bovine heart were isolated by passage of the crude 
extract over heparin-agarose packed into a Pharmacia K 16/20 column followed by 
washes with phosphate buffered saline (PBS) and 0.4 M NH4HCO3. Heparin-binding 
proteins were eluted with a 0.4 - 1.5 M NH4HCO3 gradient over 20 minutes, 
lyophylized and stored dessicated at 4°C.
Iodination of the factor
125I-labelling of the factor was acheived by several methods.
(i) The chloramine-T method was used as recently described (Hendry, 1989). Briefly, 
lOpig of HBGF were mixed with 5mCi of Na 125I (Amersham) to which 10|ig of of 
chloramine-T was added in lOOjil of Tris-HCl pH 8. The reaction was stopped after 30 
minutes with 20}ig of Na2S20s.
(ii) Iodogen (l,3,4,6-tetrachloro-3a,6a-diphenyl glycoluril; Pierce Chemical Company, 
USA) was dissolved in dichloromethane at a concentration of 6.5mg/25mls; lOOjil of 
this mixture was dried to the bottom of several acid washed tubes which were stored 
dessicated for future use. A 10|il aliquot of 1 mg/ml HBGF in bicarbonate buffer pH 8.6
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was added to the reaction tube along with 1 mCi Na 12^I solution, and the reaction 
allowed to proceed in an ice bath for 10 minutes. The reaction was terminated by 
aspiration of the mixture which was allowed to stand for 15 minutes before separation of 
the protein from the unreacted iodide. NGF, horse radish peroxidase (HRP), and bovine 
serum albumin (BSA) were labelled by this method.
(iii) The Bolton and Hunter reagent (N-succinimidyl 3-(4-hydroxy, 5-[125I]iodophenyl) 
propionate; Amersham) was used as described (Bolton, and Hunter, 1973). Briefly, a 
10|ig aliquot of HBGF was added to the dried reagent in borate buffer pH 8.5 and the 
mixture agitated for 15 minutes on ice. Unreacted ester was neutralized by the addition of 
0.2M glycine in borate buffer pH 8.6.
(iv) Enzymobeads ( an immobilized preparation of lactoperoxidase and glucose oxidase: 
Biorad, Richmond, CA) were used according to the instructions of the manufacturer. 
Briefly, lOpg of HBGF in 50ql of 0.2M phosphate buffer pH 7.2 were added to a 
reaction mixture consisting of 50|il of rehydrated Enzymobead reagent, 25|il of 1% 
glucose and 1 mCi of N a125I, and allowed to stand at room temperature for 15 minutes. 
The enzymobeads were removed by centrifugation.
Labelled protein was separated from unreacted iodine by gel filtration using Biogel P4 
(Biorad, Richmond, CA) packed in a Pasteur pipette equilibrated in PBS/1 % BSA. The 
specific activities of the various preparations ranged from l-10|i Ci /  |ig HBGF.
In addition, 125I-HBGF-1 and HBGF-2 were obtained as a gift from Amersham.
Reverse phase chromatography
Purified beef-heart factor and aFGF were applied directly to a Pharmacia Pro RPC 
column (HR5/20) equilibrated in 0.1% TFA. The protein was eluted with a 0 - 50% 
acetonitrile gradient over 100 minutes using a Pharmacia FPLC system. Flow rate was 
300p.l /  minute and fractions were collected every 2 minutes. A 100 p.1 aliquot of each 
fraction was placed in a collagen coated 96 well tissue culture plate (Nunc, Copenhagen) 
and vacuum dried overnight. Each fraction was reconstituted in DMEM-HEPES 
containing 1% horse serum and assayed for neurotrophic activity using E8 chick ciliary 
neurons as described above.
Enzymatic digestion o f the beef-heart derived factor
Active fractions from the Pro RPC column were vacuum dried (Speedvac Concentrator, 
Savant Instruments, Inc.) and oxidized with performic acid. A 1ml solution of performic 
acid was made up from 900|il of formic acid (99%; Ajax Chemicals, Auburn, Australia)
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and 100|il of H2O2 (30%; BDH Chemicals, Victoria) and allowed to stand at room 
temperature for 1 hour. lOOjil of performic acid was added to 50fig of the pure protein 
and vacuum dried over a period of about 1 hour. Tryptic digestion was carried out with 
TosPheCH2Cl-treated trypsin (Worthington Biochemical Corporation, NJ) in ammonia 
solution at pH 9 at 37°C for 16 hours. The enzyme substrate ratio was 1:50. 
Chymotryptic digests were carried out in dilute ammonia at pH 9 for 4 hours at 37°C at 
an enzyme substrate ratio of 1:50.
HPLC separation o f the peptides
Peptides were separated by reverse-phase HPLC using an Aquapore RP-300 (2.1 x 
200mm) column (ABI, Foster City, CA) equilibrated in 0.1% TFA. Peptides were eluted 
with a 0 - 60% gradient of acetonitrile over 60 minutes using a Hewlett-Packard 1090M 
equipped with a diode-array detector and Chemstation (HP,D-7030, Böblingen). The 
flow rate was 300|il per minute. Fractions were monitered at 220, 230 and 280nm and 
peaks were collected manually.
Sequence determination
50 - 100 pmol of peptides were sequenced using an Applied Biosystems pulsed liquid 
phase 477A microsequencer equipped with an on line 120 PTH analyser. All chemicals 
were supplied by Applied Biosystems (ABI, Foster City, CA).
Polyacrylamide gel electrophoresis
Acrylamide, bis-acrylamide, sodium dodecyl sulfate (SDS), N,N,N',N'- 
tetramethylethylenediamine (TEMED), ammonium persulfate, glycine and coomassie 
brilliant blue R-250 were from Biorad (Richmond, CA). Tris base, tris-HCl and 
dithiothrietol (DTT) were from Sigma Chemical Co. (St. Louis, MO). Sample buffer 
used throughout the study consisted of 10 mis glycerol, 12 mis 'upper Tris' (7.46g tris 
HCl, 0.322g tris base in 100 mis distilled H2O) and 3g SDS made up to 100 mis with 
distilled H2O; when required DTT was added at 15mg / ml. Apparatus used was either 
the Mighty Small II SE 250 (Hoefer Scientific Instruments, San Francisco; 8cm x 5cm x 
0.75mm gels) or SE 500 Dual Slab Unit (Hoefer Scientific Instruments; 14cm x 10cm x 
0.75mm gels). Slab gels were run using the buffer system of Laemmli (1970) at a 
constant current of 20mA per gel, and stained with either coomassie blue or silver by the 
method of Merril et al.(1984).
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Isoelectric focussing (IEF-PAGE) was carried out in 5% polyacrylamide gels 
incorporating pH 3.5-10 Ampholines (Biorad). Gels were poured on a capillary gel 
caster (Biorad) and samples run at a constant power of 5 watts for 3 hours on a Model 
1415 Electrophoresis Cell (Biorad), fixed in 20% trichloroacetic acid and silver stained 
by the method of Merril et al.(1984).
Gels were routinely dried on a Model 443 slab dryer (Biorad) and stored.
Polyclonal antibodies
40|ig of purified beef factor emulsified in complete Freunds adjuvant (Difco, Detroit) 
were injected into two rabbits. Rabbits were bled 7-10 days after booster injections 
(20qg factor in complete Freunds) at 4 weekly intervals. Collected blood was allowed to 
clot overnight then centrifuged and stored in aliquots at -20°C.
Immunoblots
Heparin-binding proteins were dissolved in sample buffer and electrophoresed on an 
11% 14cm x 10cm x 0.75mm polyacrylamide gel. The separated proteins were 
transferred to nitrocellulose (Schleicher and Schull, W. Germany, 0.45|i) using a LKB 
2117 Multiphor II semi-dry electrophoresis system according to the instructions of the 
manufacturer. After blocking in a solution of 50mM Tris pH 7.4 containing 0.2M NaCl, 
3mg/ml bovine serum albumin (BSA; Armour Pharmaceutical Co., Eastbome, U.K.) 
and 1 mg/ml polyethylene glycol (Sigma Chemical Company, St. Louis) for 2 hours the 
nitrocellulose was exposed overnight to a 1:1000 dilution of the polyclonal anti-beef 
heart factor. Bound antibody was detected using alkaline phosphatase conjugated anti­
rabbit (Sigma, St. Louis) at a 1:400 dilution. Nitro blue tetrazolium / bromo chloro 
indoyl phosphate were used as the substrate. [Note that this method is different to, and a 
considerable improvement on, the method presented in chapter 3.]
Results
In vitro biological activity of the factor 
Neurotrophic activity
The spectrum of activity of the beef heart-derived factor was determined by 24 hour 
neuronal survival bioassays using neurons of chick sympathetic, sensory, and ciliary 
ganglia. Figure 2.1 shows dose response curves for neurons dissociated from E6 to E l8
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Figure 2.1 shows survival curves for ciliary, sympathetic, and sensory neurons dissociated 
from E6-E18 chick embryos. Cultures were established as described in Methods; approximately 
2200 neurons were added to each well. The x-axis represents the concentration of beef-heart 
derived factor (ng/ml). The y-axis shows 24 hour neuronal survival. Each point represents the 
average of duplicate cultures.
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chick embryos. At no stage did sympathetic neurons respond to the factor over the 
concentrations tested; addition of factor to the medium (0.3 - 100ng/ml) did not increase 
survival above control levels and no convincing dose-response curve could be 
demonstrated. Similarly, the beef heart-derived factor did not support the in vitro 
neuronal survival of sympathetic neurons dissociated from newborn rats (C.E. Hill 
unpublished observations). Beef heart-derived factor is, however, active over both 
ciliary and sensory neurons; survival at 24 hrs culture is enhanced as a function of factor 
concentration. The survival response peaks at E8-E10, then gradually decreases. A factor 
induced increase in sensory neuronal survival is still evident at E l8 at which time the 
number of ciliary neurons at 24 hrs culture is negligible.
Mitogenic activity
The characteristics of the beef heart factor - viz, an acidic heparin-binding protein of MW 
~ 18 kD (see below) - are shared by a group of mitogens recently classified as class 1 
heparin-binding factors (Lobb et al. 1986; Klagsbrun et al.1987; Burgess, and Maciag, 
1989; see discussion). Possible mitogenic activity of the beef heart factor was assayed 
using quiescent cultures of BALB/c3T3 cells in serum-free medium. Figure 2.2 shows 
3H-thymidine incorporation by 3T3 cells increases as a function of factor concentration. 
Maximal mitogenic activity was seen at factor concentrations around 100ng/ml, a figure 
consistent with the mitogenic potency of acidic-fibroblast growth factor (aFGF) for a 
variety of mesoderm-derived cells (Gospodarowicz, 1987). It was also noted that the 
addition of heparin (50|ig/ml) potentiated the mitogenic potency of the beef heart factor 
for 3T3 cells. This result is shown and elucidated further in chapter 4.
Physico-chemical characteristics of the factor
Molecular weight (MW)
The molecular weight of the factor was determined by gradient (5-30%) and 
homogenous (15%) SDS-PAGE. An example of each is shown in figure 2.3. In both 
cases the pure factor consistently ran below the 21.1 kD standard (soybean trypsin 
inhibitor; STI). Because of previous confusion (Watters, and Hendry, 1987) Figure 
2.3B, lane 1 shows the position of STI from an independent preparation included on the 
gel to 'standardize' the standards. Moreover, standards were stained with commassie 
blue to avoid misindentification of possible contaminants that may be revealed by silver 
staining (see figure 2.3C, lane 1). MW determined by linear regression (inset figure 2.3) 
was 17.9 ± 0.7 kD (n=6). Also shown is aFGF from bovine brain which purifies as a
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Figure 2.2 shows the mitogenic activity of the beef heart-derived factor for quiescent cultures of 
BALB/c3T3 cells. Incorporation of 3H-thymidine is shown on the y-axis as counts per minute (CPM). Each 
point represents the average and standard error of quadruplicate determinations.
15% gel
Figure 2.3 shows homogenous (A,C) and gradient (B) SDS-PAGE of the pure factor. Gel A and the 
standards in gel B were stained using coomassie blue. The factor in gels B and C was silver stained. A. 
lane 1: aFGF purified from bovine brain; lane 2: pure beef heart derived factor; lane 3: standards. B. 
lane 1: soybean trypsin inhibitor; lane 2: standards; lane 3: pure beef-heart factor. C. lanel: standards; 
lanes 2 and 3 are samples of the factor purified in the presence and absence of protease inhibitors 
respectively. The inset shows an example of linear regression using the four lowest MW standards. The 
molecular weight standards are: phosphorylase b, 94kD; bovine serum albumin, 67kD; ovalbumin,
43kD; carbonic anhydrase, 30kD; soybean trypsin inhibitor, 21.1kD; a-lactalbumin,14.1kD.
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minor high MW component and a closely spaced lower MW doublet (Gospodarowicz, 
1987) seen as a single band on this coomassie blue stained gel see (2.3A, lane 1). The 
minor HMW component from bovine brain runs to approximately the same position ( 
taking into account the load ) as the pure beef heart factor.
The discrepancy between the reported MW of 22-23 kD (Watters, and Hendry, 1987) 
and that determined here may be a result of the presence or absence of protease inhibitors 
included during the initial extraction of the beef heart. To test this, heart extracted in the 
presence and absence of protease inhibitors (phenylmethylsulfonyl flouride, 10'4M; 
benzamidine, ImM; aprotinin, 5|ig/ml; antipain, 0.5|ig/ml; and pepstatin, 0.1|ig/ml) was 
used as source material for purification of the factor and samples of each preparation 
subject to SDS-PAGE. Figure 2.3C shows both samples to be of identical MW.
Isoelectric point (pi)
The acidic nature of the pure beef heart-derived factor was confirmed by IEF-PAGE. As 
shown in figure 2.4 the factor migrates between standards of pi 5.2 and 5.85 with an 
isoelectric point of approximately 5.5. This result confirms previous estimates of pi 
using impure biologically active fractions (Bonyhady et al. 1980; Watters, and Hendry, 
1987).
Reverse phase chromatography (RPC)
Reverse phase analysis of the heparin fraction was undertaken for several reasons. It 
remained possible that the activity of the purified beef heart preparation was due to a 
biologically potent contaminant present in low concentration (both NGF and bFGF 
possess in vitro neurotrophic activity at picomole concentrations). If this were the case 
neuronal survival activity would not be expected to correspond to the main protein peak 
eluting from a RPC column. In addition the retention time of the beef heart factor was 
compared to that of aFGF purified from bovine brain. Lastly, RPC is a useful method of 
further purifying, concentrating and desalting the factor preparation for further analysis.
Figures 2.5A and 2 6A show the elution profiles of the beef heart factor and aFGF 
respectively. The beef heart factor eluted as a single peak at 69 mins corresponding to 
32% acetonitrile. aFGF eluted as two peaks (presumably representing aFGF-1 and 
aFGF-2, see discussion and figure 2.9) at 76 and 78 mins in 38% acetonitrile. Neuronal 
survival activity was associated with the main protein peaks of both preparations (figures 
2.5B and 2.6B). The retention of biological activity by the beef heart factor after RPC is
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Figure 2.4: EEF-PAGE of the pure beef heart-derived factor. Standards are stained with coomassie blue. 
The arrow indicates the point of origin.
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Figure 2.5A shows the RPC chromatogram of the beef heart factor purified by heparin-affinity 
chromatography. 25p.g of the factor was loaded onto a Pro RPC column and eluted with a Unear gradient of 
acetonitrile (dashed line). Neurotrophic activity of each fraction is shown in B.
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Figure 2.6A aFGF (purified from bovine brain) was chromatographed under identical 
conditions to those described for the beef heart factor (figure 2.5). Neurotrophic activity 
of each fraction is shown in 2.6B.
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noteworthy. This is a characteristic of the acidic (or class 1) but not the basic (class 2) 
heparin binding proteins (Thomas, 1987b; Gospodarowicz, 1987). By the same token 
the presence of additional neurotrophic activity, distinct from the main protein peak and 
susceptible to the conditions of RPC, is not excluded by this result.
Protein microsequencing
Despite possessing several features consistent with classification as a class 1 HBGF, 
RPC revealed that the beef-heart derived factor is in some way distinct from the 
archetypal member of this class, aFGF purified from bovine brain. Protein sequencing 
was undertaken to confirm the identity of the beef heart-derived factor. The 69' fraction 
from the RPC (figure 2.5A) was vacuum dried, reconstituted, and a 10|ig sample loaded 
onto the disc of a Applied Biosystems model 477A microsequencer. However, no 
meaningful signal was obtained; PTH-amino acid recovery was low (3-5pmol) and 
inconsistent. It was concluded that the factor was blocked to N-terminal degradation.
A further sample was therefore oxidized and subject to enzymatic degradation as 
described in methods. HPLC separation of tryptic and chymotryptic fragments is shown 
in figures 2.7 and 2.8. Selected peaks, designated either T (tryptic) or CT 
(chymotryptic), were successfully sequenced. Initial PTH-amino acid recovery was 
between 30 and 50 pmol. As shown in figure 2.9 all peptides were identified as part of 
the known sequence of the 'parent' HBGF-1, ß-endothelial cell growth factor (Burgess 
et al.1986). Two of the peptides (T8,T10) yielded no sequence; presumably one of these 
is the N-terminal tryptic fragment. By analogy to the full length acidic mitogens purified 
from bovine brain (Burgess et al.1986; Crabb et al. 1986b), it is probable that the N- 
terminus is blocked by an acetyl group and this modificarion accounts for the 
chromatographic behaviour on RPC that distinguishes the beef heart factor from aFGF.
Retrograde transport
Pure beef-heart or brain derived HBGF-1 was iodinated using several techniques. In 
addition 125I-aFGF and 125I-bFGF was obtained as a gift from Amersham,U.K. 
Biological activity was tested by the ability of the labelled preparation to induce 
proliferation in quiescent 3T3 cultures. In addition binding studies using monolayer 
cultures of 3T3 cells confirmed the ability of the given factor to bind cell surface 
receptors (figure 2.11 B,C). 125I-HBGF-1 labelled using the Bolton and Hunter reagent 
was significantly less active in inducing 3T3 cell proliferation than the other preparations.
FIGURE 2.7
T 1 mo C m 1n . )
FIGURE 2.8
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Figure 2.7 Separation of tryptic fragments of the beef heart-derived factor by RP-
HPLC using an Aquapore RP-300 (2.1 x 200mm) column. Peptides were eluted using a 
0 - 60% acetonitrile gradient over 60 minutes. Flow rate was 300pi per minute.
Figure 2.8 Separation of chymotryptic fragments of the beef heart-derived factor using 
identical conditions.
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Labelled HBGF-1 or HBGF-2 (0.5 - 2qCi in 1 - 5jil PBS / 1% BSA) was injected into 
the anterior chamber of newborn chicks. The ciliary and sympathetic ganglia were 
removed under a dissecting microscope at 6, 12, 16, 24 and 36 hours after injection and 
the accumulated radioactivity measured in a gamma counter. Retrograde transport of 
125i_NGF was used to control for the experimental procedure.
After injection of labelled HBGF into the anterior chamber of the eye, it should have 
access to both sympathetic and parasympathetic nerve terminals in the iris. However, 
over many experiments, using all 125I-labelled preparations, there was no convincing 
retrograde transport of either HBGF-1 or HBGF-2 to the cell bodies of either the ciliary 
or superior cervical ganglia at 16 hours after injection (figure 2.10 A and B). The small 
amount of radioactivity accumulating in the ipsilateral ganglia was equivalent to that seen 
following the injection of BSA or HRP of similar specific radioactivity (figures 2.10 C 
and D). Moreover no significant transport was seen at any time point examined (Table
2.2) . The addition of heparin (500|ig/ml) to the injection mixture did not increase the 
amount of transport (figure 2.11 A). These results are in contrast to the significant 
transport of NGF to the ipsilateral superior cervical ganglion (figure 2.11 B). The 
method of iodination did not significantly affect the degree of transport seen (Table 2.1). 
Similarly, no significant transport was seen after injection of HBGF-1 into the vitreous 
where choroid neurons of the ciliary ganglia have access to the labelled factor (Table
2 .2 )  .
Does the factor exist in high molecular weight (HMW) form
Heparin-binding proteins present in freshly extracted heart muscle were isolated by 
heparin-agarose chromatography as described in methods (figure 12A). Figure 12B, lane 
2, shows a SDS gel of the heparin binding proteins eluted with a 0.4 - 1.5 M NH4HCO3 
gradient. HBGF-1 is readily identifiable as the prominent 18kD band; one-dimensional 
scanning of a CB stained gels showed that HBGF-1 accounts for some 10-30% of eluted 
protein. This percentage can be increased by repeated passage over the heparin-agarose 
column. Electrophoretic transfer of the heparin binding fraction onto nitrocellulose, 
followed by probing with polyclonal antibodies generated against pure beef heart factor 
resulted in the visualization of both HBGF-1 and a fainter high molecular wieght 
component (figure 2.12 B lanes 3 and 4). Both bands are susceptible to pre-adsorbtion 
of the antibody with HBGF-1 purified from either beef heart or brain (2.12 B lane 5). 
Neither band is evident if the primary antibody is replaced with preimmune serum (2.12 
B lane 6).
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Figure 2.10 shows the accumulated radioactivity in the ciliary and superior 
cervical ganglia of newborn chicks 16 hours after the injection of 0.5 (iCi of 125 I- 
labelled: A. HBGF-1; B. HBGF-2; C. Horse-radish peroxidase and; D. Bovine 
serum albumin.
300 n
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Figures 2.11 A and B show the accumulated radioactivity in the ciliary and 
superior cervical ganglia of newborn chicks 16 hours after the injection of 0.5 
|iCi of 125I-labelled: A. HBGF-1 mixed 1:1 with lmg/ml heparin and B. NGF. 
Figures C and D show specific binding of 125I-HBGF-2 and 125I-HBGF-1 to 
Balb/c3T3 fibroblasts respectively.
Table 2.1
Transport of HBGF-1 labelled with 125I by different methods
Ciliary ganglion
Method (amount injected) Ipsilateral Contral
Iodogen (0.5p.Ci) 24 ± 6 6 ± 4
Chloramine T (5|iCi) 20 ± 7 22 ± 4
Bolton and Hunter (2pCi) 9 ± 6 11 ± 2
Enzymobead (2fiCi) 1 ± 2 2 ± 1
Amersham (0.5jiCi) 7 ± 4 14 ± 1
Table 2.2
Time course of transport of 125I-HBGF-1 by ciliary neurons
Radioactivity in ganglion (cpm)
Hours Ipsilateral Contralateral
6 18 ± 5 7 ± 3
12 12 ± 4 3 ± 5
16 24 ± 6 6 ± 4
24 25 ± 9 17 ± 7
36 22 ± 6 6 ± 4
Injection into vitreous
16 16+11 13 ± 4
24 12 ± 9 3 ± 5
Table 2.1: HBGF-1 purified from bovine heart was iodinated using 5mCi 125I /  lOjig 
protein and the appropriate oxidizing agent. The anterior eye chamber of newly hatched 
chicks was injected with the labelled protein in 2|il phosphate buffered saline and the ciliary 
ganglion removed after 16 hours for estimation of radioactivity in a gamma counter.
Table 2.2: 125I-HBGF-1 was injected into the anterior eye chamber of newly hatched 
chicks and the ciliary ganglia removed at the times indicated for determination of accumulated 
radioactivity.
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The possible existence of HMW neurotrophic activity in heparin-extracted beef heart was 
investigated by gel filtration chromatography. The eluted fraction (figure 12 A) was 
lyophylized, reconstituted in 0.2M NH4HCO3 and applied to a Superose 12 column (HR 
10/30 Pharmacia) equilibrated in the same buffer. Each fraction was tested for in vitro 
neurotrophic activity using the 24 hr ciliary neuron survival assay; MW of alternate 
fractions was confirmed by SDS-PAGE. The elution profile along with the 
corresponding SDS gels are shown in figure 2.13 A. Figure 2.13 B shows neurotrophic 
activity is associated both with HBGF-1 and several of the high molecular weight 
fractions. This result demonstrates that high molecular weight, heparin-binding, 
neurotrophic activity does exist in beef heart extract. Whether this activity corresponds to 
the immunoreactive band shown in figure 2.12 B has not been determined at this stage.
Several attempts at eluting biological activity from both the high and low MW regions of 
SDS gels using a variety of techniques including elecro-elution (see also Weber, and 
Kuter, 1971; Kapp, and Vinogradov, 1978; Hager, and Burgess, 1980; Manrow, and 
Dottin, 1982; Heeb, and Gabriel, 1984) were unsuccessful. It would seem that, unlike 
CNTF and BDNF, the biological activity of the HMW fractions is destroyed by SDS. 
The susceptibility of the beef heart factor to SDS-PAGE has previously been noted 
(Watters, and Hendry, 1987).
Discussion
The beef heart-derived ciliary neurotrophic factor has been identified as a class 1 heparin 
binding growth factor by the following criteria:
(i) affinity for heparin and elution with 1M NaCl;
(ii) acidic nature (pi ~5.5);
(iii) molecular weight of 18kD. The reason for the discrepancy between this value and 
that originally reported by Watters and Hendry, (1987) is unclear. The molecular weight 
of the factor purified by extraction in the presence and absence of protease inhibitors is 
identical. Similarly, extraction by single passage of crude extract over the heparin affinity 
column (figure 2.12 A) produces impure factor with a molecular weight of 18 kD. It is 
worth noting that the published gel (Watters, and Hendry, 1987) shows only five of the 
six silver stained standards. Original estimation of the MW of the factor, using gel 
filtration chromatography was 18700 ± 1300 (Hendry et al. 1983).
(iv) In addition to its neurotrophic activity the factor possess mitogenic activity for 
BALB/c3T3 cells. Moreover, the mitogenic activity was potentiated by the addition of 
heparin (see chapter 4). Similar potentiation of the mitogenic activity of HBGF-1 has 
been reported for BEL cells and CCL-39 fibroblasts (Uhlrich et al.1986), HUVE cells
AMinutes
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Figure 2.13 A Gel filtration of heparin-binding proteins on Superose 12 (HR 10/30) 
equilibrated in 0.2M NH4HCO3. Flow rate was 0.3 mis / minute and fractiors were 
collected every 2 minutes. SDS-PAGE of alternate fractions is shown above the 
chromatogram.
Figure 2.13 B. shows the neurotrophic activity of corresponding fractions as 
determined by the 24 hr. ciliary neuronal survival assay.
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(Thornton et al. 1983; Gimenez-Gallego et al. 1986a; Rosengart et al.1988), LE-II cells 
(Schreiber et al. 1985b), capillary endothelial cells (Orlidge, and D'Amore, 1986; 
Sudhalter et al. 1989) and BHK cells (Gospodarowicz, and Cheng, 1986).
(vi) Biological activity of the factor is retained after reverse-phase HPLC in acidic 
conditions.
(v) Peptide sequencing showed 100% amino acid homology with HBGF-1 purified from 
bovine brain.
In addition, the monoclonal antibodies raised against the beef heart factor recognize 
bovine brain-derived acidic but not basic FGF on western blots (chapter 3).
The presence of mitotic activity in nervous tissue extracts had been long recognized, 
although Gospodorowicz and his colleagues were the first to identify and initially purify 
(or at least enrich) a mitogen from bovine pituitaries (Gospodarowicz et al. 1974a; 
Gospodarowicz, 1974b; Gospodarowicz, 1975a; Gospodarowicz et al.1978). It was 
characterized as a cationic protein and named after one of its biological actions viz. 
'fibroblast growth factor'. Initial identification as fragments of myelin basic protein 
(Westall et al.1978) and subsequent controversy (Thomas et al.1980; Bohlen et al.1984; 
Gospodarowicz et al.1982) are now of only historical interest.
The presence of an acidic mitogen in brain extract was described by Gospodarowicz et 
al.(1975b), and later by Maciag and his coworkers (Maciag et al. 1979b; Maciag et 
al.1982). Lemmon et al.(1982), using IHF techniques reported the presence of both 
acidic and basic mitogens in brain preparations. The subsequent purification to 
homogeniety of the basic (Lemmon, and Bradshaw, 1983; Bohlen et al.1984) and acidic 
(Thomas et al.1984; Thomas, 1987b) forms of FGF enabled their characterization as 
distinct factors. Both procedures, using standard techniques of protein purification, were 
time consuming and resulted in low yields of the pure factor.
Heparin affinity chromatography was first applied (in the current context) to the 
purification of a chondrosarcoma derived cationic mitogen (Shing et al.1984) and later to 
both acidic (Maciag et al.1984) and basic (Gospodarowicz et al.1984) FGF from bovine 
brain; the final heparin affinity step results in a 2400-5300 fold purification 
(Gospodarowicz, 1987). The technique was rapidly adopted by others (see below) and 
the purification of both mitogens by sequential elution of the heparin affinity column is 
now well described (Lobb, and Fett, 1984; Lobb et al. 1985).
Although the CNS derived FGFs typified these mitogens, several groups, using different 
biological assays, reported the purification of factors variously named after their action, 
site of extraction, or method of purification. Thus heparin affinity chromatography
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facilitated the purification of several anionic mitogens, including endothelial cell growth 
factor (a-E C G F, ß-ECGF; Maciag et al. 1984; Burgess et al. 1985), heparin binding 
growth factor-a (H G Fa; Lobb, and Fett, 1984; Lobb et al. 1985), astroglial growth 
factor-1 (AGF-1; Pettmann et al.1985), anionic hypothalumus-derived growth factor 
(aHDGF; Klagsbrun, and Shing, 1985; D'Amore, and Klagsbrun, 1984), retinal-derived 
growth factor (RDGF; D'Amore, and Klagsbrun, 1984), a-retinal-derived growth factor 
(aRDGF; Baird et al.1985), eye-derived growth factor II (EDGF-II; Courty et al.1985), 
prostatropin (Crabb et al. 1986a), brain-derived growth factor (BDGF-A and BDGF-B; 
Huang et al. 1986) and bone-derived growth factor 1.1 (BDGF1.1; Hauschka et 
al. 1986). Similarly, the cationic mitogens were termed heparin binding growth factor ß 
(HGFß; Lobb, and Fett, 1984; Lobb et al.1985), astroglial growth factor-II (AGF-II; 
Pettmann et al.1985), cationic hypothalumus derived growth factor (cHDGF; Klagsbrun, 
and Shing, 1985}, ß-retinal-derived growth factor (ßRDGF; Baird et al.1985), eye- 
derived growth factor-I (EDGF-I; Courty et al.1985), cartilage-derived growth factor 
(CDGF; Sullivan, and Klagsbrun, 1985), chicken muscle growth factor (CMGF; 
Kardami et al.1985) and bone derived growth factor 1.5 and 1.7 (BDGF 1.5 or 1.7; 
Hauschka et al.1986).
Rationalization by combined effort (Lobb et al.1986; Schreiber et al. 1985a) determined 
that, apart from some N-terminal microheterogeniety (see below), these mitogens fall 
into two classes based on their pi and affinity for heparin. The nomenclature has since 
been standardized (Lobb et al.1986; Burgess, and Maciag, 1989): anionic mitogens (pi 
5-6) that elute from heparin with 1M NaCl have been designated class 1 heparin-binding 
growth factors (HBGF-1) and cationic mitogens requiring 1.5-2M NaCl for elution from 
heparin (pi 9-10) are categorized as class 2 heparin-binding growth factors (HBGF-2). 
Based on these criteria alone the beef heart-derived ciliary neurotrophic factor is yet 
another HBGF-1.
The identity of the factor was confirmed by sequencing the beef heart factor-derived 
tryptic and chymotryptic peptides. No signal was seen when the purified molecule w'as 
loaded into the sequencer indicating the N-terminus was blocked to Edman degradation. 
The amino acid sequence of the bovine amino-terminal truncated (residues 15-154; 
Gimenez-Gallego et al.1985; Esch et al. 1985a; Strydom et al.1986; Thomas et al. 1987a) 
and the complete 154 residue factor (Burgess et al.1986; Crabb et al. 1986b) have been 
reported. The latter studies have confirmed the presence of a blocking acetyl group on the 
N-terminus of the uncleaved molecule. The truncated (15-154) form of human HBGF-1 
is 92% homologous to the bovine molecule differing in 11 of the 140 amino acid 
residues (Harper et al.1986; Gimenez-Gallego et al. 1986c). The data obtained by protein
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sequencing is in agreement with that predicted from the nucleotide sequence of both 
human and bovine HBGF-1 cDNA clones (Jaye et al. 1986; Abraham et al. 1986a; Alterio 
et al.1988). The existence of the various N-terminal modifications viz.- ß-ECG F 
(FIBGF-1; 1-154) FGF-1 (HBGF-1; 15-154 ) and a-ECGF/FGF-2 (HBGF-1;21-154), 
have led some to propose tissue specific modification or post-translational processing of 
the factor (Strydom et al.1986; Esch et al. 1985a). In support of this contention is the 
recovery of HBGF-2 cleaved at G ly-15—>His-16 (Esch et al.1985b); a position 
homologous to Gly-20—>Asn-21 bond cleavage that produces aFGF-2/a-ECGF. Both 
bonds are not known to be specifically susceptible protease action. However, N-terminal 
microheterogeniety of the (truncated 15-154) human HBGF-1 is limited to cleavage of 
the N-terminal Phe such that some 50% recovery begins with a deamidated Asn (Asp) 
residue 2 (Harper et al.1986; Gimenez-Gallego et al. 1986c; Gimenez-Gallego et 
al. 1986b). Moreover, all studies (including our own; Crabb et al. 1986b; Sasaki et 
al.1989) using neutral extraction conditions and/or addition of protease inhibitors have 
failed to detect any cleaved or unblocked forms of the HBGF-1 molecule (see also 
Quinkler et al.1989), suggesting the modified N-termini to be an artifact of the isolation 
prodedure. To date no differences in biological activity have been attributed to N-terminal 
modification.
Although the current study did not identify the blocking group, it is likely that the N- 
terminal tryptic peptide is identical to that derived from bovine brain or prostate derived 
HBGF-1 and therefore contains an N-terminal acetyl group (Burgess et al.1986; Crabb et 
al. 1986b). Similarly, expression of the human HBGF-1 gene in yeast results in N-acetyl 
HBGF (1-154) (Barr et al.1988). Several proteins containing N-terminal acetyl groups 
have been described (see e.g. Schaefer et al.1989), although no biological function has 
yet been attributed to this blocking group.
The FGFs have been the subject of frequent and exhaustive reviews(see Rifkin, and 
Moscatelli, 1989; Lobb et al.1986; Gospodarowicz et al.1986a; Baird et al.1986; 
Gospodarowicz, 1987; Thomas, 1987b; Klagsbrun et al. 1987; Thomas, and Gimenez- 
Gallego, 1986; Burgess, and Maciag, 1989); their biology is not covered in detail here. 
Suffice to say the HBGFs are pleiotropic peptides implicated in processes ranging from 
carcinogenesis (Schweigerer et al.1987), prostatic hyperplasia (Crabb et al. 1986a), liver 
regeneration (Kan et al.1988), neovascularization (D'Amore, and Klagsbrun, 1984) 
ovarain function (Gospodarowicz et al. 1974a; Gospodarowicz et al.1989), and 
neurotrophism (see below). It is worth noting however that evidence to date suggests 
that HBGF-1 and 2 cell surface receptors are related, if not identical, glycoproteins 
(Neufeld, and Gospodarowicz, 1985; Olwin, and Hauschka, 1986; Neufeld, and
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Gospodarowicz, 1986; Friesei et al. 1986; Feige, and Baird, 1988; Burgess, and Maciag, 
1989 - cited as unpublished observation), providing some justification to the inclusion of 
HBGF-2 in the following discussion.
The full implications of the protein sequence have been covered in detail by previous 
authors and are not reproduced in detail here. Of relevance to further studies presented in 
this thesis are the clusters of basic residues, flanked by hydropathic residues, that are 
proposed to mediate the binding of HBGF-1 to heparin: specifically residues HBGF- 
l;23-26 (Lys-Lys-Pro-Lys) and 114-116 (Lys-Lys-His) (Esch et al. 1985a; Harper et 
al. 1986). However, later studies have implicated residues closer to the C-terminus. 
Reductive methylation of the lysine residues of HBGF-1 decreases both its affinity for 
heparin and its mitogenic potency (Harper, and Lobb, 1988). The major site of 
modification was shown to be Lys-132 which is predicted to exist within a ß-tum that 
includes Lys-126, Lys-127 and Arg-136. The importance of this residue has been 
confirmed by site-directed mutagenesis (cited as unpublished results in Burgess, and 
Maciag, 1989). Replacing Lys-132 with glutamic acid results in an HBGF-1 with 
markedly reduced affinity for heparin. Similarly, thrombin cleavage results in a 14kD 
fragment (presumably missing residues 137-154 and disrupting the loop containing Lys 
126,127,132 and Arg 136) with low affinity for heparin and 40-100 times less potent 
than the native molecule in stimulating mitogenisis (Lobb, 1988). All basic residues 
alluded to above are conserved in the human molecule, although there is significant 
substitution between residues 129-133. Similar regions of high positive charge density 
exist in HBGF-2 (Esch et al. 1985b; Strydom et al.1986).
Several authors have proposed that FGF's affinity for heparin reflects its in vivo 
association with the more widespread heparan sulfate proteoglycans (HSPGs). Acidic 
and basic FGF bind to heparinase sensitive sites within cultured endothelial cell (Baird, 
and Ling, 1987; Vlodavsky et al. 1987) or cardiac muscle cell (Weiner, and Swain, 1989) 
derived extracellular matrix ; in fact the original application of heparin affinity 
chromatography purified HBGF-2 from chondrosarcoma derived extracellular matrix 
(Shing et al.1984). 125I labelled acidic or basic FGF will bind to cryostat sections of 
embryonic mouse eye (Jeanny et al.1987); binding is restricted to basement membrane 
structures and abolished by pretreatment with heparinase. In vivo, bFGF has been 
immunohistochemically localized to basement membranes of the eye and skeletal and 
cardiac muscle (Folkman et al. 1988; DiMario et al. 1989; Kardami, and Fandrich, 1989). 
Matrix bound HBGF-2 is released by heparinase, heparin or heparan sulfate, but not by 
the related glycosaminoglycans chondroitin sulfate or hyaluronic acid (Bashkin et 
al.1989; Folkman et al. 1988; Thompson et al.1989). Remarkably the flourescent signal
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observed in the endomysium was increased around regenerating muscle fibres of the 
Mdx mouse (DiMario et al. 1989). The intensification was seen before onset of the 
degeneration/regeneration cycle and is attributed to an as yet uncharacterized primary 
event.
Together, these data have led several authors (e.g. D'Amore, and Klagsbrun, 1984; 
Bashkin et al. 1989; Thompson et al.1989; Schubert et al. 1987b; Moscatelli, 1988) to 
propose that the binding of the HBGFs to HSPGs constitutes an extracellular 'sink' from 
which the factors are liberated by the action of heparin, heparan sulfate proteoglycans or 
degradative enzymes. A similar association has been described for interleukin 3 (IL-3) or 
granulocyte/macrophage colony stimulating factor (GM-CSF; Gordon et al.1987; 
Roberts et al. 1988). Basement membrane GAGs adsorb colony stimulating activity from 
conditioned media and proliferating stem cells can be maintained on heparan sulfate 
preincubated with IL-3 or GM-CSF. Similarly, substrate bound bFGF will support 
neurite outgrowth by dissociated hippocampal neurons (Walicke, 1988a; Walicke et 
al.1986) and enhance survival of ciliary neurons (Unsicker et al.1987). bFGF bound to 
nitrocellulose strips retains mitogenic activity for 3T3 cells (Danielsen et al.1988) 
although a permissive microenvironment created by the leaching of small amounts of 
active factor from the substrate cannot be excluded by these studies.
Affinity for heparin is not limited to the heparin-binding growth factors; heparin affinity 
chromatography has been widely used as a method of enzyme purification (Farooqui, 
1980), and was more recently applied to the isolation of a rat brain derived schwann cell 
mitogen (Ratner et al.1988), vascular endothelial growth factor (Leung et al.1989) also 
known as vascular permeability factor (Keck et al.1989), and a novel mitogen from 
embryonal carcinoma conditioned medium (Heath et al.1989).
At the time of writing both the presence of HBGF-1 in heart tissue, and its putative role 
as a neurotrophic factor are well described. Both HBGF-1 and HBGF-2 have been 
characterized as 'neurotrophic' or 'neurotropic' based on in vitro bioassays similar to 
those established for NGF. Initial reports that bFGF promoted survival and neurite 
outgrowth in dissociated cultures of rat cortex (Morrison et al.1986) and hippocampus 
(Walicke et al.1986) were rapidly extended to include neurons of the embryonic rat 
septum, thalumus, striatum and cerebellum (Walicke, 1988b; Hatten et al.1988). In 
addition, aFGF increased survival of neurons dissociated from the entorhinal cortex, 
parietal cortex, hippocampus, striatum and subiculum. Except for the subicular neurons - 
which did not respond to bFGF - some 100-fold more acidic than basic FGF was 
required to support survival of these neuronal populations. Unsicker et al.(1987) 
reported that both HBGF-1 and HBGF-2 support dissociated chick ciliary neurons in
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culture and activity of HBGF-1 is potentiated 100-fold by heparin (see also Schubert et 
al. 1987b). In contrast to the present study no activity was reported for chick sensory 
neurons; the reason for this discrepancy is unclear. The survival of sensory neurons in 
response to both HBGFs has been observed in serum-free and serum containing media 
incubated in both air and CO2, and on a variety of substrates including laminin, poly- 
ornithine and collagen (results not shown). The observation is relevant to further studies; 
DRGs provide an accessible source of large numbers of neurons that can be used, for 
example, for receptor studies. Moreover if it could be demonstrated that NGF and FGF 
support overlapping populations, dissociated DRGs may be a useful system for 
investigation of second messenger pathways, avoiding criticism that changes in a given 
biochemical parameter reflect death of control cultures. Such distinct second messenger 
pathways have been suggested by the response of cultured chromaffin cells to NGF and 
bFGF (Stemple etal.1988).
The HBGFs are well characterized as mitogens for most anchorage dependent cells 
investigated to date (Burgess, and Maciag, 1989). The possibility that the neurotrophic 
action of HBGFs is secondary to proliferation of non-neuronal cells that are inevatibly 
cocultured with neuronal dissociates has been raised by several authors. However, most 
workers, including ourselves, have noted that the neuronal survival is not proportional to 
the number of surviving non-neuronal cells. Ciliary neuronal survival can be achieved in 
cultures preplated before seeding on collagen in DMEM/HEPES / cytosine arabinoside - 
conditions known to deter non-neuronal cells. A more formal approach to the question 
(Walicke, and Baird, 1988) found that, using a variety of culture conditions, survival of 
hippocampal neurons was not proportional to the numbers of surviving glial cells. 
Moreover, a high affinity receptor for HBGF-2, similar to that previously described for 
mesenchymal cells (Neufeld, and Gospodarowicz, 1985), has been isolated from highly 
purified neuronal cultures of hippocampus, frontal, parietal, occipital and entorhinal 
cortex, subiculum and striatum (Walicke et al. 1989)
These data would suggest that the HBGFs are indeed direct neurotrophic agents. This 
contention is further supported by several reports that describe a neurotrophic action on 
PC12 cells (Togari et al. 1983; Togari et al.1985; Schubert et al.1987b; Wagner, and 
D'Amore, 1986; Neufeld et al.1987). HBGF-2 has been shown to reproduce the 
responses by PC 12 cells previously characterized for NGF, including cell flattening, 
spike formation, neurite outgrowth, cessation of cell division, patterns of protein 
phosphorylation, synthesis of specific glycoproteins, induction of AchE activity and 
expression of c-fos and c-myc (Rydel, and Greene, 1987; Greenberg et al.1985). The 
ability of HBGF-1 to induce neurite outgrowth is potentiated by heparin (Rydel, and
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Greene, 1987; Wagner, and D'Amore, 1986); in fact in the presence of heparin, HBGF- 
1 was some 4-fold more potent than NGF in eliciting neurite outgrowth. Both HBGF-1 
and 2 will induce neurite outgrowth and stimulate proliferation of adrenal chromaffin 
cells in vitro (Claude et al.1988; Stemple et al.1988), although interestingly the neurite 
promoting but not the proliferative effect of HBGF-1 was potentiated by heparin (Claude 
et al.1988).
The biological effects of aFGF have, in general, paralleled those of the basic molecule 
albeit at a somewhat higher concentration. However, at least two neuronal populations - 
dissociates of the embryonic rat subiculum (see above) and postnatal rat retinal ganglion 
cells - appear uniquely sensitive to HBGF-1 (Walicke, 1988b; Lipton et al.1988). 
Although without effect on survival, HBGF-1 increased regeneration of neuntes by 
dissociated ganglion cells; in the presence of heparin, HBGF-1 is the most potent neurite 
promoting factor yet discovered. HBGF-2 was without effect, implying some specificity 
in the biology of the HBGFs and the possible existence of distinct receptors.
It is now recognised that HBGF-1 distribution in vivo is not restricted to neural tissue 
(Crabb et al. 1986a; Hauschka et al.1986; Gautschi-Sova et al.1987; Winkles et al.1987). 
In particular, the presence of both HBGF-1 and HBGF-2 in cardiac tissue is well 
documented (Quinkler et al.1989; Sasaki et al.1989; Speir et al.1988; Kardami, and 
Fandrich, 1989; Thompson et al.1989; Weiner, and Swain, 1989). Extraction of heart 
muscle in physiological conditions and/or the presence of protease inhibitors yielded an 
HBGF-1 species blocked to N-terminal sequencing (Sasaki et al.1989; Quinkler et 
al.1989). Recovery was similar to that reported here; 500p.g HBGF-l/kg heart. Cultured 
cardiac myocytes derived from neonatal rat heart express aFGF mRNA (Weiner, and 
Swain, 1989) and a biologically active mitogen immunologically indistinct from aFGF 
was recovered from the cardiac cell derived ECM.
The presence of a high MW band on immunoblots of heparin extracted beef heart is 
intriguing. W hilst it is possible that this band is the result of an immunogenic 
contaminant present in bovine heart derived preparations used to immunize the rabbits the 
observation that (i) both heart and brain-derived HBGF-1 blocked binding of the 
polyclonal antibody to high and molecular weight bands to a similar degree, as well as 
(ii) the presence of high molecular weight neurotrophic activity eluting from the Superose 
column would suggest the presence of a higher MW form of the factor. Both human and 
bovine HBGF-1 cDNA clones have revealed a single open reading frame flanked by stop 
codons, indicating that HBGF-1 is not translated as a high MW precurser (Jaye et 
al.1986; Alterio et al.1988). It is possible that the polyclonal antibody is recognizing
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HBGF-1 containing complex. Alternatively, the high MW band may represent an as yet 
undescribed FGF-like protein. The former possibility would require an HBGF-1 
complex resistant to SDS-PAGE; such stable protein-protein associations have been 
described. For example, the association of urokinase with inhibitors released by heart 
cells will withstand boiling in SDS-mercaptoethanol (Pittman, and Patterson, 1987). It 
should be noted that three independent groups (including our own) have initially 
described HBGF-1 from different sources as a high MW complex. (MW 50,000- 
100,000; Bonyhady et al.1982; D'Amore, and Klagsbrun, 1984; Maciag et al.1982). 
However in each case the HBGF-1 complex was dissociable to its lower MW form 
(Thompson et al. 1989; Tsuda et al.1989) in relatively mild conditions - i.e. following 
exposure to high ionic strength or by lowereing pH - although an earlier study (D'Amore 
et al. 1981) stated that the "non-dialysable" nature of the molecule (i.e. retained by a Mr 
cut-off 50,000 filter) was unaltered by overnight incubation in urea or guanidine. 
Whether these forms of HBGF-1 represent self-aggregation or association with a carrier 
molecule has not been resolved.
One of the most exciting developments in the current field, and indeed in cell biology, 
has been the recent identification of several FGF-like molecules that together form a 
family of heparin-binding growth factors. Except for keratinocyte growth factor (KGF), 
these molecules are translation products of transforming DNA samples derived from 
human and rodent tumors.
The transforming gene hst /KS3 or kfgf was identified by transfection of NIH 3T3 cells 
with DNA derived from &uman ^omach (Taira et al.1987) or Kaposi's sarcoma (Delli 
Bovi et al.1987). kfgf cDNA codes for a 206 amino acid protein with a 30 residue N- 
terminal signal sequence (Delli-Bovi et al. 1988); residues 72-104 are 43% homologous 
to bFGF, 38% homologous to aFGF and 40% homologous to mouse Int-2. The kFGF 
protein (recently designated HBGF-4 Burgess, and Maciag, 1989) is expressed as a MW 
22kD glycosylated mitogen with potent proliferative activity for NIH 3T3 fibroblasts 
(Delli Bovi et al.1987; Miyagawa et al. 1988; Delli-Bovi et al. 1988), C3H10T1/2 
fibroblasts (Patemo et al.1989), HUVE cells (Miyagawa et al. 1988; Delli-Bovi et 
al.1988), BCE cells (Delli-Bovi et al.1988), and human melanocytes (Delli-Bovi et 
al. 1988). k-FGF binds heparin (Miyagawa et al.1988; Patemo et al.1989), requiring 1- 
1.2M NaCl for elution. Significantly, heparin increases the half life of kFGF in medium 
after secretion from transfected COS-1 cells and potentiates mitogenic activity for NIH 
3T3, HUVE and BCE cells (Miyagawa et al.1988; Delli-Bovi et al.1988).
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Int-2 was identified originally as a gene target transcriptionally activated by insertion 
mutations induced by the mouse mammary tumor virus (cell 33 or 37). The predicted 
amino acid sequence (Moore et al.1986; Brookes et al. 1989) shows significant 
homology to both acidic and basic FGF (Dickson, and Peters, 1987) and contains a short 
hydrophobic N-terminus that may function as a signal sequence. The Int-2 protein 
synthesized in a rabbit reticulocyte lysate system will induce DNA synthesis in 
C3H10T1/2 fibroblasts although it is some 10-fold less potent than either bFGF or 
kFGF (Patemo et al. 1989). Despite the high proportion of Arg and Lys residues that are 
clustered at several points, the Int-2 protein apparently does not bind heparin (Patemo et 
al. 1989), making its designation as HBGF-3 (Burgess, and Maciag, 1989) premature. 
Int-2 expression in the early embryo is consistent with a role as an inductive signal for 
the otocyst and mesodermal segmentation (Jakobovits et al.1986; Wilkinson et al. 1988). 
Both the hst and Int-2 genes have been mapped to chromosome 11 band q l3 (Nguyen 
et al.1988) and are coamplified in several human tumors (Theillet et al.1989; Tsuda et 
al.1989).
The FGF-5 gene was isolated following transfection of human tumor derived DNA into 
NIH3T3 cells (Zahn, and Goldfarb, 1986; Zahn et al.1987). Its predicted amino acid 
sequence is 40-50% homologous to acidic and basic FGF and hst /KS3 (Zahn et 
al.1988). Conditioned media from FGF-5 transformed cell lines induces DNA synthesis 
in BALB/c3T3 and fetal bovine heart endothelial cells (Zahn et al.1988); mitotic activity 
elutes from heparin with 1-1.5M NaCl.
Keratinocyte growth factor (KGF) was purified from medium conditioned by M426 
fibroblasts (a human embryonic lung fibroblast cell line) using heparin affinity 
chromatography (Rubin et al.1989). The 22kD factor induces mitogenesis in epithelial 
cell lines but not fibroblasts or endothelial cells. cDNA sequencing has revealed an open 
reading frame encoding a 194 amino-acid translation product with significant homology 
to other members of the FGF family, and containing a hydrophobic signal sequence 
(Finch et al.1989). In accord with its hypothesized role as a growth factor specific for 
epithelial cells, KGF expression is apparently restricted to stromal cells of the dermis.
The FGF-6 gene was discovered by screening of a human cosmid library with a human 
hst probe under low stringency conditions (Maries et al.1989). The FGF-6 gene is 73 % 
homologous to hst and has been shown to possess transforming activity.
The known genomic structures of the above factors are essentially identical (Wang et 
al.1989; Abraham et al. 1986b; Mergia et al.1989; Zahn et al.1988; Yoshida et al.1987;
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Brookes et al.1989). All contain two aligned introns (although of different lengths); the 
second exon, displaying the highest degree of homology, is also the same length (104bp) 
with identical 3'and 5' ends. This would suggest that the FGF related genes have 
evolved from their ancestral gene with similar exon structure with intervening sequences 
introduced prior to gene duplication.
At the time of writing none of the above proteins have been shown to possess 
neurotrophic activity. However the known biology of the FGF-like factors is essentially 
(apart from the apparent target cell specificity of KGF) identical to acidic or basic FGF. 
For example, in addition to their mitogenic activity k-FGF and Int-2 possess mesoderm 
inducing activity (Patemo et al.1989), a known property of both acidic and basic FGF 
(Slack et al.1987). Moreover, k-FGF has been reported to induce transient differentiation 
of PC-12 cells (Delli-Bovi et al.1988 reported as unpublished observation). Localization 
of Int-2 transcripts to purkinje cells of the fetal and neonatal mouse, the retinal 
neuroblastic layer and sensory and support cells of the inner ear has been taken as 
evidence for a role in neural migration and differentiation or as a trophic factor for 
vestibular neurons (Wilkinson et al.1989). Similarly, FGF-5 is expressed in the neonatal 
brain and has been proposed to act as a neurotrophic factor (Zahn et al.1988). It is 
therefore highly likely that at least some of these proteins will be shown to possess 
trophic activity for neurons; indeed the presence of a conventional signal sequence may 
make the FGF-like factors more relevant to neurobiology than acidic or basic FGF. 
Identification of target cells, timing and location of expression and investigation of 
possible effects of their antibodies should provide useful data for the neurotrophic 
theorists.
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Chapter 3
Characterization of a monoclonal antibody generated against the beef- 
heart derived neurotrophic factor: in vitro and in vivo activity
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Introduction
Several authors have emphasized the importance of in vivo investigation in establishing 
the biological relevance of neurotrophic agents identified in vitro (see eg Hendry et 
al. 1981; Davies, 1988; Barde, 1988; Walicke, 1989); the ability of a given factor to 
support neuronal survival in vitro does not stand alone as evidence for a similar role 
during normal development. Dr.Diane Watters, while working in the laboratory, 
successfully raised several monoclonal antibodies against the beef heart-derived factor. 
One of these clones (3D 12) produced antibodies capable of blocking the in vitro 
neurotrophic activity of the factor (Watters et al. 1989). The availibility of this antibody 
presented a unique opportunity to establish the in vivo relevance of the beef heart 
neurotrophic factor using similar experimental paradigms previously described for NGF. 
The following chapter describes the initial characterization of monoclonal antibodies 
generated against the beef heart factor and experiments designed to determine whether, 
like anti-NGF, the blocking antibody is neurotoxic in vivo.
Materials and Methods
Purification of factors
The beef heart and brain derived HBGF-1 and beef brain HBGF-2 were purified as 
described (Lobb, and Fett, 1984; Lobb et al.1986; Watters, and Hendry, 1987) with the 
modifications noted in chapter 2. Beef brain derived acidic and basic FGF to be used for 
immunoblotting were first concentrated by reapplication to heparin-agarose (1ml packed 
on a Pharmacia C10/10 column), eluted with saturated NH4HCO3, lyophylized, and 
dissolved in sample buffer before SDS-PAGE.
Monoclonal antibodies
Monoclonal antibodies to the beef heart derived factor were prepared by Dr. Watters 
using a combination of in vivo and in vitro immunization procedures (Watters 
et.al.1989). Eight clones produced antibodies which bound to the purified factor as 
determined by ELISA. Of these, one failed to grow and four subsequently lost the ability 
to produce antibodies. The remaining hybridomas (4G8,3D12,2B11,5G9) were cloned 
by limiting dilution and expanded. Clones were maintained in 60ml flasks in Dulbecco's 
modified Eagles medium containing extra glucose to 6mg/ml, ImM sodium pyruvate, 
2mM glutamine, 5 x 10‘5M mercaptoethanol, vitamin supplement, 100 U/ml penicillin, 
100mg/ml streptomycin, and 10% fetal calf serum. In an effort to stabilize the antibody
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the 3D 12 'parent' line was subcloned by limiting dilution and several of these subclones 
were expanded for further study.
Production o f ascites fluid
Ascites tumours were established by the intraperitoneal injection of 4 xlO6 hybridoma 
cells into Balb/C mice previously primed with pristane (Sigma Chemical Co., St. Louis). 
Ascites fluid was aspirated, centrifuged to remove cells and debris, and the supernatant 
stored at -20° C.
Ammonium sulfate fractionation
Antibodies were concentrated from culture medium by the addition of saturated 
ammonium sulfate (Ultrapure; Bethesda Research Laboratories, Gaithersburg, MD) 
solution (1:1, v/v), the precipitate collected by centrifugation and redissolved in one-tenth 
of the original volume PBS. After dialysis against two changes of PBS, the antibody 
solution was sterilized by filtration through 0.22(im filters (Millipore, Bedford, MA) and 
stored at -20°C. Antibodies were precipitated from ascites fluid by the same method 
except the pellet was redissolved in the original volume of PBS.
Bioassay o f ciliary neurotrophic activity
Neurotrophic activity was assayed as previously described (Bonyhady et al.1982; 
chapter 2). Briefly, 96 well tissue culture plates were coated with collagen and a dilution 
series to be assayed set up in lOOjil medium (DMEM containing 25mM HEPES and 1 % 
heat-inactivated horse serum) in each well. To this were added approximately 2200 
neurons dissociated from ciliary ganglia of E8 chicks, and the cultures incubated in an air 
atmosphere at 37°C. After 24hrs the number of viable neurons was assessed by phase 
contrast microscopy.
Antibody typing
The subtype produced by the clonal cells was determined using a commercial ELISA kit 
(K-Mist: Chemicon) according to the directions of the manufacturer.
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Immunobiotting
2\ig samples of the purified beef heart factor or bovine brain acidic or basic FGF were 
incubated in SDS, 5% mercaptethanol for 20 minutes before electrophoresis on a 5-30% 
polyacrylamide gel gradient using the buffer system of Laemmli, (1970). The gels were 
silver stained by the method of Wray et al.( 1981). The protein was transferred 
electrophoretically from the gel to nitrocellulose paper (Schleicher and Schull, W. 
Germany, 0.45|i) with a transblot cell ( Biorad, Richmond, CA). After transfer, the 
nitrocellulose was blocked with 3% BSA in PBS for Ihr before incubation for 2hrs at 
room temperature with either undiluted hybridoma medium or ammonium sulfate 
concentrated ascites fluid at 1:400 dilution . Bound antibody was detected using the 
streptavidin-biotin-HRP kit supplied by Amersham, U.K.
In vivo antibody administration
Mice were injected with ascites fluid freshly prepared as described above. Three injection 
regimes were followed: (i) prenatal only, (ii) postnatal only or (iii) prenatal and postnatal. 
The first group of pregnant mice were injected intraperitoneally twice weekly with 250|il 
ascites fluid from day 7 of gestation until the pups were bom. Group (ii) pups were 
injected subcutaneously every second day from birth with 2.5|il ascites/g body weight 
until they reached 14d of age. The last group combined both regimens. Animals were 
killed by an overdose of ether and the irides assayed for choline acetyl transferase (CAT) 
and tyrosine hydroxylase (TOH) activity.
Enzyme assays
Tissue was homogenized in 5mM Tris pH 7.4 containing 0.1% Triton X-100 and 10|il 
aliquots were stored on ice. Choline acetyltransferase activity was determined by the 
method of Fonnum, (1969) as modified by Black et al.( 1971) and Hendry, (1975b). 
Briefly, to each aliquot was added 10|il of 50mM sodium phosphate containing [3H] 
acetl-CoA (O.lmM); choline bromide (lOmM); physostigmine sulfate (ImM); sodium 
ethylene diamine tetraacetic acid (EDTA; lOmM); sodium cyanide (lOmM); sodium 
chloride (300mM) and bovine serum albumin (0.1%). After 30 minutes at 37°C the 
reaction was terminated by the addition of ice cold 0.01 M phosphate buffer pH 7.4 
containing acetylcholine bromide (0.035g/l). The tritiated acetylcholine was extracted into 
butyl acetate containing tetraphenylboron, and separated by centrifugation. An aliquot of 
each sample was placed in a scintillation vial containing 5mls of scintillation fluid ( 2
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parts xylene, 1 part triton X 114, + diphenyloxazole 0.5%) and quantitated in a liquid 
scintillation counter. Tyrosine hydroxylase was assayed as previously described 
(Hendry, and Iversen, 1971; Black et al.1971). Each aliquot of tissue homogenate 
received 15p.l of 0.8M sodium phosphate buffer pH 6 containing [3H ]tyrosine 
(0.004mM); 6,7-dimethyl tetrahydropterine (1.25mM); 2-mercaptoethanol (0.3125mM) 
and NSD (0.15mM). After 30 minutes at 37°C the reaction was stopped by the addition 
of 250fil of 0.4M perchloric acid containing 2|ig/ml L-dihydroxyphenylalanine (L- 
DOPA). The mixture was neutralized by the addition of 0.1 M Tris containing EDTA 
(0.05M) and NaOH (0.075M). The tritiated L-DOPA was separated by passage of the 
mixture over alumina columns equilibrated in 0.1M sodium phosphate buffer pH 8.6. 
After two washes with 0.005M Tris pH 8.6 the columns were eluted with 0.5M acetic 
acid into scintillation vials containing 5 mis of scintillation fluid and counted in a liquid 
scintillation counter.
ELISA
ELISA plates were coated with pure beef heart-derived HBGF-1 in PBS (2jig/ml) at 4°C 
overnight then washed (x3) with PBS / 0.5% Tween 20 and blocked with 1% BSA in 
PBS for 2 hrs at room temperature. Column fractions (50|il) were incubated overnight at 
4°C and bound antibody detected using the biotin-streptavidin-HRP kit supplied by 
Amersham, U.K. 2,2' Azino-di-[3-ethylbenzthiazoline sulphonate] (ABTS) was used as 
the substrate. Absorbance was measured on a Dynatech MR 600 Microplate Reader.
Antibody purification
Anion exchange chromatography
Ascites fluid (1ml) was dialysed against Tris-HCl pH 7.7 (starting buffer) overnight and 
clarified by centrifugation and filtration. 200fil aliquots were loaded onto a Mono Q 
(HR5/5: Pharmacia) column equilibrated in the starting buffer and eluted with a 0 - 0.5M 
NaCl gradient over 20 mins using a Pharmacia FPLC system. Flow rate was 2 
mls/minute. Antibody containing fractions were detected by ELISA. Purity was checked 
by SDS-PAGE under reducing conditions. Antibody containing fractions were tested for 
blocking activity using HBGF-1 supported cultures of E8 chick ciliary neurons.
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ABx chromatography
HPLC purification of monoclonal antibodies was carried out using a Bakerbond ABx 
(7.75x100mm; 5|im particle size) column attached to a Waters model 510 equipped with 
490 programmable detectors. The column was standardized with known amounts of pure 
and impure IgGi and IgM, and - in agreement with the manufacturers claims - appeared 
to bind antibody only. Culture medium harvested from 3D 12 monoclonal cultures was 
concentrated by ammonium sulfate fractionation. Ascites or culture medium samples 
were prepared by overnight dialysis against the starting buffer (lOmM MES pH 5.6) and 
cleared by centrifugation and filtration. Antibody containing samples were applied to the 
ABx column and eluted using a NaOAc gradient (0—>0.5M over Ihr.). Antibody 
containing fractions were detected by ELISA and tested for blocking activity using the E8 
chick ciliary neuron survival assay. It had been observed that biological activity of the 
crude antibody was susceptible to storage either at 4° or -20°C. Purification procedures 
and biological assays were therefore carried out on the same day.
Results
Effect o f the monoclonal antibodies on neurotrophic activity
The blocking effect of the 3D 12 antibody was confirmed using the E8 chick ciliary 
neuron survival assay. Ammonium sulfate concentrated antibody preparations were 
tested for their ability to inhibit ciliary neurotrophic activity. Dose response curves to the 
purified neurotrophic factor in the absence and presence of a constant amount of antibody 
are shown in figure 3.1 A. The blocking effect of 3D 12 derived antibody is clearly 
evident. Ascites produced by either the 5G9 or X63 (the parent myeloma cell line) clones 
was without effect on HBGF-1 induced neuronal survival (figure 3.IB).
Antibody subtype
Antibody subtyping by ELISA is shown in figure 3.2. 4G8, 2B11 and 5G9 possess fi 
heavy chains whereas 3D 12 contains an a  chain. All four have k light chains.
Purification o f the 3D 12 antibody
Anion exchange chromatography
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Figure 3.1 A. Dose response curves to beef heart-derived HBGF-1 in the absence 
(control) and presence of media or ascites from the 3D 12 hybridoma. Serial dilutions of 
the factor were set up according to the standard bioassay procedure. A constant amount of 
antibody (lOjil) from ammonium sulfate concentrated medium or ascites fluid was added 
to each well. Surviving neurons were counted at 24hrs culture.
Figure 3.IB. shows a separate experiment set up under identical conditions. The 
effects adding a constant amount (lOjil) of ammonium sulfate concentrated ascites derived 
from the 5G9 and X63 clones are compared to the effect of 3D 12 antibody.
4 G 8  serum 5 G 9  3 D 12
free
medium
Figure 3.2. Antibody subtyping by ELISA. The 4G8, 5G9 and 3D 12 clones are 
shown.
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Figure 3.3A shows the elution profile obtained after separation of 3D 12 ascites 
components by ion-exchange chromatography on a Pharmacia Mono Q column. A 
coomassie blue stained gel of the antibody containing fractions (figure 3.3B) shows that 
in addition to the heavy and light chains several high molecular contaminants are present.
ABx chromatography
Medium harvested from hybridoma cell lines subcloned from the parent 3D 12 line was 
concentrated by ammonium sulfate precipitation and subject to ABx HPLC as described 
in Methods. Figure 3.4 shows the elution profile of antibody produced by two subclones 
- 3D12 1F2, 3D12 1G4 - and the 3D12 parent line. All peaks (after the initial flow 
through peak) contained anti-beef heart factor activity as determined by ELISA. 
Considerable chromatographic heterogeniety is evident. No 10 - 15' peak is seen in 
samples derived from the parent 3D 12 cultures; in addition the 25-35 minute peak is 
biphasic and eluted earlier than the equivalent peak from the subclones. Moreover, the 
single 30 - 35' peak seen in the subclone derived samples varied in relative size. Figure 
3.5 shows SDS-PAGE (7% gel) of the purified antibody derived samples run under 
reducing and non-reducing conditions. The 10-15 minute peak contains a single species 
of MW ~60kD that increases in apparent molecular weight with reduction (lanes 6 and 
7). The 30-35' peak from the 3D12.1G4 contains several high and low molecular weight 
species that cluster around 65kD on reduction (lanes 2 and 3). The 25-30' peak from the 
3D 12 parent line contains several high molecular weight proteins that are seen at ~60kD 
with reduction (lanes 4 and 5).
None of the antibody fractions purified by column chromatography retained the ability to 
block in-vitro biological activity of beef heart-derived HBGF-1; purified antibody added 
in molar excess did not alter the dose response curve seen with the addition of factor 
alone. Further, recombination of the antibody peaks obtained after ABx chromatography 
did not restore blocking activity. Similarly, crude antibody preparations - either culture 
medium or ascites fluid - lost biological activity after storage at 4°C or with freezing. 
However, frozen purified or crude antibody preparations did retain HBGF-1 binding 
activity as determined by ELISA or ability to recognise HBGF-1 on nitrocellulose 
immunoblots (e.g. figure 3.6 below ). The only 3D 12 antibody preparation that retained 
some biological activity was that prepared by ammonium sulfate fractionation (figure 
3.1).
Western blotting
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Figure 3.4. ABx HPLC. 1ml samples of concentrated culture medium from the
indicated 3D12 subclones were applied to an ABx column (7.75x100mm; 5(im particle 
size) equilibrated in lOmM MES pH 5.6, and eluted with a linear gradient of NaOAc
(0—>1M over 60 minutes). The flow rate was 1ml per minute and 1ml fractions were 
collected.
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Figure 3.5 SDS-PAG of antibody fractions purified by ABx chromatography. Lane 1: 
standards - phosphorylase b, 94kD; bovine serum albumin, 67kD; ovalbumin, 43kD; 
carbonic anhydrase, 30kD. Lane 2: 30-35' peak 3D12.1G4 (refer figure 3.4) - unreduced 
sample. Lane 3: 30-35' peak 3D12.1G4 reduced sample. Lane 4: 25-30' peak 3D12 parent 
clone - unreduced sample. Lane 5: 25-30' peak 3D12 parent clone - reduced sample. Lane 6: 
10-15' peak 3D12.1G4 - unreduced sample. Lane 7: 10-15' peak 3D12.1G4 - reduced 
sample.
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Ascites fluids produced by 3D 12, 5G9, and 2B11 hybridomas recognize a single band 
on blotted beef-heart derived factor preparations (figure 3.6). In addition, the same 
antibodies recognize acidic but not basic FGF purified from bovine brain (figure 3.7). 
Ascites fluid generated by the parent myeloma X-63 does not bind either factor.
In vivo administration of the 3D 12 and 5G9 antibodies
The effect of pre and postnatal administration of the 3D 12 antibody on the development 
of CAT in the mouse iris is shown in figure 3.8. The normal developmental increase in 
enzyme activity is prevented; CAT activity reaches only 50% of control levels at 3 
weeks, and no further increase is seen over the next 10 weeks. Figure 3.9 shows the 
effect of different injection regimens at 3 weeks of age. All injection regimens using the 
biologically active 3D 12 antibody resulted in impaired developm ent of the 
parasympathetic nervous system. Pre and postnatal administration of 3D 12 produced the 
largest decrease in CAT activity (P<0.005 using Student T-test with Bonferroni 
correction). Injection of the biologically inactive 5G9 antibody was without effect on 
CAT activity at 3 weeks of age. Similarly, X-63 derived ascites did not significantly 
reduce CAT activity below control levels.
In contrast to the pronounced decrease in CAT activity produced by perinatal 
administration of 3D 12 antibody, injection of the antibody (2.5|il ascites/g body weight 
on alternate days) into adult mice for two weeks had no effect on iridal CAT activity 
(figure 3.10)
The specificity of the antibody effect is shown in figure 3.11. TOH activity in the same 
irides used in figure 3.10 is not significantly affected by any treatment regimen, thus 
eliminating the possibility of a generalized non-specific toxic effect of the antibody on all 
axon terminals within the iris.
Discussion
All stable clones produced antibody that recognized HBGF-1 in solid phase assay. 
Antibodies were initially screened by ELISA (Watters et al.1989) and bound HBGF-1 on 
western blots (figures 3.6 and 3.7). No antibodies bound immunoblots of HBGF-2. In 
contrast, Pettmann et al.(1986) produced 8 monoclonal antibodies against HBGF-2, all 
of which recognized both HBGF-1 and HBGF-2. The reason for this apparent 
discrepancy is unclear although may relate to purity of the antigen; overall sequence
IA B C D
Figure 3.6. Detection of beef heart-derived HBGF-1 on western blots. Lanes A,B,C 
show immunoblots using 2B11, 5G9 and 3D 12 monoclonal antibodies respectively. Lane 
D shows the corresponding silver stained gel of the pure factor. Primary antibodies were 
prepared as ammonium sulfate fractions of ascites fluid and used at 1:400 dilution.
- 9 4
Figure 3.7. Detection of bovine brain-derived acidic but not basic FGF on western 
blots by the indicated monoclonal antibodies: a=acidic FGF, b=basic FGF. X-63 is the 
parent myeloma cell line. The accompaning silver stained gel is shown on the right. 
Freshly collected tissue culture medium was used as the source of primary antibodies.
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Figure 3.8. Time course of the effect of 3D 12 antibody administration on the normal 
developmental pattern of choline acetyltransferase activity in the mouse iris. 3D 12 
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Figure 3.9. Effect of (i) different treatment regimens and (ii) different antibodies on 
choline acetyltransferase activity in the 3 week old mouse iris. Treatment regimens were 
as described in methods. Control animals received no treatment. X-63 ascites was 
generated by the parent myeloma cell line. * differs from control P < 0.05; ** differs 
from control P < 0.005. Values represent means and standard errors for groups of 6-8 
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Fig 3.10. Effect of different treatment regimens on choline acetyltransferase activity in 
the 13 week old mouse iris. Pre and postnatal regimens were as described in methods. 
Adult animals were injected with 50|il of 3D 12 ascites fluid on alternate days from 11 to 
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Figure 3.11. Effect of different antibody treatments on tyrosine hydroxylase activity in 
the 13 week old mouse iris. Injection regimens were as described for figure 3.10.
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homology between the two factors is only 53% (74 out of 140 amino acids; Esch et 
al. 1985a; Strydom et al. 1986).
Of the monoclonal antibodies raised, only 3D 12 inhibited in vitro biological activity of 
HBGF-1 as determined by the ciliary neuronal survival assay. While it is recognized that 
the degree of inhibition depends on antibody concentration and affinity of the antibody 
for the factor, the consistency of 3D 12 in inhibiting the HBGF-1 response suggests it is 
directed at or near the active site of the factor. Monoclonal antibodies capable of blocking 
the in vitro activity of NGF have been produced (Warren et al.1980; Businaro et al. 1981; 
Zimmermann et al.1981), although, as described above for the anti-beef factor, several 
antibodies that bound NGF in solid phase assay were without effect on the biological 
activity of NGF (Businaro et al.1981). This would suggest that, despite their size, 
antibodies can bind epitopes on either factor that do not result in inhibition of receptor 
binding or activation. Alternatively, the binding of the given factor to a solid support 
generates or exposes epitopes that, in solution, may mediate only weak binding. 
Accumulated evidence would suggest that the biologically active antibodies interact with 
NGF to prevent binding to its receptor rather than precipitating the factor from solution 
(Zimmermann et al.1981). In one case inhibition of NGF activity by Fab fragments was 
identical to the intact monoclonal antibody (Warren et al.1980). It would be of interest to 
determine if Fab fragments derived from the 3D 12 antibody retain blocking activity 
against HBGF-1.
The isotype produced by the 3D 12 clone is relevant in several respects. Production of 
IgA secreting hybridomas using standard (i.e. short term systemic) immunization 
procedures is rare (Komisar et al. 1983), although spleen-derived IgA producing 
hybridomas have been reported (Sharon et al. 1981). Protocols that involve stimulation of 
gut associated lymphoid tissue (GALT) and/or fusion of GALT derived plasma cells 
have been designed to specifically increase the probability of obtaining IgA producing 
clones (Rits et al. 1986; Colwell et al. 1982; Komisar et al.1982; Colwell et al.1983). It is 
possible that in vitro immunization may favour the differentiation of IgA producing 
plasma cells, although the spleen cells used would not be expected to contain more than 
normal numbers of IgA plaque-forming cells. Both chromatographic and electrophoretic 
evidence of 3D 12 polymeric heterogeniety was obtained and it is probable that the degree 
of aggregation changed with time in culture (results not shown). Secretion of polymeric 
IgA by hybridomas is well described (Sharon et al.1981; Rits et al.1986). In one study 
50% of the antibody was secreted in polymeric form, with aggregates up to H 12L 12 
distinguishable. The authors attributed the high degree of IgA polymers to a 'double 
dose' of the J peptide, contributed both by the parent myeloma and spleen cells (Sharon
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et al. 1981). The 3D 12 clone was however generated by the fusion of the non-secreting 
X-63 cell line. It is possible the degree of polymerization may determine the biological 
activity of the antibody; steric hindrance by high MW forms could be expected to disrupt 
receptor binding or activation. However, given that the antigen is monomeric and 
unlikely to be precipitated from solution, the higher effective valency conferred by 
multiple sub-units is not relevant in this case.
Explanations for the heterogeniety observed in figure 3.5 are not entirely satisfactory. 
Evidence that the fractions are indeed pure is based only on previous standardization of 
the ABx column with IgG and IgM containing ascites fractions. Using the gradient 
described, IgG normally eluted at around 16 minutes and IgM at about 22 minutes; no 25 
- 30' peaks were seen with either sample. It is possible that the bands seen in figure 3.5 
lane 2 are the result of different combinations of heavy and light chains. It is worth 
noting that in BALB/c mice the light chains of IgA are not disulfide bonded to the heavy 
chains (Goding, 1983). All high molecular weight bands disappear with reduction. The 
multiple bands seen in the regions of the heavy chain in the reduced sample may 
represent variation in the degree of intrachain reduction, different glycosylation states or 
impurity.
Despite the reported resistance of IgA to proteolysis (Goding, 1983; Roitt, 1984) 
stability of the 3D 12 antibody was a major problem. Biological activity, but not 
necessarily binding activity, of the 3D 12 antibody was lost with time in culture, storage 
and purification. Maximal activity was retained when the antibody was stored as an 
ammonium sulfate precipitate and reconstituted and dialysed before use. It is possible 
preferential breakdown or loss of high MW forms may result in loss of biological activity 
with retention of binding activity as assessed by solid phase assay; the ability to 
recognize HBGF-1 on immunoblots would presumably be retained by the lower 
molecular weight forms.
The ability of the 3D 12 antibody to disrupt parasympathetic but not sympathetic 
development would appear to be analogous to the immunosympathectomy resulting from 
anti-NGF exposure. In both cases there is a developmental period during which the 
antibody is maximally active and the neurotoxic effect is attenuated in the adult (Angeletti 
et al. 1971; Black et al.1972). Monoclonal NGF antibodies capable of producing an 
immunosympathectomy has been described (Businaro, and Revoltella, 1982). In 
accordance with the present study, only the monoclonal antibodies effective in inhibiting 
the biological activity of NGF in vitro produced an immunosympathectomy when 
injected into neonatal mice. Antibodies without in vitro activity were ineffective in vivo.
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Together these data would suggest a similar mechanism of action for anti-NGF and anti- 
HBGF-1. Several lines of evidence have suggested that anti-NGF neutralizes 
endogenous NGF (or cross reacting molecules ) by a mechanism that does not require 
complement activation (Banks et al. 1978; Goedert et al.1980). Indeed the ability of IgA 
to fix complement is variable and normally occurs through the alternative pathway (Roitt, 
1984). Rat IgA immune precipitates will convert rat C3 but not human or guinea pig 
(Rits et al.1987); polymeric antibody was more efficient at C3 conversion than the IgA 
monomer. If indeed complement activation is required for 3D 12 induced neurotoxicity, 
preferential breakdown of the polymeric forms may again account for the loss of 
biological activity.
Additional experiments aimed at further describing the in vivo effects of 3D 12 antibody 
were planned but were later abandoned because of inability to stabilize the biological 
activity of the IgA. Late in the project the immunoparasympathectomy was repeated by 
injection of hybridoma cells under the loose dorsal skin of the neonatal mouse. Over the 
course of 3 weeks antibody producing subcutaneous tumors were formed without overt 
deleterious effects on the host. Again CAT activity in the iris was decreased some 50%; 
5G9 derived tumors were without effect on enzyme activity.
Antibodies have been generated against two other putative neurotrophic factors. Anti- 
purpurin, although able to disrupt the attachment promoting properties of purpurin 
(Schubert, and LaCorbiere, 1985a) has not been reported to exert an in vivo (or indeed in 
vitro) neurotoxic action. The in vivo administration of anti-neuroleukin to adult or 
neonatal rats is without effects on motor neuron survival. It is worth noting however that 
antibodies effective in inhibiting terminal sprouting in the adult rat in response to 
botulinum toxin (Gurney et al. 1986c) were able to block the in vitro neurotrophic activity 
of neuroleukin (Gurney et al. 1986b).
Unlike IgG, IgA does not cross the placenta (Roitt, 1984). It is likely that the effects 
resulting from prenatal administration of 3D 12 are due to maternal transfer of antibody in 
milk. Such a mechanism is extremely effective in producing an immunosympathectomy. 
The titre of NGF antibodies in 2 week old fetuses bom to NGF-immunized females 
fostered to normal mothers is only one-tenth those bom to normal females then fostered 
to antibody producing mothers (Gorin, and Johnson, 1979). Neonatal rats nursed by 
NGF-immunized females will develop only 10-37% of total SCG protein and TOH 
activity compared to controls (Gorin, and Johnson, 1979; Johnson et al.1980). 
Similarly, administration of heterologous NGF antisemm to lactating mothers will 
immunosympathectomize their young (Levi-Montalcini, and Angeletti, 1966).
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The failure of the 3D 12 antibody to completely eliminate CAT activity may have several 
explanations:
(i) it is possible that some parasympathetic neurons mature prenatally when antibody 
administered to the mother is not available to the fetus (cf sensory neurons);
(ii) similarly, the antibody titre achieved postnatally may have been insufficient to 
completely inhibit activity of the factor. The possible additive effect of antibody obtained 
by suckling would seem to support this contention . A dose related 
immunosympathectomy has been reported in studies using polyclonal anti-NGF 
(Edwards et al. 1972; Hendry, and Iversen, 1971). However, it is worth noting that a 
single postnatal injection of biologically active monoclonal anti-NGF (0.02ml ascites/g 
body weight at day 1) was sufficient to produce an immunosympathectomy in mice, with 
SCG TOH activity 1% of control values at day 9 (Businaro, and Revoltella, 1982).
(iii) Even postnatally, 3D 12 antibody may have been unable to gain access to all sources 
of the endogenous factor.
(iv) there may be some subpopulations of ciliary neurones that mature independently of 
the factor (or any cross-reacting factors). An analogous situation exists with respect to 
NGF. While the vast majority of paravertebral sympathetic neurons are dependent on 
NGF for survival, subpopulations of prevertebral sympathetic neurons are insensitive to 
treatment with NGF antiserum (Levi-Montalcini, 1962; Hill et al. 1985).
Is HBGF-1 therefore a biologically relevant neurotrophic factor? A series of experiments 
analogous to earlier investigations that established NGF as a survival factor (see e.g. 
Hendry, 1975a; Hendry, 1975c; Hendry, and Campbell, 1976; Hendry, 1977; Dibner et 
al.1977; Hamburger et al. 1981) have shown the HBGFs possess in vivo neurotrophic 
activity. bFGF applied to the distal end of the transected sciatic nerve rescues some 53% 
of sensory neurons that would otherwise degenerate (Otto et al.1987). Using the same 
paradigm, NGF rescued 100% of the axotomozed sensory neurons. Similarly, both 
basic and acidic FGF, when applied between the distal and proximal stumps of the 
transected optic nerve, increase the number of surviving retinal ganglion cells at 30 days 
post axotomy (Sievers et al.1987). Intraventricular infusion of bFGF after fimbria-fornix 
transection in adult rats rescues 45% of diagonal band of Broca and 47% of medial septal 
cholinergic neurons (Anderson et al.1988). This proportion increases to 74% and 66% 
respectively in younger animals. Moreover, bFGF can replace target tissue in 
maintaining preganglionic sympathetic innervation to the adrenal medulla (Blottner et 
al. 1989). Implantation of bFGF soaked gel foam into the cavity formed by electro­
cautery of the adrenal medulla prevents degeneration of the intermediolateral neurons that 
supply the adrenal. More recently, bFGF has been reported to prevent ontogenetic cell
death in the chick ciliary ganglion (Dreyer et al.1989). Some 44% of ciliary neurons 
present at E8 will degenerate by E l4; administration of bFGF to the chorio-allantoic 
membrane over this period reduces this proportion to 13%.
Thus the HBGFs, as in vitro and in vivo survival promoting agents, would seem to fulfil 
several criteria that define a neurotrophic factor. HBGF-1 does exhibit some specificity 
with respect to neuronal source; whilst able to maintain both chick DRG and ciliary 
neurons in vitro, no activity could be demonstrated for sympathetic neurons.The 
apparent specificity of HBGF-1 for subicular and retinal neurons was alluded to in 
Chapter 2. Moreover, maximal activity for both the sensory and ciliary neurons was 
observed at embryonic ages that correspond to the time of developmental cell death in 
vivo (Landmesser, and Pilar, 1974b; Hamburger et al.1981). The observation that 
antibodies to HBGF-1 disrupt parasympathetic development and that in vivo 
administration of HBGF-2 prevents a significant proportion of developmental cell loss 
(Dreyer et al.1989) would suggest an in vivo dependence on HBGFs during this critical 
period of development. Furthermore, the studies discussed above have shown HBGFs 
can replace the neurotrophic effect of the target tissue after axotomy.
Several aspects of the known biology of these proteins are, however, not in keeping with 
classical neurotrophic theory; these relate to (i) concentration in target tissues; (ii) 
mechanism of storage and release from target tissues; and (iii) their distribution in target 
tissues. FGF has been immunohistochemically localized to neurons of the rat cortex, 
hippocampus and cerebellum (Pettmann et al.1986; Janet et al.1987) as well as central 
and peripheral neurons of the rat and chicken in vitro (Janet et al.1988). Non-neuronal 
cells were unstained. Whilst these studies used antibodies that react with both HBGF-1 
and HBGF-2, they do reveal the intraneuronal presence of FGF or FGF-like molecules 
in relatively high concentration. Moreover, recovery of HBGF-1 from both the brain and 
heart by heparin affinity chromatography is about 500qg/kg of tissue (chapter 2). This 
would seem to contravene a basic premise of neurotrophic theory which holds that any 
relevant trophic molecule is present in the target cell in limiting concentration. Both NGF 
and BDNF are present in target tissue in concentrations about 100-fold less than HBGF- 
1 (K orsching, and Thoenen, 1983a; Barde et al. 1982); NGF cannot be 
immunohistochemically localized in normal untreated target tissue (Rush, 1984; Finn et 
al.1986) nor can NGF be purified from a target tissue other than the male mouse sub­
maxillary gland.
Sequence data for both HBGF-1 and HBGF-2 reveal the absence of a conventional 
hydrophobic or signal sequence that characterizes secreted molecules (Abraham et
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al. 1986; Jaye et al.1986) and intracellular HBGF is not seen within vesicular or 
membranous structures (Janet et al. 1987). This feature is shared by CNTF (Lin et 
al. 1989; Stockli et al. 1989), but not BDNF (Leibrock et al. 1989) or NGF (Scott et 
al. 1983; Ullrich et al.1983) each of which contain a classical signal peptide (although the 
307 amino acid precursor NGF protein does not contain a hydrophobic signal peptide 
(Scott et al.1983; Ullrich et al.1983), it is likely that initiation of prepro-NGF occurs at a 
methionine some 66 amino acids downstream, which is followed by a classical signal 
sequence. Identification of transcripts lacking the first initiator codon as the major form 
in most mouse tissues (Edwards et al.1986; see also Schwarz et al. 1989) would support 
this). The absence of a glycosylation consensus sequence would further suggest that 
HBGF-1 is a cytosolic protein. The question therefore arises as to how the HBGFs exit 
from the cell: their association both in vivo and in vitro with the extracellular matrix, and 
the presence of high affinity receptors on a variety of cell types (see Chapter 2) would 
suggest such a mechanism exists. For example, cultured cardiac myocytes express aFGF 
mRNA although no translated protein can be recovered from cell lysates; biologically 
active aFGF does however accumulate in the muscle cell derived ECM (Weiner, and 
Swain, 1989). Several authors have proposed a novel secretion whereby the HBGFs are 
released in association with GAGs, in particular HSPGs (Baird, and Ling, 1987; 
Winkles et al. 1987; Bashkin et al.1989). Although purpurin - a heparin binding protein 
with neurotrophic activity (Schubert et al. 1987a) - is found in association with GAG 
complexes in conditioned media (Schubert et al. 1983b; Schubert et al. 1983a; Tsui et 
al. 1988), its mRNA does code for a 21 amino acid amino-terminal signal sequence 
(Berman et al. 1987). Others have proposed that HBGFs are released following cell 
damage or death (eg Bashkin et al.1989; Jaye et al.1986); such a mechanism seems 
somewhat non-specific and without the control that would be expected of a regulatory 
peptide. The suggestion that a potential neurotrophic factor is released with 
developmental cell death (Unsicker et al. 1987) is clearly inconsistent with the 
neurotrophic hypothesis. An unconventional release mechanism cannot be excluded. 
Interestingly, the addition of a signal peptide to bFGF by the transfection of a chimeric 
expression vector induces autocrine transformation of NIH3T3 cells (Blam et al. 1988; 
Rogelj et al. 1988). It is also worth noting that all of the recently described HBGFs 
(i.e.excluding acidic and basic FGF and to some extent Int-2) do contain a N-terminal 
signal sequence (see discussion chapter 2). The possibility that any or all of these 
molecules are neurotrophic factors remains to be investigated. Given the sequence 
homology existing between HBGF-1 and the remainder of the HBGFs, it is possible that 
the neurotoxic effect of the 3D 12 antibody is due to binding of a shared epitope on an as 
yet uncharacterized trophic molecule.
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Finally, we were unable to demonstrate convincing retrograde transport of either the 
basic or acidic forms of FGF (Chapter 2; autoradiography would be required to exclude 
transport to a small number of neurons). Whilst not considered an absolute requirement 
for a neureotrophic factor by some authors (Thoenen, 1988) this observation 
nevertheless is not in keeping with the NGF paradigm as described in the introduction; 
despite possessing in vivo neurotrophic activity, these molecules fail to comply with 
criteria previously laid down for a retrogradely transported neurotrophic factor. Indeed it 
is possible that several aspects of current neurotrophic dogma require modification.
Competition for a limited resource is dependent not only on absolute amounts of the 
given trophic factor present in the target tissue but also its availability to the ingrowing 
axons. Oppenheim has recently suggested that increased availability rather than increased 
production of trophic factor may account for the decrease in histogenetic cell death seen 
with chronic neuromuscular blockade (Oppenheim, 1989). According to his hypothesis, 
axons compete for access to a target-derived neurotrophic factor that may be present in 
saturating concentrations. It is possible HBGF sequestered either intracellularly or in the 
extracellular matrix may not be readily available to neuronal processes; proteolytic 
activity associated with the growth cone (Pittman, 1985) and its modulation by target 
tissue derived protease inhibitors (Pittman, and Patterson, 1987) may govern the amount 
of FGF released into the neuronal micro-environment.
Whilst NGF and its receptor are transported retrogradely from the peripheral process to 
the cell body of the sympathetic (Hendry et al. 1974a), and sensory (Brunso-Bechtold, 
and Hamburger, 1979) neuron, to date there is no evidence that such retrograde transport 
of NGF is required for the molecule to exert its neurotrophic action. It remains possible 
that an as yet unidentified second messenger is responsible for the nuclear actions of the 
NGF molecule and its retrograde transport may be just an effective mechanism of 
removal from the target tissue. A neurotrophic molecule, which under normal conditions 
remains tightly bound to the extracellular matrix, may have no need for such a clearance 
mechanism; inability to demonstrate retrograde transport does not exclude the possibility 
that a second messenger system transmits information to the nucleus.
The role of the FGFs in neurogenesis may not be restricted to those developmental stages 
traditionally addressed by neurotrophic theory. For example bFGF stimulates the in vitro 
proliferation of neuroblasts dissociated from E13 rats (Gensburger et al. 1987; see also 
Murphy et al.1989); EGF, PDGF, IGF-1, IL-2, and thrombin were ineffective. The 
observation that neither acidic or basic FGF affect proliferation of E7 chick sympathetic 
neurons (Emsberger et al.1989) implies some specificity to its mitotic action. FGFs may
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also be involved in the differentiation of the neuronal precursor cells. Adrenal chromaffin 
cells exposed to bFGF will aquire neuronal characteristics including neurite, expression 
of SCG10 and dependence on NGF for long term (>6d) in vitro survival (Stemple et 
al. 1988).
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Chapter 4
Relationship between the ability of heparin to bind to, and potentiate the 
biological activity of, HBGF-1: characterization by structural
modification of heparin
56
Introduction
The sulfated polysaccharides are high molecular weight polymers widely distributed in 
both plant and animal tissues. The four families of vertebrate glycosaminoglycans 
(GAGS) include chondroitin/dermatan sulfate, heparin/heparan sulfate, keratin sulfate 
and hyaluronic acid. Except for hyaluronic acid, the GAGs exist in vivo as 
proteoglycans, i.e. the sulfated polysaccharide component covalently attached to a core 
protein.
Of the GAGs heparin/heparan sulfate have received the most attention in the experimental 
literature. This has been due firstly to their relatively high charge density and hence 
propensity to interact with a variety of ligands including ECM components, transport 
proteins, enzymes and growth factors, and secondly, their ability to specifically interact 
with antithrombin III (A'l’Ill) which has resulted in the widespread clinical use of heparin 
as an anticoagulant. The current study describes the structural features of the heparin 
molecule that determine (i) HBGF-1 binding and (ii) potentiation of HBGF-1 biological 
activity. The remainder of the GAGs are considered in the succeeding section.
Heparin and heparan sulfate
Heparin and heparan sulfate proteoglycans (HSPGs) have been implicated in a range of 
biological functions, including cell-cell (Cole et al.1986) and cell-substratum (Culp et 
al.1980; Schubert, and LaCorbiere, 1985b; Cole, and Glaser, 1986) adhesion, cellular 
proliferation and differentiation (Fritze et al.1985; Castellot et al. 1981; Fedarko, and 
Conrad, 1986) neurite outgrowth (Hantaz-Ambroise et al.1987), synaptic function 
(Anderson, and Fambrough, 1983) myelination (Carey et al.1987), matrix assembly 
(Laurie et al.1986), in vivo coagulation (Marcum, and Rosenberg, 1989), and capillary 
permeability (Farquhar, 1981). Many examples of tissue pathology associated with 
altered HSPG synthesis or distribution have been described (Poole, 1986).
Structure
Like all the GAGs (except keratin sulfate which is not considered further in these studies) 
heparin and heparan sulfate are made up of repeating disaccharide units comprising a 
uronic acid and an amino sugar. They are defined by their prevalent structure, the 
trisulfated disaccharide a - 1,4 linked L -iduronic acid 2 sulfate-* D glucosamine N,6- 
disulfate (IdoUA-2S—>GlcNS03-6S; see fig.4.1a; Casu, 1989) which accounts for 
greater than 70% of the disaccharide units in heparin (Guo, and Conrad, 1989). Marked
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structural heterogeneity exists, with respect to both chain length and structure. 
Incomplete biosynthesis and the substrate specificities of the biosynthetic enzymes allow 
for some 17 different uronic acid —> amino sugar and 10 amino sugar —» uronic acid 
disaccharide units which occur semi-randomly along the polysaccharide chain producing 
an complex mixture of polymer structures differing in their disaccharide sequences, 
content o f glucuronic acid (GlcUA), IdoUA and N- and O-linked sulfates. Despite 
differences in distribution and sites of synthesis (see below) the polysaccharide chains of 
heparin and heparan sulfate are qualitatively similar, characterized by the large 
percentage of sulfated glucosamine residues (Lindahl et al.1989). Definitions of 
distinction between the two polysaccharide chains have varied over time and with 
authorship (Marcum, and Rosenberg, 1989; Lindahl et al.1989). In general, differences 
reflect the degree of polymer maturation (Lidholt et al.1989); the more highly epimerized 
and sulfated polymers (i.e.containing higher iduronic:glucuronic acid ratios and an 
increased percentage of N-sulfated hexosamines) are more typical of heparin than 
heparan sulfate, although no strict structural criteria exist. Conrad (1989) states 
"structural definitions between heparan sulfate and heparin, if they can be drawn at all, 
are subtle."
In vivo distribution
In vivo both heparin and heparan sulfate are synthesized as proteoglycans by different 
cell types on distinct core proteins (Lindahl et al.1989). Heparin is synthesized and 
sequestered in mast cells where endoglucuronidase cleaves the polysaccharide chains to 
produce the heterogeneous mixture of chains (MW 5000-30,000) found in commercial 
preparations (Lindahl et al.1989; Lindahl, and Kjellen, 1987). In contrast, the heparan 
sulfate proteoglycans are ubiquitous components of the extracellular matrix and cell 
membranes (Hook et al.1984; Ruoslahti, 1988; Hassell et al.1980); their synthesis (at 
least in vitro) is a function of almost all mammalian cell lines investigated including 
epithelial cells and fibroblasts (Rapraeger, and Bemfield, 1983; Saunders, and Bemfield, 
1988), hepatocytes (Bienkowski, and Conrad, 1984), endothelial cells (Moscatelli, 
1988), myotubes (Noonan et al.1986) neurons (Schubert, and LaCorbiere, 1985b; 
Matthew et al. 1985) and various tumor lines including PC12 cells (Matthew et al. 1985) 
and L6 muscle cells (Schubert et al. 1983b). In general the HSPGs are smaller than the 
heparin proteoglycans, their chains fewer, shorter and more sparsely distributed on the 
protein core (Gallagher et al.1986). Significant diversity in size and structural 
organization exists and there is immunological evidence for different classes of core 
proteins (Conrad, 1989).
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HSPGs are associated with both central and peripheral nervous tissue. Total HSPG 
levels in brain and the SCG have been quantitated and shown to change with early 
development (Margolis et al. 1975; Greif, and Reichardt, 1982). HSPGs have been 
immunohistochemically localized to basal laminae throughout the peripheral nervous 
system, including synaptic and extrasynaptic basal laminae of muscle fibres, the 
perineurium and endoneurium of axonal sheaths, and the BL of ganglionic satellite cells 
(Eldridge et al.1986; Chiu et al. 1986; see also Greif, and Reichardt, 1982). In vitro 
HSPGs are incorporated into the membranes of neurons dissociated from the cerebellum, 
cerebral cortex, the SCG and the DRG (Matthew et al. 1985) and a subpopulation of 
embryonic chick retinal neurons (Schubert, and LaCorbiere, 1985b; Morris et al. 1987).
Heparin interaction with protein ligands
Heparin will bind - and in many cases alter the biological activity of - a large number of 
protein and glycoprotein ligands. These include collagen (Laurie et al.1986; Koliakos et 
al.1989; Grant et al.1989), fibronectin (Yamada et al.1980; Wightman et al.1986; Gold 
et al. 1983; Benecky et al. 1988), laminin (Woodley et al. 1983; Kleinman et al. 1983; 
Kouzi-Koliakos et al.1989) and N-CAM (Cole et al.1985; Cole, and Glaser, 1986; Cole 
et al.1986; Cole, and Akeson, 1989).
HSPGs function as receptors both for exogenous ligands and in various processes that 
involve cell adhesion. For example lipoprotein lipase is attached to the luminal surface of 
blood vessels via an HSPG, where it acts on circulating lipoproteins to release fatty acids 
(Oka et al.1989). A similar receptor function has been proposed for TGF-ß (McCaffrey 
et al.1989), the HBGFs (D'Amore, and Klagsbrun, 1984; Bashkin et al.1989; 
Moscatelli, 1988) and a recently described neuronal cell surface mitogen for schwann 
cells (Ratner et al.1988). An HSPG is a cell surface component of chick embryo retinal 
cells which interacts with the glycoprotein complexes termed adherons to promote cell­
cell and cell-substratum adhesion (Schubert, and LaCorbiere, 1985b). The cell surface 
HSPG was later shown to interact specifically with two components of adherons - a 
170,000 MW glycoprotein later shown to be identical to N-CAM (Cole et al.1985; Cole, 
and Glaser, 1986) and a 20,000 MW protein termed purpurin, itself a survival factor for 
chick retinal and ciliary neurons (Schubert, and LaCorbiere, 1985a; Schubert et 
al. 1987a). Culp and his co-workers have provided good evidence that cell surface HSPG 
binding to a fibronectin substrate is necessary for close contact formation and 
microfilament organization (Laterra et al.1980; Culp et al.1989; Gill et al.1986; Silbert et 
al.1989). BALB/c3T3 cells detached from the substrate by EGTA leave 'footpad 
adhesion sites' enriched in fibronectin and HSPGs (Culp et al.1980; Mugnai et al.1988).
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The association of laminin and HSPGs is one that has held particular interest for 
neurobiologists. It is now clear that the so called 'polyomithine attachable neurite 
promoting factors' - molecules released by a variety of cultured cell lines and able to bind 
polycationic surfaces to promote neurite outgrowth (Collins, 1978b; Adler, and Varon, 
1980; Adler et a l l 981; Lander et al.1983)- are composed of laminin-HSPG complexes 
(Länderet al.1982; Länderet al. 1985a; Länderet al.1985b; Calof, and Reichardt, 1985; 
Davis et al.1985). Whilst most authors agree that the neurite promoting activity resides in 
the laminin molecule, it has been known for some years that antibodies which inhibit the 
neurite promoting activity of purified laminin are inactive against the conditioned media 
derived laminin-HSPG complex (Edgar et al.1988; Lander et al.1983; Lander et 
al. 1985b; Davis et al.1985). Although it is possible that the CM derived laminin is 
structurally different from the purified (EHS-derived) laminin - and there is some 
evidence for this (Edgar et al.1988; Davis et al.1985) - it is highly probable that HSPG 
activates the laminin in much the same way as has been described for fibronectin (Khan 
et al.1988), plasminogen activator (Stein et al.1989), N-CAM (Cole et al.1985) and the 
fibroblast growth factors (Schreiber et al. 1985b).
Interestingly, a monoclonal antibody capable of blocking CM-derived neurite promoting 
activity (Matthew, and Patterson, 1983), inhibiter of neurite outgrowth or INO, 
recognizes an epitope unique to the laminin-HSPG complex (Chiu et al.1986). It is 
possible that this epitope, generated either by a conformational change in the laminin 
molecule or by the combination of laminin and the HSPG, is the in vivo substrate for 
axonal elongation or regeneration. Such a contention is supported by the 
immunohistochemical localization of the INO epitope (Chiu et al.1986) and the ability of 
INO to perturb neurite regeneration in vitro (Sandrock, and Matthew, 1987a) and in vivo 
(Sandrock, and Matthew, 1987b), and disrupt cranial neural crest migration (Bronner- 
Fraser, and Lallier, 1988). Anti-laminin alone was without effect in these studies 
(Sandrock, and Matthew, 1987a; Bronner-Fraser, and Lallier, 1988).
Heparin-FGF interactions
An interaction between the mitotic growth factors and heparin was first reported by 
Thornton and her colleagues (Thornton et al.1983) who showed that the addition of 
heparin to cultured HUVE cells supported by a crude ECGF preparation (bovine 
hypothalamus extracted at neutral pH; Maciag et al. 1979a) increased both the 
proliferative capacity and lifespan of the endothelial cells. Cultures grew to higher cell 
densities, doubling time was decreased and ECGF requirement was reduced 100-fold.
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This observation was followed by the report that a chondrosarcoma derived cationic 
mitogen - now known to be bFGF - bound with high affinity to heparin sepharose and 
this interaction greatly facilitated its purification (Shing et al.1984). Heparin is now 
known to potentiate the mitotic (Gimenez-Gallego et al. 1986a; Schreiber et al. 1985b; 
Uhlrich et al.1986), chemotactic (Terranova et al.1985; Herbert et al. 1988), neurotrophic 
(Unsicker et al. 1987; Lipton et al. 1988; Wagner, and D'Amore, 1986; Rydel, and 
Greene, 1987) and angiogenic (Lobb et al.1985) properties of the pure acidic mitogen 
(HBGF-1). Moreover, heparin affinity chromatography was rapidly applied to the 
isolation of acidic (Maciag et al.1984) and basic (Gospodarowicz et al.1984) forms of 
FGF and now forms the basis of the standard purification for these proteins (Lobb et 
al.1986; chapter 2)
Current thought is that these two phenomena are linked (Burgess, and Maciag, 1989); 
i.e. the binding of heparin to FGF acts to potentiate its biological activity. Evidence for 
such a mechanism is as follows:
(i) The binding of heparin to HBGF-1 causes a conformational change in the protein. The 
affinity of two neutralizing monoclonal antibodies to HBGF-1 was enhanced by heparin, 
suggesting exposure of epitopes by a change in conformation of the protein (Schreiber et 
al.l985b). This has been substantiated by fluorescence spectroscopy (Jaye et al.1987). 
Similar conformational changes have been demonstrated following the binding of heparin 
to N-CAM (Cole et al.1985), AT-III (Chang, 1989) and fibronectin (Khan et al.1988). 
No studies to date have shown that such a conformational change is required for heparin 
induced potentiation of HBGF-1 biological activity.
(ii) Heparin binding is known to protect HBGF-1 against attack by a number of 
proteolytic enzymes, including trypsin, thermolysin, plasmin and thrombin (Rosengart et 
al.1988; Lobb, 1988). That a HBGF-heparin complex is required is suggested by the 
loss of the ability of heparin to protect against trypsin proteolysis after heat denaturation 
of HBGF-1. Heparin also protects both basic and acidic FGF from acid and heat 
denaturation, an effect lost in the presence of salt concentrations that would result in 
dissociation of either factor from heparin (Gospodarowicz, and Cheng, 1986; see also 
Rosengart et al.1988). The addition of heparin to tissue culture medium can recover the 
potency of both acidic and basic FGF stored at -80° for 3 months to a level equivalent to 
freshly prepared bFGF (Gospodarowicz, and Cheng, 1986). Interestingly, the simple 
passage over a heparin affinity column restored some 80% of the biological activity of a 
HBGF-1 sample that had been stored at -20° for 6 months (Schreiber et al. 1985b) 
although the mechanism here remains obscure - presumably heparin leaches from the 
column and remains bound to the eluted HBGF-1. This evidence would suggest that the 
binding of heparin not only changes the 3 dimensional structure but also confers
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conformational or structural stability to HBGF-1 and/or physically covers the sites of 
proteolytic attack. Protection against denaturation by heparin is not limited to the FGFs; 
for example, early studies reported that heparin binds to and protects trehalose phosphate 
synthetase from heat denaturation and proteolytic attack (Elbein, and Mitchell, 1975). 
Several further in vitro observations are also relevant:
(iii) The higher cell densities achieved by the addition of heparin to HBGF-1 supported 
cultures could be reproduced by the more frequent addition of HBGF-1 alone, 
suggesting heparin prolongs the biological activity of the factor (Rosengart et al. 1988). 
Similarly heparin does not potentiate the ability of aFGF to induce neurite outgrowth by 
PC 12 cells when FGF is exchanged every 5 hrs, but does potentiate activity when aFGF 
is added once at the time of culture initiation (Damon et al. 1989). Further, the presence 
of heparin increased the in vitro biological half-life of FGF from 7 to 36 hrs, an effect 
attributed to protection from degradation by an aprotinin sensitive protease (Damon et 
al.1989). Incubation of FTBGF-1 in serum containing medium over HUVE or LEII 
(murine lung capillary endothelial ) cells results in its proteolytic fragmentation, 
producing a similar inactive 14kD fragment to that resulting from thrombin exposure 
(Lobb, 1988). Incubation with fetal bovine serum caused the same effect, pointing to the 
serum proteases as the cause of the proteolytic modification. Furthermore, an experiment 
reminiscent of the early attempts to define the ATIII binding site (Gordon et al.1989) 
found that 40% of HSPGs extracted from the ECM of cultured endothelial cells bound to 
an aFGF affinity column; this fraction was some 100-fold more active in potentiating the 
mitogenic action of aFGF than heparin. The flow through fraction inhibited aFGF 
induced mitogenesis of endothelial cells. The two fractions were found to differ in both 
size of their core proteins and GAG chains.
(iv) Schrieber et.al., (1985) have provided compelling evidence that the modulation of 
ECGF activity by heparin also occurs at the receptor level. Heparin enhanced the binding 
of ECGF to LEII cells , decreasing the apparent Kd some 2.5-fold. This corresponded to 
a 5-fold decrease in the EC50 for the stimulation of thymidine uptake. Other studies have 
shown that decreasing the affinity of HBGF-1 for heparin by proteolytic or chemical 
modification produces a corresponding decrease in the affinity for the receptor and a 
decrease in mitotic activity (Lobb, 1988; Harper, and Lobb, 1988). However Neufeld et 
al.(1987) report that the interaction of aFGF with its receptor on PC 12 cells is unaffected 
by heparin.
The ability of heparin to potentiate basic FGF is less clear. Most authors concede that 
heparin has essentially no effect on the activity of basic FGF (Thomas, and Gimenez- 
Gallego, 1986). However a 2-2.5 times increase in the activity of human bFGF has been 
reported for bovine BEL cells and CCL39 fibroblasts (Uhlrich et al.1986) and HUVE
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cells (Gimenez-Gallego et al. 1986a). Heparin potentiation of bFGF induced neunte 
outgrowth by PC 12 cells was shown to be dependent on HBGF-2 concentration; 
inhibition of bFGF activity by heparin may be the result of competition with the FGF 
receptor for low concentrations of bFGF (Neufeld et al. 1987). The situation has been 
partially clarified by Gospodarowicz and Cheng (1986), who found the addition of 
heparin decreased the ability of subsaturating concentrations of fresh bFGF to stimulate 
the proliferation of BHK cells, although it potentiated the activity of stored bFGF to a 
level equivalent to freshly prepared bFGF. Interestingly bFGF is not susceptible to 
thrombin proteolysis (Lobb, 1988), although matrix derived HSPGs will bind basic 
FGF and protect it from plasmin degradation (Saksela et al. 1988).
The aim of the current study is to further characterize the relationship between heparin 
and HBGF-1. A previous report emphasized the importance of both the polysaccharide 
chain length and degree of sulfation to its ability to potentiate HGBF-1 (Sudhalter et 
al.1989). Highly sulfated oligosaccharides were found to potentiate aFGF induced 
m itogenesis to a degree proportional chain length; oligosaccharides (up to 
tetradecasaccharides) of low sulfate content were inactive. We have extended this study 
by structurally modifying of a batch of commercial heparin and determining if the 
modified heparin species will (i) bind HBGF-1, (ii) potentiate the mitogenic action of 
FGF on both BALB/c3T3 and HUVE cells, and (iii) potentiate the neurotrophic action of 
aFGF on dissociated ciliary neurons of the E8 chick. If current dogma is correct, a 
correlative relationship between the binding capacity and the potentiating activity of a 
given modified heparin would be predicted.
Materials and methods
Reagents
Beef heart-derived HBGF-1 was purified as described (Watters, and Hendry, 1987) with 
the modifications noted in chapter 2. Native heparin was obtained from Sigma Chemical 
Co., St Louis, and chemically modified by Dr. Chris Parish. N-desulfation, N- 
acetylation and carboxyl reduction were accomplished according to published methods 
(Nagasawa, and Inoue, 1980a; Nagasawa, and Inoue, 1980b; Irimura et al.1986) N- 
acetoacetyl-heparin was synthesized using acetoacetic anhydride under alkaline 
conditions (Parish and Jakobsen ; in preparation). The following species (see figure 4.1) 
were produced (a) N-desulfated, (b) N-desulfated-reacetylated, (c) N-desulfated- 
reacetoacetylated, (d) N-acetoacetylated-desulfated (i.e.molecule (c) was O-desulfated),
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Figure 4.1 shows some of the heparins used in the current study, (a) native heparin; (b) N- 
desulfated; (c) N-desulfated-reacetylated; (d) totally desulfated; (e) N-resulfated; (0 
decarboxylated. Not shown are N-desulfated-reacetoacetylated and N-acetoacetylated- 
desulfated. Modified from Irimura et.al., (1986).
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(e) totally desulfated (i.e.molecule (d) was deacetoacetylated), (f) decarboxylated, (g) N- 
resulfated.
Mitogenic assay
BALB/c3T3 cultures were maintained as previously described (chapter 2). Dose 
responses to both (i) the modified heparins in the presence of a constant amount 
(10ng/ml) of factor and (ii) HBGF-1 in a constant amount of modified heparin were 
determined. HBGF-1 was added to serum starved cultures at the concentration shown in 
the presence of 50|ig/ml of the indicated modified heparin and incubated for 24 hrs at 37° 
(5% CO2 ) before the addition of 3H-thymidine (Amersham, U.K.). Alternatively, a 
dose response to the modified heparins was set up in the presence of a constant amount 
(10ng/ml) of HBGF-1. After a further 24 hrs incubation the cultures were frozen and 
thawed twice and harvested onto glass fibre using a Titertek 530 Cell Harvester (Flow 
Labs). The fiber discs were placed in scintillation vials (Packard Instrument Company 
Inc., ILL) containing 2.5 mis scintillation fluid (2 parts xylene, 1 part triton X 114,+  
diphenyloxazole 0.5%) and counted. Experiments were set up in duplicate. Dose 
responses to the modified heparins are shown as the percentage of control values 
detemined as the average of 12 wells grown in the presence of factor alone. Pooled data 
from four separate experiments were analysed using Microsoft Works and are displayed 
graphically (Cricket Graph).
Binding assay
The relative affinities of the modified heparins for HBGF-1 were determined using a 
binding assay based on competition for heparin-agarose (Biorad, Richmond, CA). Each 
modified heparin was added at various concentrations (up to 500p.g/ml) to a microfuge 
tube containing 4|ig of HBGF-1 in PBS. Each tube then received 40|il of a 50% (v/v) 
suspension of heparin-agarose in PBS to make a final volume of 200|il. After 1 hr 
agitation at 4°C each heparin agarose pellet was washed three times in PBS followed by 
the addition of 25\x\ of SDS -PAGE sample buffer containing 15mg/ml DTT. Samples 
were boiled for 3mins then applied to a 14cm x 10cm x 0.75mm polyacrylamide gel and 
electrophoresed at a constant current of 16mA for 3hr. Gels were stained with 
coommassie blue and HBGF-1 bands quantified by 2-dimensional laser densitometry 
(Ultrscan XL, LKB, Bromma, Sweden). Each band was outlined and its total density 
integrated using Gel Scan XL Version 1.2. For each gel, HBGF-1 bands were 
normalized to the average of 4 standards (4|j.g HBGF-1) and expressed as a percentage 
of this value (^percentage displacement). Concentrations giving 50% inhibition of
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binding were determined from linear regression formulae derived using Cricket Graph 
software.
Neuronal bioassay
Cultures of E8 chick ciliary neurons were set up as described in Chapter 2. A dose 
response to the modified heparins was performed in the presence of a constant 
concentration (25ng/ml) of beef heart-derived HBGF-1. Duplicate cultures were 
incubated in an air atmosphere at 37°C and the number of viable neurons assessed at 24 
hrs by phase contrast microscopy. Dose responses to the modified heparins are shown as 
a percentage of control values determined as average survival of 6 wells cultured in the 
presence factor alone.
Human umbilical vein endothelial (HUVE) cells
HUVE cells (passage 5 - 1 2 )  were isolated by Dr. C.R. Parish. Cultures were 
maintained in Medium 199 (Flow Labs), 16% fetal calf serum (CSL, Parkville, 
Victoria), 25|ig/ml Endothelial Cell Growth Factor (Sigma, St. Louis) and 50|ig/ml 
heparin. Mitogenic assays were carried out on quiescent cells in the presence of 16% 
fetal calf serum. Dose responses to the modified heparins were set up in the presence of 
10ng/ml of of HBGF-1 (purified by the author), and 3 H-thymidine incorporation 
determined as described above.
Results
Binding studies
The density of the HBGF-1 bands on each gel was integrated and normalized as 
described in methods and plotted against heparin concentration (figure 4.2). The native 
and decarboxylated heparins compete for binding of HBGF-1 with equal relative 
affinities; 50% inhibition was achieved at 15 and 17 qg/ml respectively. N-desulfated 
heparin did not bind HBGF-1 at concentratations up to 500qg/ml. Acetylation or aceto- 
acetylation of the N position of the glucosamine residues restored binding capacity 
although these species were some 10-fold less effective at competing with heparin 
agarose than native heparin (50% inhibition at 170 |ig/ml for acetylated and 140 qg/ml 
for acetoacetylated heparin). Desulfated-acetoacetylated, totally desulfated, and N- 
resulfated (O-desulfated) heparins all failed to bind HBGF-1 over the concentrations
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the left. A lesser degree of potentiation was seen with the addition of the decarboxylated 
molecule (fig. 4.5D). N-desulfation of the heparin chain diminished its capacity to 
augment HBGF-1 induced mitosis although did increase the activity of HBGF-1 at every 
concentration tested (fig. 4.5B). Reacetylation or acetoacetylation of the desulfated Im­
position in the heparin chain increased its potentiating ability at 50|ig/ml although not to 
the level of activity seen for the native molecule (fig. 4.5C); HBGF activity in the 
presence of the acetylated or acetoacetylated molecules is similar to that in the presence of 
the decarboxlyated heparin. The acetylated and acetoacetylated molecules show identical 
biological activities. The N-acetoacetylated-desulfated and totally desulfated heparins 
possessed no growth augmenting capacity (fig. 4.5A). N-resulfation of the desulfated 
molecule produced a heparin species that slightly potentiated HBGF-1 at all 
concentrations tested (fig. 4.5B).
HUVE cells
The ability of the modified heparins to potentiate HBGF-1 induced proliferation of 
HUVE cells is shown in figure 4.6 (A-D). As described above for the 3T3 cells, native 
heparin is the most biologically active form of the molecule with an ED50 of 0.9 [lg/ml. 
Decarboxylated heparin is about an order of magnitude less potent with an ED50 of 8.7 
|ig/ml (fig.4.6C). The acetylated and acetoacetylated forms exhibit identical biological 
activity with ED50S of 4.5 pg/ml (fig. 4.6A). The N-desulfated heparin was less active 
although it significantly potentiated activity at high concentrations with an ED50 of 73 
pg/ml (fig. 4.6D). The totally desulfated, acetoacetylated-desulfated and N-resulfated 
forms were inactive (figs. 4.6B,D).
Discussion
Binding studies
It is now well established that heparin binds to and in some cases alters the secondary 
structure of proteins by interactions of its sulfate and carboxyl groups with clusters of 
basic amino acid residues (Khan et al.1988; Cardin, and Weintraub, 1989; Cardin, and 
Jackson, 1988; Ruoslahti, 1989). The binding of heparin to protein ligands falls into two 
classes; either specific - i.e. dependent on a particular polysaccharide sequence, or non­
specific, based only on electrostatic interactions between regions of high negative charge 
density on the heparin chain and high positive charge density on the protein. The only 
well characterized example of the former is the binding of heparin to AT-III, an 
interaction that alters the three dimensional conformation of the protein (Atha et al. 1985;
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Chang, 1989) and accelerates the rate at which it inactivates the proteases of the 
coagulation cascade (Rosenberg, 1977). The search for the active site on heparin for AT- 
III was the subject of a prolonged and intensive investigation (see e.g. Lam et al.1976; 
Rosenberg et al.1978; Lindahl et al.1980) which resulted in the isolation of a unique 
pentasaccharide sequence which is randomly distributed along the heparin chain 
(Oscarsson et al. 1989). The positions of the essential charged groups within this 
sequence have been fully characterized (Van Boeckel et al. 1989). The remainder of the 
heparin-protein interactions described to date fall into the 'non-specific' category. 
Putative heparin (or indeed GAG) binding sites have been identified on lipoprotein lipase 
(Oka et al.1989), apolipoproteins E and B (Cardin, and Jackson, 1988), histidine rich 
glycoprotein (Lijnen, and Collen, 1989), AT-III (Chang, 1989), N-CAM (Cole, and 
Akeson, 1989), and despite the anionic nature of HBGF-1, the HBGFs (Harper et 
al. 1986; Esch et al. 1985a; Harper, and Lobb, 1988; Lobb, 1988). Whilst no sequence or 
secondary structure is common to the heparin binding sites, all consist of clusters of 
basic amino acids separated by one or more hydropathic residues. Cardin (see Cardin, 
and Jackson, 1988; Cardin, and Weintraub, 1989; Cardin et al.1989) has proposed the 
consensus sequence BBXB or BBXXB, where B is any basic amino acid; the 
intervening hydropathic residues are proposed to minimize electrostatic repulsion and 
increase conformational flexibility.
The results of the binding studies are summarized as follows:
(i) The affinity of the decarboxylated heparin for HBGF-1 is identical to that of the native 
molecule.
(ii) N-desulfation, which results in a positive charge at the N position of glucosamine, 
produces a polysaccharide that will not compete for FGF binding at concentrations up to 
500pg/ml.
(iii) Acetylation or acetoacetylation, which produces a neutral charge at the N position 
restores some of the binding capacity. Both forms displayed similar binding affinities 
which were some 30-50 fold less than either the decarboxylated or the native heparin 
chains.
(iv) The desulfated-N-acetoacetylated and the totally desulfated heparins do not compete 
for FGF binding.
(v) N-resulfation of the desulfated molecule, leaving a neutral charge on the O positions, 
does not restore binding capacity.
In contrast the structural requirements for anticoagulant activity are more rigid. Free 
carboxyl groups on the iduronic acid residues are an absolute requirement (Agarwal, and 
Danishefsky, 1986); they are proposed to participate in ATIII binding and determine the
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conformation of the pentasaccharide sequence that constitutes the ATIII binding site (Van 
Boeckel et al.1989). Specific N and O linked sulfates of the pentasaccharide sequence are 
also essential for ATIII binding (Van Boeckel et al.1989; Atha et al. 1985) and N- 
acetylated heparin does not retain anticoagulant activity (Castellot et al. 1987).
The structural requirements for FGF binding to heparin are similar to those reported for 
the inhibition by heparin of complement C3 convertase (Kazatchkine et al. 1981) and the 
inhibition of smooth muscle cell proliferation (see below), and point to a binding 
mechanism more dependent on charge density than a given structural motif, although the 
following provisos apply:
1. Free carboxyl groups are not required for the binding of heparin to FGF. Indeed it is 
likely that the uronic acid residues play only a small part in FGF binding as several 
sulfated GAGs without carboxyl groups bind FGF with a similar affinity to that of native 
heparin (Chapter 5). Moreover, the carboxylated non-sulfated GAG hyaluronic acid 
displayed no binding activity (Chapter 5).
2. Either the N-resulfated-O-desulfated heparin does not possess sufficient charge 
density (note that there are 2 O-sulfates to 1 N-sulfate per 'prevalent disaccharide') or a 
sulfate or negative charge on the O positions is absolutely required for FGF binding. The 
latter requirement does not apply to the N-position on the glucosamine where a neutral 
charge (N-acetyl) will restore binding, albeit at lower affinity compared to the native 
molecule. This would suggest some constraints on the placement of charged groups on 
the polysaccharide chain.
Bashkin et al.(1989) have reported similar structural requirements for the release of 
matrix bound HBGF-2 in vitro. Whilst native heparin was effective at releasing 125I- 
bFGF from endothelial cell derived extracellular matrix, N-desulfated heparin, N- 
acetylated O-desulfated heparin and totally desulfated heparin were inactive. N- 
reacetylated heparin displayed intermediate activity, suggesting the results obtained here 
with HBGF-1 apply to the more biologically relevant in vivo association with the 
HSPGs.
Biological activity
The ability of heparin to enhance HBGF-1 induced mitosis is well documented 
(Thornton et al.1983; Gim enez-Gallego et al.1986a; Rosengart et al.1988; 
Gospodarowicz, and Cheng, 1986). Our results using 3T3 and HUVE cells are in line 
with those previously reported. However, the ability of the modified heparins to 
potentiate the mitogenic activity of HBGF-1 correlates only to a limited degree with their 
affmity for HBGF-1. The decarboxylated molecule displayed similar affinity for HBGF-
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1 compared to the native heparin, although it was consistently less potent in augmenting 
mitogenesis, suggesting a biological role for the carboxyl group. It is of interest to note 
that an interaction with both the sulfate and carboxyl groups of the heparin chain is 
necessary to alter the three dimensional structure of fibronectin required for the 
phenomena of matrix driven translocation (Khan et al. 1988). The acetylated and the 
acetoacetylated species, although possessing less affinity for HBGF-1 than the 
decarboxylated molecule, conferred similar biological activity to HBGF-1 over both 3T3 
and HUVE cells (figs. 4.5C,D; 4.6A,C). Moreover, N-desulfated heparin, although 
exhibiting no binding activity, increased mitogenic activity of HBGF-1 for both 3T3 and 
HUVE cells above that seen with HBGF-1 alone. To a lesser extent the N-resulfated-O- 
desulfated heparin potentiated HBGF-1 activity over 3T3 cells, an effect not seen with 
HUVE cells; N-resulfated-O-desulfated heparin did not compete for HBGF-1 binding at 
concentrations up to 500p.g/ml. It should be noted that HBGF-1 induced HUVE cell 
proliferation requires the presence of serum whilst 3T3 cells will respond to FGF in 
serum and supplement free DMEM/HCO3. Previous studies have shown that serum can 
be replaced by HDL and transferrin (Gospodarowicz et al. 1986c; Tauber et al. 1981) or 
insulin and transferrin (Gospodarowicz, and Cheng, 1986). Division by these cell lines 
is therefore dependent on multiple factors and it is possible that the modified heparins 
exert distinct effects on their action. The acetoacetylated-desulfated and the totally 
desulfated heparins neither competed for HBGF-1 binding nor potentiated HBGF-1 
above control levels.
A previous study has emphasized the importance of both charge and size to the ability of 
heparin-derived polysaccharides to potentiate aFGF induced division of capillary 
endothelial cells (Sudhalter et al. 1989). For example, small oligosaccharides of low 
sulfate content were inactive, whilst larger low sulfate fragments were less active than 
intact heparin. Highly sulfated fragments potentiated aFGF to a degree proportional to 
their size. The ability to potentiate cell division was unrelated to anticoagulant activity.
Potentiation of neurotrophic activity revealed further variation in the activity of the 
modified heparin species. Indeed, heparin species without activity in the mitogenic 
assays were effective in promoting HBGF-1 neurotrophic activity. These included the 
totally desulfated and N-acetoacetylated-desulfated heparin chains; the decarboxylated 
and to a lesser extent the N-desulfated molecules also potentiated mitogenic activity. 
Taken together these results suggest additional mechanisms of HBGF-1 activation apart 
from those based entirely on a heparin-HBGF-1 association (Schreiber et al. 1985b; 
Gospodarowicz, and Cheng, 1986; Damon et al. 1989; see introduction). Indeed, a cell 
specific mechanism must be invoked to account for the observed variation in the ability
70
of the modified heparins to potentiate the mitogenic and the neurotrophic actions of 
HBGF-1, as well as the biological activities of the N-desulfated, N-resulfated and 
decarboxylated molecules. Several possibilities exist:
(i) the neuronal survival bioassay is of shorter time course than the cell proliferation 
assays; the critical period for neuronal survival is during the first 6 hours after dissection. 
This compares to the ongoing HBGF-1 induced proliferation of asynchronous cultures 
over the 48 hour time course of the mitogenic assays where a heparin related increase in 
the biological ti /2 of HBGF-1 would be revealed as an increase in activity. Nevertheless, 
differential mitogenic effects of heparin have been reported. For example, whilst 
augmenting the FGF response by HUVE cells (Herbert et al. 1988; Gospodarowicz et 
al. 1986c) and BHK cells (Gospodarowicz, and Cheng, 1986), heparin inhibits both 
basic and acidic FGF induced proliferation of capillary or brain derived capillary 
endothelial cells (Gospodarowicz et al. 1986c), retinal derived endothelial cells 
(Gospodarowicz et al. 1986b) and BAEC cells (Herbert et al. 1988)
(ii) The reported potentiating activity of heparin for some cell lines and not others 
(Gospodarowicz et al. 1986c; Herbert et al. 1988) may reflect increased secretion of 
proteolytic enzymes by heparin-responsive cells. However, it is unlikely that the 
modified heparins that do not bind HBGF-1 confer protection against denaturation or 
proteolytic inactivation and therefore increase its biological half-life. Several lines of 
evidence have shown that a HBGF-heparin complex is required for such protection 
(Rosengart et al. 1988; Gospodarowicz, and Cheng, 1986). Moreover, several GAGs 
that do not bind to HBGF-1, including chondroitin-4-sulfate, chondroitin-6-sulfate, 
hyaluronic acid and dermatan sulfate (chapter 5) do not protect HBGF-1 from either heat 
or acid denaturation (Gospodarowicz, and Cheng, 1986).
(iii) Although heparin has been reported to increase the affinity of HBGF-1 for its 
receptor (Schreiber et al. 1985b), it has not been shown that this effect requires a heparin- 
HBGF-1 complex. Although this mechanism of action cannot be excluded on present 
evidence, preliminary experiments have failed to demonstrate a heparin induced increase 
in HBGF-1 receptor affinity for 3T3 cells (Hendry, 1990 unpublished observation). 
Similarly, the interaction of HBGF-1 with its receptors on BHK cells is unaffected by 
the presence of heparin (Neufeld et al. 1987). It is worth noting, however,that a heparin 
induced dissociation of TGF-ß from a-2  macroglobulin has recently been shown to 
potentiate its antiproliferative activity and enhance receptor binding (McCaffrey et 
al.1989).
71
(iv) Heparin is known to be involved in cell attachment and spreading (see introduction); 
differential effects of the modified heparins on this aspect of cell behavior may account 
for some of the observed differences in activity. Neurons must first attach to the tissue 
culture substratum in order to survive; it is possible that such mechanical factors are 
influenced to different degrees by the modified heparins. Early reports indicated that 
heparan sulfate and heparin were non-permissive substrates for neuronal attachment and 
neurite outgrowth (Manthorpe et al. 1983; Carbonetto et al. 1983) although more recently, 
Hantaz-Ambroise et al.( 1987) reported that the EHS derived HSPG increases neurite 
elongation by dissociated E14 rat spinal neurons. Also relevant is the observation that 
heparin is able to inhibit neurite outgrowth on a fibronectin substrate (Carbonetto et 
al. 1983; Akeson, and Warren, 1986). However, all the heparin treated cultures were 
morphologically identical when observed using phase contrast microscopy, and no 
floating cells or aberrant neuronal processes were seen.
(v) It is possible that heparin and its active derivatives act directly on target cells at a site 
distinct from the FGF receptor; such a mechanism has not been considered in detail by 
other authors (although see Gospodarowicz, and Cheng, 1986; Neufeld et al.1987). This 
proposed action is, of course, not exclusive of other mechanisms of action. Several 
examples of a possible direct action of heparin have been reported. Heparin is proposed 
to act on smooth muscle cells to inhibit division both in vivo (Clowes, and Karnovsky, 
1977), and in vitro (Castellot et al. 1981; Hoover et al.1980; see also Castellot et al.1987; 
Karnovsky et al.1989; Reilly et al.1986). The antiproliferative effect of heparin is 
unrelated to its anticoagulant activity (Guyton et al.1980) and is relatively specific for 
smooth muscle cells - a variety of fibroblast, endothelial, and epithelial cell lines are 
unresponsive (Castellot et al. 1985b). Smooth muscle cells possess high affinity 
receptors for heparin and can internalize the polysaccharide via an endocytotic process. 
FITC labelled heparin could be seen clustered at the cell surface, endocytosed in vesicles 
and transported to the perinuclear region (Castellot et al. 1985a). Heparin exposure 
correlates with an inhibition of DNA and RNA synthesis and selective induction of 
several proteins (Castellot et al. 1985b; Cochran et al. 1985). The structural requirements 
for the antiproliferative action of heparin are similar to those reported here for the 
potentiation of HBGF-1 induced 3T3-cell mitogenesis (Castellot et al.1984; Wright et 
al.1989). N-desulfation removed most but not all of the antiproliferative activity which 
was almost fully restored by N-acetylation. The totally desulfated heparin was inactive 
and N-resulfation (producing an O-desulfated heparin) resulted in 30% of control 
antiproliferative activity. Carboxyl reduced heparin was some 35% less potent an 
antiproliferative agent than the native molecule. Interestingly, full antiproliferative activity 
could be restored by over-sulfation of the carboxyl-reduced heparin (Wright et al.1989),
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further emphasizing the importance of O-linked sulfates. As with heparin's potentiating 
activities (Sudhalter et al. 1989) both size and degree of sulfation were important 
covariables for smooth muscle cell antiproliferative activity.
Several further studies have described the metabolism of heparin by several cell lines. 
Cell surface binding sites for heparin have been described on smooth muscle cells 
(Castellot et al.1985a), hepatocytes (Kjellen et al. 1977; Kjellen et al.1980), endothelial 
cells (Glimelius et al. 1978), fibroblasts (Chong, and Parish, 1986), neurons (Vidovic et 
al. 1986), as well as cells of the reticuloendothelial system including macrophages and 
monocytes (Bleiberg et al. 1983; Chong, and Parish, 1986) and lymphocytes (Parish, 
and Snowden, 1985). A significant proportion of HSPGs synthesized by hepatocytes in 
vitro is secreted into the extracellular matrix and internalized by a receptor mediated 
endocytotic mechanism (Bienkowski, and Conrad, 1984). Some 10% of this internalized 
fraction is delivered to the nucleus (Ishihara et al.1986; Fedarko, and Conrad, 1986), 
where it appears as free heparan sulfate chains. Interestingly, the nuclear pool was found 
to contain a disproportionate amount of GlcUA-2S residues although to date no 
endogenous ligand has been reported. Moreover, both the structure and the concentration 
of the nuclear pool varied with cell density and are responsive to hormones and growth 
factors (Conrad, 1989); for example, growth conditions that result in a reduced nuclear 
heparin sulfate pool were correlated with a loss of contact inhibition (Ishihara et 
al. 1987). The same authors provide good evidence that at least one HSPG species is 
attached to the cell membrane by a phosphatidyl inositol moiety which is subject to 
cleavage by cell surface phospholipase-C prior to internalization. It may well be possible 
that the INO epitope (Chiu et al.1986), and indeed other GAGs localized to neuronal 
nuclei (Aquino et al. 1984a), represent biologically relevant pools of polysaccharides.
Several earlier studies described a nuclear action for heparin, although under somewhat 
non-physiological conditions. Heparin ( and several other polyanions) increase DNA 
synthesis by isolated nuclear preparations or chromatin (Kraemer, and Coffey, 1970a; 
Arnold et al.1972; Furukawa, and Bhavanandan, 1982; Furukawa, and Bhavanandan, 
1983). Promotion of DNA synthesis was associated with an increase in the viscosity of 
the chromatin (Bornens, 1973), nuclear swelling (Kraemer, and Coffey, 1970b), a 
variety of ultrastructural changes (Arnold et al.1972) and correlated with the ability of the 
heparins and other GAGs to bind to histone fractions. These results were interpreted as 
the binding of the polyanions to DNA bound proteins, resulting in their dissociation and 
lifting of template restrictions. In addition, higher concentrations of heparin were found 
to directly inhibit the DNA polymerase reaction with purified DNA (Kraemer, and
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Coffey, 1970a; Furukawa, and Bhavanandan, 1983) and block the binding and initiation 
of RNA polymerase to phage DNA (Dynan, and Burgess, 1979).
Heparin has also been reported to bind to the inositol-triphosphate (IP3) receptor 
(Worley et al. 1987), and competitively inhibit IP3 induced calcium release from 
intracellular storage sites in liver cells (Hill et al. 1987), smooth muscle cells (Chopra et 
al. 1989; Ghosh et al. 1988), as well as from microsomal preparations (Ghosh et al. 1988; 
Guillemette et al. 1989) and across sarcoplasmic reticulum incorporated into lipid bilayers 
(Ehrlich, and Watras, 1988). Heparin is also a potent inhibiter of IP3 kinase (Guillemette 
et al.1989). Although heparin has been used as an experimental tool in these studies, for 
example, to demonstrate the importance of IP3 mediated calcium release following 
adrenergic and muscarinic stimulation (Kobayashi et al.1989), some authors have 
suggested this action of heparin may be relevant in vivo (Chopra et al.1989). Recently, 
heparin has been shown to modulate the phosphorylation of bFGF by protein kinase C 
(PK-C) and the catalytic subunit of protein kinase A (PK-A; Feige et al.1989). Heparin 
increases the ability of PK-A to phosphorylate bFGF and changes the site of 
phosphorylation from Thr-112 to Ser-64. In contrast, heparin inhibits the 
phosphorylation of bFGF by PK-C. It is tempting to speculate on possible roles for the 
intracellular GAGs; it may be that their reported enhancing and inhibitory effects are a 
result of such modulation of second messenger systems.
There is little doubt that binding of heparin to HBGF-1 results both in its protection from 
protease action and prolongation of its in vitro biological half-life, and that these actions 
result in increased HBGF activity as measured by a given in vitro mitogenic or cell 
survival/neurite outgrowth assay. However, the simple association of HBGF with 
heparin cannot account for all the observations reported here or by others. For example, 
Sudhalter et al.(1989) reported that a heparin-derived sulfated hexasaccharide that binds 
HBGF-1 did not potentiate its in vitro mitogenic activity, although it could be argued that 
the small size of the polysaccharide does not allow it to bridge the HBGF-1 molecule and 
stabilize its conformation. Furthermore, protection from heat and acid exposure of 
HBGF-1 in the presence of heparin did not increase HBGF-1 activity above that of the 
unexposed molecule (Gospodarowicz, and Cheng, 1986); i.e. potentiation of both the 
exposed and control HBGF-1 samples was observed only when tested on cultures 
already subjected to high concentrations of heparin: thus in addition to a protective effect, 
heparin was exerting an additional effect and the authors concluded "heparin, by acting at 
the cell level could make these (cell types) responsive to concentrations of mitogens to 
which they might otherwise not respond". Heparin, heparan sulfate and chondroitin 
sulfate have been reported to potentiate the neurotrophic effects of NGF on PC I2 cells
(Neufeld et al. 1987; Damon et al. 1988). None of these polysaccharides bind NGF 
(Watters and Hendry, unpublished observation). Heparin has also been reported to have 
differential effects on adrenal chromaffin cells; although potentiating the neurite 
outgrowth response to HBGF-1, heparin was without effect on HBGF-1 induced 
mitogenesis (Claude et al. 1988).
In conclusion, it has been shown that the ability of heparin to potentiate the biological 
activity of HBGF-1 is not a direct function of it's ability to bind HBGF-1. It is proposed 
that at least some of the biological activity of heparin is the result of a receptor mediated 
direct effect. This hypothesis is further investigated in chapter 5.
75
Chapter 5
Investigation of the ability of several plant and animal derived GAGs as 
well as synthetic polysulfates to bind to, and potentiate the biological 
activity of, HBGF-1.
7 6
Introduction
The remainder of the characterized vertebrate GAGs, including dermatan and the 
chondroitin sulfates and hyaluronic acid, as well as several plant, bacterial, and 
synthesized polysaccharides are considered in this chapter. Except for hyaluronic acid 
(HA), all animal derived GAGs exist in vivo as proteoglycans, and are widespread 
components of the cell surface, connective tissue stroma, and basement membranes 
(Hassell et al.1986; Ruoslahti, 1988; Couchman et al.1984). Like the HSPGs they have 
been implicated in a range of cell behavior, including attachment, migration and 
differentiation (Kujawa, and Tepperman, 1983; Wightman et al.1986; Abatangelo et 
al.1982; Barnhart et al.1979).
Structure
The animal derived GAGs covered in this study all consist of alternating copolymers of a 
uronic acid and hexosamine (Hook et al.1984; see table 5.1). The chondroitin and 
dermatan sulfates are made up of repeating ß-l,4-linked uronic acid—»N-acetyl-D- 
galactosamine residues. Glucuronic acid is the dominant uronic acid moiety of 
chondroitin sulfate (CS); C-5 epimerization produces a higher percentage of iduronic acid 
in the dermatan sulfate (DS) chain. The galactosamine residues are sulfated at the 4 
and/or 6 positions of chondroitin sulfate, producing chondroitin-4-sulfate (C4S) 
chondroitin-6-sulfate (C6S) or chondroitin-4,6-disulfate (C46DS). The 4 position of 
dermatan sulfate is sulfated. Thus dermatan can be considered a C4S with an increased 
percentage of iduronic acid residues (Hook et al.1984; Conrad, 1989). A given 
chondroitin sulfate proteoglycan (CSPG) comprises only one chain type (Couchman et 
al.1984). The polysaccharide chains do display some structural heterogeniety, although 
not to the same degree as heparin. For example, galactosamine residues of CS show 
variable sulfation, the iduronic acid residues of CS may be sulfated at the C2 position, 
and a range of iduronic/glucuronic acid residues is found in dermatan sulfate. A 
significant proportion of disulfated disaccharide units is present in both polysaccharides 
(Suzuki et al.1968). Hyaluronic acid is a high molecular weight copolymer of glucuronic 
acid—>N-acetylglucosamine. It is unsulfated (Hook et al.1984).
Several plant, bacterial and synthesized polysaccharides were included in the present 
study (Table 5.1)
Monosaccharides
Moles/Disaccharide
Polysaccharide Origin
Carboxyl Sulfate
Groups____________ Groups
Hyaluronic acid Animal GlcUA GlcNAc 1 0
Chondroitin-4-
sulfate Animal GlcUA GalNAc 1 0.2-1.0
Chondroitin-6-
sulfate Animal GlcUA GalNAc 1 0.2-1.3
Dermatan
sulfate Animal IdUA GalNAc 
GlcUA
1 1.0-2.0
Heparin Animal IdUA GlcNAc 
GlcUA
1 2.0-3.0
Fucoidin Plant L-Fuc 0 2.0
Pentosan-
polysulfate Plant D-Xyl 0 4.0
Kappa carrageenan Plant D-Gal 0 1.0
Iota carrageenan Plant D-Gal 0 2.0
Lambda carrageenan Plant D-Gal 0 3.0
Dextran sulfate-2.3* Bacteria D-Glc 0 4.0
Table 5.1 Structural components of glycosaminoglycans. GlcUA=Glucuronic acid; 
IdUA=Iduronic acid; GlcNAc=N-acetyl-glucosamine; GalNAc=N-acetyl-galactosamine; 
Gal=galactose; D-Xyl=D-xylose; L-Fuc=L-fucose; Glc=glucose.
* Artificially oversulfated
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Interactions and functions
The interactions and possible functions of the CS and DS proteoglycans, and hyaluronic 
acid have, in general, received less attention than the heparin/heparan sulfate family. Like 
the HSPGs, they have been implicated in cell adhesion, although whereas the HSPGs 
are concentrated at newly formed adhesion sites and appear to initiate adhesion, the other 
GAGs become associated with adhesion sites as cells begin to spread and move over the 
substrate (Culp et al. 1980; Laterra et al.1980). CSPG can bind collagen and fibronectin 
(Oldberg, and Ruoslahti, 1982; Yamagata et al.1986) and can inhibit cell adhesion to 
both collagen and fibronectin substrates (Ruoslahti, 1988). DSPG binds to a cryptic site 
on fibronectin to inhibit 3T3 cell adhesion (Culp et al.1989). Hyaluronic acid added to 
tissue culture medium promotes cell detachment (Abatangelo et al.1982; Barnhart et 
al.1979).
Several relatively specific interactions have been reported. Dermatan sulfate is able to 
bind to and activate heparin cofactor II (Tollefsen et al.1989). Structure activity studies 
have identified active DS fragments, although to date it is unclear whether this interaction 
is dependent on a a specific structure or simply the result of electrostatic interactions.
A chondroitin sulfate proteoglycan copurifies with and has been identified as a ligand for 
cytotactin, a widely distributed ECM glycoprotein (Grumet et al.1985; Chiquet, and 
Fambrough, 1984; cytotactin is also known as glioma mesenchymal extracellular matrix 
(GMEM) protein, hexabrachion, myotendinous antigen and tenascin; see Erickson, 1989 
for a recent review). In vitro the CSPG is predominantly synthesized by neurons whilst 
cytotactin is synthesized by glial cells (Hoffman, and Edelman, 1987; Hoffman et 
al.1988). Cytotactin and its CSPG ligand colocalize in both the adult and embryonic 
cerebellum, although some differences in their distribution were seen in peripheral 
tissues (Hoffman et al.1988). In particular, at the time of neural crest cell migration the 
CSPG becomes localized to the caudal half of the scleretome while cytotactin expression 
is confined to the rostral half, corresponding to the crest cell migratory pathway (Tan et 
al.1987). The CSPG was further found to be a non-permissive substrate for crest cell 
migration in vitro and is able to inhibit migration on a fibronectin substrate. Although no 
function has yet been ascribed to cytotactin-CSPG binding it does provide an interesting 
example of a proteoglycan-matrix protein association similar to the laminin-HSPG- 
collagen complex of the BM (Grant et al.1989). It should be noted however that the CS 
chains do not take part in cytotactin-CSPG binding; in fact, chondroitinase treatment of 
the CSPG increases its affinity for cytotactin (Hoffman et al.1988).
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GAGs of the nervous system
The GAGs HS CS and HA can be precipitated from extracts of whole brain (Margolis et 
al.1975; Oohira et al.1986; Kuriyama, and Okada, 1971). HA is the major GAG of the 
fetal and early post-natal rat brain (Oohira et al.1986; Werz et al. 1985a), although CS 
takes over as the major GAG of the adult. In the cat brain HA persists as the major GAG 
throughout adulthood (Young, and Custod, 1972). O f these GAGs only HS shows 
significant turnover postnatally (Margolis et al.1975; Werz et al. 1985b; Werz et 
al. 1985a), although some CS synthesis has been reported in the newborn mouse brain 
(Kuriyama, and Okada, 1971). Interestingly, CS, HA and HS have been isolated from a 
purified nuclear preparation of rat brain (Margolis et al.1976). Changes in GAG 
concentration and turnover have been correlated by some authors with specific 
neurodevelopmental events, for example neuroblast proliferation and migration; in 
particular HA has been proposed to provide a hydrated extracellular domain that 
facilitates cell migration (Werz et al. 1985a; Margolis et al.1975). A similar role for this 
GAG has been proposed during neural crest cell migration (Pratt et al.1975).
Both CS and HA have been immunohistochemically localized in the rat cerebellum 
(Aquino et al. 1984a; Aquino et al. 1984b; Ripellino et al. 1988; Nakanishi, 1983). Both 
GAGs are restricted to the extracellular space or cell membrane in the neonate and 
become predominantly intracellular with development. Not all cells displayed GAG-like 
immunoreactivity; apart from connective tissue elements no staining of cell bodies, 
axons, myelin or schwann cells of the peripheral nerves was seen, although a later report 
localized an epitope associated with C6S to several BMs including those of peripheral 
nerve fibers (Couchman et al.1984). Nuclear staining was seen within several central 
neurons.
At least two neuronal or glial cell markers have been characterized as neuronal CSPGs. 
The NG2 antigen defined by antibodies raised against pseudoneurons and glia - cell lines 
that display characteristics of both neurons and glia (Wilson et al. 1981) - was later 
characterized as a CSPG (Stallcup et al.1983). In vivo the antigen is present on 
protoplasmic astrocytes (Levine, and Card, 1987). Interestingly, NG2 positive cells 
exhibit considerable phenotypic plasticity in vitro (Stallcup, 1981; Stallcup, and Beasley, 
1987), expressing astrocyte or oligodendrocyte specific markers depending on the 
culture conditions. The relationship between the proteoglycan marker and this plasticity 
is unknown.
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The HNK-1 epitope - determined as 3-sulfo-glucuronic acid (GlcUA-3S) - has been 
detected on a CSPG of CNS tissue. GlcUA-3S is not a saccharide component of CS nor 
is the epitope destroyed by chondroitinase. Rather, the GlcUA-3S appears to be a 
component of oligosaccharides also linked to the PG (Krusius et al.1987).
The major aim of the current study is to determine:
(i) whether other sulfated polysaccharides will compete with heparin-agarose for HBGF- 
1 binding and; (ii) the biological activity of the polysaccharides i.e. do they potentiate 
either the neurotrophic or the mitogenic activity of HBGF-1
Materials and methods
Beef heart-derived HBGF-1 was purified as described in chapter 2. The polysaccharides 
hyaluronic acid ( Grade III-S from human umbilical cord), chondriotin-4-sulfate 
(chondroitin sulfate type A from whale cartilage), chondroitin-6-sulfate (chondroitin 
sulfate type C from shark cartilage), dermatan sulfate (chondroitin sulfate type B from 
porcine skin), fucoidin (from Fucus vesiculosus ), pentosan polysulfate, kappa- 
carrageenan (Type m  form Eucheuma cottonii), lambda carrageenan (Type IV from 
Gigartina aciculaire and Gigartina pistillata ) and iota-carragenan (Type V from 
Eucheuma spinosa ) were purchased from Sigma Chemical Co., St. Louis. Dextran 
sulfate 2.3 (2.3 sulfates per monosaccharide) was from Pharmacia. All polysaccharides 
were stored in normal sahne (0.15M NaCl) at -20°C at 20 mg/ml except hyluronic acid at 
10mg/ml. The synthetic poly sulfates, poly anethole and polyvinyl sulfate were obtained 
from Sigma.
Binding assay
The relative abilities of the GAGs to compete for the heparin binding site on HBGF-1 
were determined using the binding assay described in chapter 4. To each 4pig sample of 
HBGF-1 were added various concentrations of the given GAG or synthetic polysulfate 
(up to 1 mg/ml ), and 40|il of a 50% (v/v) suspension of heparin agarose. After Ihr 
agitation at 4° C each heparin-agarose pellet was washed and bound HBGF-1 eluted in 
sample buffer. The amount of HBGF-1 present in each sample was quantified by SDS- 
PAGE and 2-dimensional laser densitometry. For each gel, HBGF-1 bands were 
normalized to the average of 4 standards (each of 4p.g HBGF-1) and expressed as a 
percentage (=percentage displacement). Results are depicted as a series of graphs for 
ease of viewing.
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Bioassavs
Balb/c3T3 cells
Balb/c3T3 cell mitogenisis assays were established as previously described (Chapter 4). 
Dose responses to (i) the given GAG or synthetic polysulfate in the presence of a 
constant amount (10ng/ml) of HBGF-1; (ii) HBGF-1 in the presence of a constant 
amount (50|ig/ml) of GAG and; (iii) the GAGs alone were determined. Experiments 
were set up in duplicate. Dose responses to the GAGs in constant factor concentration 
are shown as the percentage of control values determined as the average of 12 wells 
grown in the presence of HBGF-1 alone. Pooled data from 3 separate experiments was 
analysed using Microsoft Works and displayed graphically using Cricket Graph.
Ciliary neurons
Cultures of dissociated E8 ciliary neurons were established as described in chapter 2. A 
dose response to the GAGs or synthetic polysulfates was performed in the presence of a 
constant amount (25ng/ml) of beef heart-derived HBGF-1. Each experiment was set up 
as duplicate cultures and control values determined as average survival of 6 wells in the 
presence of factor alone.
Results
Binding activity
The ability of the GAGs to compete for the heparin-binding site on HBGF-1 is shown in 
figure 5.1. Four groups of binding affinities can be distinguished, (i) very high affinity 
(50% displacement < 10|!g/ml); Dextran sulfate, K-carrageenan, pentosan sulfate, 
polyanethole sulfonate (ii) high affinity (50% displacement 10-50|ig/ml); heparin, 
fucoidin (iii) low affinity (50% displacement 100-1000 fig/ml); X-carrageenan, t- 
carrageenan, polyvinyl sulfate (iv) very low or no demonstrable affinity (50% 
displacement > 1 mg/ml); hyaluronate,dextran, dermatan sulfate, chondroitin-6-sulfate, 
chondroitin-4-sulfate. The chondroitin and dermatan sulfates did show some inhibition at 
high concentration whereas the dextran and hyluronate dose:inhibition curves are 
essentially flat.
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Biological activity 
Balb/c3T3 cells
All cultures were inspected daily prior to harvesting. With HBGF-1 stimulation the 
'cobblestone' pattern of quiescent fibroblasts was replaced by islands of proliferating 
fusiform or spindle shaped cells. The added presence of the GAGs did not alter this 
morphological pattern; no cell retraction or detachment from the substratum were seen.
Figure 5.2 shows potentiation of HBGF-1 mitotic activity by the GAGs. Chondroitin-6- 
sulfate, chondroitin-4-sulfate, chondroitin-4,6-disulfate, dextran and dermatan sulfate do 
not possess potentiating activity (figs. 5.2 B-D). However, hyaluronate did exert a mild 
effect with maximal activity of 2 x control at 100jig/ml (fig. 5.2D). The carrageenans, 
dextran sulfate, fucoidin, and pentosan sulfate all showed an apparant dose related 
potentiation of HBGF-1 activity (figs. 5.2 A,F). The synthetic polysulfates inhibited 
mitogenesis at concentrations greater than 10|ig/ml, although they increased mitogenic 
activity at lower concentrations (fig. 5.2F).
Dose responses to HBGF-1 in the presence of a constant amount of GAG are shown in 
figure 5.3. Apparent potentiating activity is in general agreement with figure 5.2. Thus 
the addition of the carrageenans, polyvinyl sulfate, fucoidin, dextran sulfate and 
pentosan sulfate all result in a marked shift of the HBGF-1 dose response curve to the 
left (figs. 5.3 C,E,F,G). Chondroitin-6-sulfate and chondroitin-4,6-disulfate were less 
active, causing in a slight left shift of the dose response curve (figs. 5.3 B,D). 
Chondroitin-4-sulfate, hyaluronate, dextran and dermatan sulfate were inactive (figs. 5.3 
A,B,D). Polyanethole, at the concentration tested, did not alter the biological activity of 
HBGF-1 (fig. 5.3 E).
It is apparent from figure 5.3 that at low HBGF-1 concentrations several dose response 
curves failed to return to control levels. In particular the carrageenans and fucoidin 
appear to be exerting mitogenic activity independently of HBGF-1 concentration. This 
was confirmed by determining the mitogenic response of 3T3 cells to the GAGs or 
synthetic polysulfates alone. Figure 5.4 shows that fucoidin, i-carrageenan and the 
synthetic polysulfates are potent inducers of proliferation in their own right. Fucoidin 
promoted division in dose-dependent fashion up to 200|ig/ml, whereas i-carrageenan, 
polyanethole and polyvinyl sulfate were maximally active at 6pg/ml, 20(ig/ml, and 
2pg/ml respectively (figs. 5.4 A-C). K-carrageenan, X-carrageenan and pentosan sulfate
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also induced significant dose dependent 3T3 cell proliferation although in terms of 
maximal thymidine incorporation were less potent; maximal activity was seen at 
200|ig/ml, 60p.g/ml and 6p.g/ml respectively (figs. 5.4 A,C). Hyaluronate exerted a mild 
mitogenic effect with maximal activity at 100-200|ig/ml (fig. 5.4 B). Chondroitin-4,6- 
disulfate, chondroitin-4-sulfate, dermatan sulfate, chondroitin-6-sulfate, dextran and 
dextran sulfate were inactive. All cultures in which cell proliferation was evident 
exhibited the same morphological appearance to HBGF-1 stimulated cultures (as above).
Figure 5.3 shows that at the concentration used (50|ig/ml) fucoidin and carrageenans are 
exerting a dual action on 3T3 cell proliferatin. In addition to their intrinsic mitogenic 
action they potentiate the activity of HBGF-1; maximal proliferation is greater than the 
sum of the mitogenic response to the factor or the polysaccharide alone. This dual effect 
is seen more clearly by comparing the effects of polyvinyl sulfate and pentosan sulfate in 
figures 5.3 and 5.4. Both GAGs potentiate HBGF-1 induced mitogenesis (figure 5.3 
E,F), although at the concentration tested (50p.g/ml) do not exert significant mitogenesis 
alone (see figure 5.4 A,B). Polyanethole sulfonate, although a mitogen when added 
alone, did not potentiate HBGF-1. Moreover, the mitogenic activity of polyanethole 
sulfonate was apparently abolished in the presence of HBGF-1. This result may be 
explained, at least in part, by the nature of the assay. Cells maximally stimulated over the 
first 24 hours of culture will rapidly reach confluence and fail to incorporate 3H- 
thymidine over the succeeding 24 hours. A similar decrease in thymidine uptake is seen 
with high concentrations of factor in the presence of heparin (figure 4.5 D).
Ciliary neurons
The ability of the GAGs to promote the neurotrophic activity of HBGF-1 is shown in 
figure 5.5. Chondroitin-4-sulfate, chondroitin-6-sulfate, dextran, dermatan sulfate and 
hyaluronate all augment the neuronal survival response to HBGF-1, with maximal 
survival of around 3x control values at 100|ig/ml GAG (figs. 5.5 B-D). Chondroitin- 
4,6-disulfate, pentosan sulfate and dextran sulfate exhibited less convincing activity with 
maximal survival around 2x control values (figs. 5.5 B,F). The carrageenens, polyvinyl 
sulfate and fucoidin were inactive (figs. 5.5 A,E,F). Polyanthole was toxic to the ciliary 
neurons at concentrations greater than 3p.g/ml (fig. 5.5 E). All cultures appeared 
morphologically identical.
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Discussion
Binding studies
The GAGs tested can be divided into four broad groups with respect to their affinities for 
the heparin binding site on HBGF-1:
(i) Dextran sulfate, K-carrageenan,pentosan sulfate, polyanethole sulfonate;
(ii) heparin, fucoidin;
(iii) ^-carrageenan, i-carrageenan, polyvinyl sulfate;
(iv) hyaluronate, dextran, dermatan sulfate,chondroitin-4-sulfate, chondroitin-6-sulfate.
Binding of the GAGs to HBGF-1 showed an overall trend to charge dependency 
although there are notable exceptions. The highly sulfated, dextran and pentosan sulfates 
(containing 3-4 sulfates /  dissacharide) bound HBGF-1 with higher affinity than heparin. 
The chondroitin sulfates (0.2-1.3 sulfates / dissacharide) competed only at high 
concentration; polysaccharides containing no sulfate groups (dextran and hyaluronate) 
displayed no binding activity. Whilst charge density of the polysaccharide chain clearly 
plays a role in its binding to HBGF-1, the position of the charged groups or composition 
of the saccharide chain places structural constraints on such binding. K-carageenan (1 
sulfate/disaccharide) bound HBGF-1 with higher affinity than heparin and dermatan 
sulfate. Similarly, fucoidin exhibited affinity for HBGF-1 equivalent to the more highly 
sulfated heparin. The binding characteristics of the carrageenans provides the strongest 
evidence for the existence of structural specificity; K-carageenan was found to be 
significantly more potent at preventing the binding of HBGF-1 to heparin-agarose than 
either of its more highly charged counterparts. Similarly, the higher affinity of the N- 
desulfated reacetylated heparin for HBGF (fig.4.2) than the dermatan /  chondroitins 
could be attributed to either an increased percentage of 2S-iduronic acid residues within 
the heparin chain or the absolute requirement for a 6S glucosamine rather than a 4 and/or 
6S galactosamine.
The results are in general agreement with Bashkin et al.(1989) who reported that the 
GAGs HA, and CS are unable to displace HBGF-2 from endothelial-cell derived ECM. 
Heparin, and to a lesser extent DS, were effective in releasing matrix bound HBGF-2 at 
concentrations below 1 mg/ml.
It should be noted that the binding assay assumes that heparin-agarose and the given 
GAG are competing for the same, or at least overlapping, binding sites on the HBGF-1
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molecule. Although clusters of basic amino acids present in heparin binding ligands are 
thought to bind other polyanions (Cardin, and Weintraub, 1989), the exact amino acid 
residues involved may not correspond exactly. For example pentosan sulfate is able to 
bind and activate ATIII, although it covers only part of the heparin binding site and does 
not induce a conformational change in the ATIII molecule (Chang, 1989; Sun, and 
Chang, 1989). It can be concluded from the above studies that the HBGF-1 binding site 
for polyvinyl sulfate, pentosan sulfate, polyanethole sulfate, the carrageenens, dextran 
sulfate and fucoidin correspond to or overlap that of heparin, whilst C4S, C6S, HA or 
dextran either do not bind, or bind to a site sufficiently remote from that of heparin to 
prevent steric hindrance. The latter seems unlikely given the anionic nature of HBGF-1 
and the presence of only two potential regions of positive charge density (Esch et 
al. 1985a), which may be in close proximity as a result of disulfide bonding (Strydom et 
al. 1986).
The 'non-binding' GAGs C4S, C6S, HA and DS are unable to protect either basic or 
acidic FGF from from heat or acid denaturation or proteolytic cleavage (Gospodarowicz, 
and Cheng, 1986; Rosengart et al. 1988) However, hexuronyl hexosaminoglycan sulfate 
(HHS) - a GAG able to both bind to and potentiate the biological activity of HBGF-1 - 
does protect HBGF against denaturation and similarly, dextran sulfate prevents trypsin 
proteolysis (Gospodarowicz et al. 1986c). This observation is in in accord with other 
evidence demonstrating that a heparin-factor complex is required for such protection 
(Gospodarowicz, and Cheng, 1986; Rosengart et al.1988). It would of interest to 
determine whether polyvinyl sulfate, pentosan, polyanethole, the carrageenens or 
fucoidin also offer similar protection against HBGF-1 denaturation or cleavage.
Biological activity
Potentiation of HBGF-1 induced mitogenesis of BALB/c3T3 cells was a property of 
most of the GAGs tested; only chondroitin-4-sulfate, dermatan sulfate, hyaluronate and 
dextran failed to enhance HBGF-1 activity significantly above control levels (fig. 5.3). 
As with binding capacity for HBGF-1, potentiation of biological activity was not directly 
related to charge density. For example, K-carrageenan was more active in enhancing 
HBGF-1 induced mitogenesis than the more highly charged dermatan sulfate and the 
dextran sulfates and pentosan sulfates exhibited similar biological activity to fucoidin and 
the carrageenans. Furthermore, the position of the sulfate within the chondroitin sulfate 
chain determined, to some degree, its biological activity. C6S was active and no 
significant difference between C6S and C46DS was observed, suggesting the sulfate on 
position 4 of the galactosamine to be unimportant to biological activity. Interestingly,
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these molecules show distinct distributions in vivo (Couchman et al.1984). Monoclonal 
antibodies generated against chondroitinase digestion products of a chondrosarcoma 
derived proteoglycan have localized C4S to the loose connective tissue of the dermis, 
blood vessels, nerve fibres and striated muscle. Significantly, C6S was found in 
basement membranes, in particular those of muscle and peripheral nerve fibres. C46DS 
is found exclusively in the secretory granules of T cell-factor dependent mast cells 
(Stevens et al. 1985) and their in vivo counterparts, mucosal mast cells (Stevens et 
al. 1986). It is tempting to suggest position of the sulfate groups of the galactosamine 
residue confers specific functions to this class of GAGs.
These results confirm and extend the GAG-HBGF-1 interactions previously reported. 
For example, HHS is able to both bind to and potentiate the mitogenic activity of HBGF- 
1 on HUVE cells (Gospodarowicz et al. 1986c) and BHK cells (Gospodarowicz, and 
Cheng, 1986). Similarly, pentosan and dextran sulfate augment HBGF-1 activity on 
HUVE cells with similar potency to heparin (Herbert et al. 1988; Thornton et al. 1983). 
Dextran, chondroitin sulfate (type not specified) and hyaluronic acid were inactive 
(Thornton et al. 1983).
The observation that some of the GAGs alone in serum-free medium induce proliferation 
of 3T3 cells was unexpected. Polyanethole, i-carrageenan, polyvinyl-sulfate and fucoidin 
stimulated division with maximally active concentrations varying from 2 to 200|lg/ml. K 
and X  carrageenan and pentosan were less potent mitogens. Previous reports of GAG 
induced mitogenesis have been restricted to hemopoeitic cell lines. Dextran sulfate is a 
mitogen for B lymphocytes (Wetzel, and Kettman, 1981; Dorries et al.1974), and 
peripheral blood T lymphocytes (Palacios et al.1982), although the percentage of cells 
responding was very low without the added presence of lipopolysaccharide or accessory 
cells.
The ability to potentiate HBGF-1 induced survival of ciliary neurons was an almost 
exclusive property of those GAGs without activity in the mitogenic assay (compare figs. 
5.2 C-D with 5.5 C-D). Dextran, hyaluronate, dermatan sulfate, chondroitin-4,6- 
disulfate and chondroitin-4-sulfate all exhibited convincing potentiation of HBGF-1 
induced neuronal survival. The potent enhancers of 3T3 cell mitogenesis - the 
carrageenans and fucoidin - were without activity in the neurotrophic assay. Only 
chondroitin-6-sulfate, dextran sulfate, and pentosan sulfate possessed both neurotrophic 
and mitogenic augmenting activity, although none were potent over both assays. 
Chondroitin-6-sulfate exhibited convincing enhancing activity for HBGF-1 induced 
neuronal survival although it was only a weak promotor of mitogenesis: the converse
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was true for both dextran and dermatan sulfate. A analagous result was reported in the 
previous chapter using the modified heparins: the lesser charged N-acetoacetylated- 
desulfated and desulfated species were without activity in the mitogenic assays, although 
potentiated HBGF-1 induced survival of ciliary neurons. Together these results point to a 
mechanism distinct from GAG-factor association to explain potentiation of neurotrophic 
activity (discussed below).
Although neurons of the rat SCG possess receptors for a variety of GAGs, (Vidovic et 
al.1986) most reports to date have found the animal derived GAGs to be a non- 
permissive substrate for neuronal attachment neurite outgrowth (Carbonetto et al. 1983; 
Verna et al.1989). [The exception is when the GAG substrate is subsequently exposed to 
bFGF. In this case neurite outgrowth by dissociated hippocampal neurons is 
proportional to the amount of substrate bound bFGF (Walicke, 1988a) ] However, in 
line with the current study, (Damon et al. 1988) have reported that PC12 fibre outgrowth 
in response to acidic FGF is potentiated by heparin, heparan sulfate and both dermatan 
and chondroitin sulfate, although the latter was some 15 times less potent than dermatan 
sulfate. Differential effects were reported for neurite potentiation by these GAGs for both 
bFGF and NGF.
Several possible mechanisms of action can be proposed to account for changes in the 
biological activity or HBGF-1 in the presence of GAGs :
(i) the binding of the GAGs to HBGF-1, particularly the high affinity binding of 
polyvinyl sulfate, pentosan and polyanethole may protect HBGF from degradation or 
denaturation and increase its biological half-life, as has been described for heparin and 
HHS (Damon et al.1989; Gospodarowicz, and Cheng, 1986). It is probable that the 
carrageens, dextran sulfate, polyvinyl sulfate, pentosan sulfate and fucoidin, in binding 
HBGF-1, protect it from in vitro degradation as has been described for heparin (see 
Introduction Chapter 4; further studies are currently underway to confirm this 
hypothesis). The present studies utilized serum-free medium, excluding serum proteases 
as the agents of such degradation. However, the augmentation of biological activity of 
HBGF-1 by the various GAGs cannot be explained only in terms of HBGF-GAG 
association. Although most of the GAGs that potentiated HBGF-1 also competed for the 
heparin binding site there were several exceptions. For example, chondroitin-6-sulfate 
potentiated 3T3 mitogenesis and all the GAGs exhibiting 'very low' affinity for HBGF-1 
(group iv above) potentiated the neurotrophic action of HBGF-1 on E8 chick ciliary 
neurons. Moreover, the carrageenens, polyvinyl sulfate, and fucoidin, all of which 
bound HBGF-1, were without effect on its neurotrophic activity.
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(ii) The GAGs may enhance receptor binding in a manner similar to that previously 
described for heparin (Schreiber et al. 1985b); this mechanism cannot be excluded by the 
present data.
(iii) It is possible that the present data can be explained by disruption of normal cell- 
substratum or cell-cell attachment. For example, the binding of fucoidin to cultured 
endothelial cells results in their retraction and separation (Glabe et al. 1983); such an 
effect could release or overcome contact inhibition and result in cell division. 
Hyaluronate and chondroitin-6-sulfate (which showed moderate potentiating activity in 
the present study) when added at high concentration (i.e. 0.5 -2mg/ml) to BALB/c3T3 
cells interact with the substrate to facilitate cell detachment (Abatangelo et al. 1982). 
Chondroitin-4-sulfate and dermatan sulfate, which did not potentiate aFGF induced 
mitogenesis above control levels in the present study, were without effect on cell 
detachment. It is known that exposure to trypsin will stimulate proliferation of 
fibroblasts, presumably by disruption of cell-substratum adhesion (Carney, and 
Cunningham, 1977). However the gross morphology of all the GAG treated cultures 
was identical. Proliferation of 3T3 cells was always associated with 'islands' of spindle 
shaped cells in close contact and no floating cells or cell processes were seen.
Both heparan and chondroitin sulfate modulate the in vitro behavoiur of bFGF supported 
PC 12 cells (Schubert et al. 1987b). The addition of heparan sulfate resulted in the 
formation of tight cellular aggregates; however in the presence of CS and bFGF the 
PC 12 cells formed remarkable bilayered circular structures. It is possible similar GAG 
induced alterations in cell-cell or cell-substratum interactions modulate neuronal survival.
(iv) The GAGs may interact with receptors on the cell surface to activate second 
messenger pathways. Such a contention is supported by the finding that several of the 
plant-derived and synthetic GAGs, when added to 3T3 cultures in serum free medium, 
induce mitogenesis in Balb/c3T3 cultures. Such cultures appear morphologically identical 
to those stimulated by HBGF-1. The mitogenic action of these GAGs was separable 
from, and occurred in addition to, potentiation of HBGF-1 induced mitogenesis. Several 
lines of evidence support the contention that GAGs act at distinct cell surface sites to 
induce mitosis. Receptors for a variety of sulfated GAGs have been identified on 
lymphocytes (Parish, and Snowden, 1985), monocytes, macrophages, and fibroblast 
and mastocytoma cell lines (Chong, and Parish, 1986), neurons (Vidovic et al.1986), 
and endothelial cells (Glabe et al. 1983). Endocytotic uptake of fucoidin by endothelial 
cells, and fucoidin and K-carrageenan by macrophages has been reported (Glabe et 
al. 1983; Chong, and Parish, 1986). Of particular relevance was the finding that
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carrageenan, polyanethole and polyvinyl sulfate - GAGs which displayed potent 
proliferative activity for 3T3 cells - were universal inhibitors of binding to GAG cell 
surface receptors (Parish, and Snowden, 1985). Evidence that would suggest heparin to 
be a direct inhibitor of smooth muscle cell proliferation, including its binding, uptake and 
metabolism, has been discussed in the previous chapter. It is of interest to note that, like 
heparin, pentosan and dextran sulfate inhibit the in vitro serum dependent proliferation of 
smooth muscle cells (Paul et al.1987). Hyaluronate, C4S and heparan sulfate have been 
isolated from nuclear preparations of melanoma cells (Bhavanandan, and Davidson, 
1975), rat liver cells (Furukawa, and Terayama, 1977) and CNS tissue (Margolis et 
al.1976). Dextran sulfate, pentosan, CS and the carrageenans stimulate DNA synthesis 
by nuclei isolated from rat liver (Furukawa, and Bhavanandan, 1983). Stimulation was 
generally proportional to the degree of sulfation and also the ability of the GAGs to 
complex with histone fractions. C4S, C6S and heparin were also shown to inhibit DNA 
synthesis by DNA polymerase; the ability of the GAGs to inhibit DNA synthesis by 
nuclei isolated from tumor cell lines (Furukawa, and Bhavanandan, 1982) was attributed 
to the already maximal template activity and 'unmasking' of the inhibition of DNA 
polymerase.
Thus it is likely that the GAGs exert several effects at distinct sites. In particular the 
existence of cell surface receptors for GAGs capable of activating second messenger 
pathways is hypothesized to account for at least some of the observations presented in 
t h i s  c h a p t e r .
89
Chapter 6
Retinoic acid potentiates the neurotrophic but not the mitogenic action of 
HBGF-1
90
Introduction
The retinoids constitute a large family of natural and synthetic compounds that possess 
vitamin A activity or structural homology to retinol (Goodman, 1984). Their effects on 
cellular proliferation, differentiation and positional specification during development have 
led to intense interest in these compounds as both putative morphogens and possible 
therapeutic agents for neoplastic processes (Bertram et al.1987). These aspects of their 
biology are presented as an introduction; particular emphasis has been placed on the 
effects of aW-trans -retinoic acid (RA) which, along with its cis isomer, is the most 
potent and, in all probability, the most biologically relevant of the retinoid morphogens.
Retinoic acid and positional specification
It has been known for some years that posteriorly located chick wing bud mesenchyme 
(termed the zone of polarizing activity or ZPA), when grafted anteriorly on the wing bud, 
produces mirror image symmetrical duplication of the host digit pattem (Saunders, and 
Gasseling, 1968). Homoplastic and xenoplastic combinations have shown the duplicated 
appendages to be always of host type (wing or leg) and species, demonstrating that the 
grafted mesenchyme does not itself contribute to the supemumary structure but induces 
anteroposterior (AP) polarity in the host (Balcuns Maccabe et al.1973). The effect is 
dependent on the stage of the embryo, time of exposure and 'dose ' of ZPA cells. For 
example, irradiation of the ZPA prior to transplantation (Smith et al.1978), or dilution of 
the ZPA cells with inactive cells from the anterior wing bud (Tickle, 1981) attenuates the 
polarizing activity such that the duplicated 432234 pattern is replaced by 3224 then 2234 
and the normal 234. This, together with results obtained by grafting the ZPA to 
successive positions along the AP axis (Tickle et al.1975), led to the hypothesis that limb 
specification is the result of the acquisition of positional information by diffusion of a 
ZPA derived morphogen.
Interest in RA as the natural morphogen was generated by the remarkable observation 
that RA applied to the anterior chick limb bud mimics the action of the ZPA in inducing 
additional digits in mirror image symmetry to those of the host (Summerbell, 1983; 
Tickle et al.1982). Like the ZPA the effect is dependent on developmental stage of the 
embryo, time of exposure, and concentration of RA, and is ineffective when applied to 
the posterior limb bud. Low doses of RA result in either normal limbs (234 pattern) or 
deletions, whilst progressively higher doses result in duplications ranging from 2234 
->3224 —>3234 —>432234. High doses, especially administered at early stages, result in 
the loss of host digits and proximal limb structures. It has been further shown that
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release of radiolabelled RA or its analogues from implanted ion-exchange beads forms a 
steady-state concentration gradient across the wing bud over the period of digit pattem 
formation (Tickle et al. 1985; Eichele et al.1985).
Interestingly, changes in limb bud shape prior to the appearance of additional digits 
appear to be mediated by a second factor (Tickle et al. 1989). Epithelium of the apical 
ectodermal ridge responds to a mesodermal derived factor that is in turn induced by RA. 
At least one study has suggested that the ZPA releases FGF or FGF-like growth factors 
(Aono, and Ide, 1988). FGF induced mitogenesis of wing bud segments showed a 
similar spectrum of activity to coculturing with posterior (ZPA containing) wing bud 
fragments. The authors suggest RA may induce ZPA-like activity in limb bud 
mesenchyme which in turn releases an FGF-like growth factor.
Retinoids also alter the positional information acquired by the regenerating cells of the 
amphibian limb. Following amputation, distal cells of the limb stump - including 
cartilage, muscle, connective tissue, and dermal derived cells - dedifferentiate to form the 
blastema which in turn directs regeneration of the entire limb. Local or systemic 
administration of RA 'proximalizes' the 'positional memory' of the blastema thus 
inducing duplications in the proximo-distal axis of the regenerated limb (Maden, 1982; 
Thoms, and Stocum, 1984; Stocum, and Crawford, 1987). An effect of retinoids on AP 
and dorsoventral (DV) axis specification of the regenerating urodele limb bud can be 
demonstrated by surgically constructing half or double half limbs prior to amputation and 
RA exposure (Stocum, and Crawford, 1987; Kim, and Stocum, 1986). Interestingly, the 
regenerating anurian limb combines the features of both chick and urodeles; exposure to 
retinoids induces duplication in both the PD and AP axis (Maden, 1983).
As with the chick limb bud, dose and stage dependency have been demonstrated; the 
higher the dose of administered retinoid, the more proximal the level at which duplication 
occurs (Thoms, and Stocum, 1984; Maden, 1985). RA is most effective during the 
period of dedifferentiation and accumulation of blastema cells (Thoms, and Stocum, 
1984). Dedifferentiation extends to a level more proximal than controls, the blastema 
cells seen to aggregate in non-dividing clumps (Stocum, and Crawford, 1987; Maden, 
1982; Maden, 1985). Only when treatment is ceased do cells divide and regeneration 
commence. In contrast to the chick limb there is no evidence of a polarizing zone in 
amphibian limb regeneration.
The identification of endogenous retinoids in the chick limb bud has further implicated 
these molecules as the natural morphogens. Biologically active retinoic acid has been
92
isolated in limb bud in concentrations similar to those required of exogenous RA to 
induce extra digits (Thaller, and Eichele, 1987). Significantly, RA was enriched some 
2.5-fold in the posterior quarter of the limb bud. Retinol concentration was 25 times that 
of RA and equivalent across the AP axis. The demonstration that limb bud cells are 
capable of synthesizing RA from all-trans -retinol or all-trans -retinal (Thaller, and 
Eichele, 1988) is suggestive of control at the level of synthetic enzyme expression or 
activity.
Retinoic acid receptors
The identification of retinoic acid receptors (RARs) as ligand-responsive transcription 
enhancing factors belonging to the thyroid/steroid hormone superfamily (Evans, 1988) 
has provided further evidence to support RA's role as a putative morphogen.
The RARa receptor was isolated on the basis of homology to the steroid receptor family; 
identification of the natural ligand was the result of elegant gene reconstruction 
experiments whereby the DNA binding domain of the unknown receptor was exchanged 
for the domain of a receptor for which responsive elements have been defined (Petkovich 
et al.1987; Giguere et al.1987). Co-transfection of cells with a chloramphenicol acetyl 
transferase reporter gene linked to a promoter containing estrogen or glucocorticoid 
responsive elements allowed screening of a variety of possible ligands. RA was found to 
be specifically active at 10'7 - 10'8M (Petkovich et al.1987; Giguere et al.1987).
The gene for the RARß receptor was initially identified as DNA surrounding the hepatitis 
B vims integration site and was later found to contain the domain structure characteristic 
of the steroid/thyroid hormone receptor superfamily (Benbrook et al. 1988). The DNA 
binding region of the ß receptor shares 97% homology with the a  receptor suggesting 
both recognize the same or similar response elements (Benbrook et al. 1988; Brand et 
al.1988). The hormone binding domain is 88% homologous to the aRAR.
Screening of a mouse embryo cDNA library with human RARa and RARß revealed a 
third set of clones encoding a mouse RARy receptor (Zelent et al.1989); the human 
counterpart was subsequently localized (Krust et al.1989). RAR-y exhibits 95% 
homology to the DNA binding domains and 85-90% homology to the ligand binding 
domains of the a  and ß RARs.
A fourth RAR receptor - RAR5 - has been identified by the screening of a newt blastema 
cDNA library with human R A Ra under conditions of low stringency (Ragsdale et
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al. 1989). Although related to the mammalian y receptor, the primary amino acid 
sequence was considered sufficiently divergent to justify a new receptor subclass.
The functions of the different receptors are presently unknown. Krust et al.(1989) have 
pointed out that cross-species (human-mouse) homology for a given receptor subclass is 
greater than that existing between the subclasses of either species, indicating possible 
receptor-specific functions. In this regard it is worth noting that RARy expression 
appears to be restricted to skin (Zelent et al.1989; Krust et al.1989). The increased 
affinity of the RARß receptor for RA compared to the a  receptor (Brand et al. 1988) has 
led the authors to propose differing affinities as a mechanism of fine tuning RA 
concentration gradients (Brand et al.1988; Benbrook et al. 1988). Expression of the newt 
RARß in the regenerating limb has been studied by in situ hybridization (Giguere et 
al.1989). RAR mRNA was found in the mesenchymal cells under the wound epidermis 
although no gradient of RAR expression was seen along the AP or PD axis. Thus at least 
in the case of urodele limb regeneration differential expression of the RAR gene is not a 
mechanism of positional specification.
The nuclear RA receptors are distinct from the earlier described cellular retinoic acid 
binding protein (CRABP; see Ong, and Chytil, 1978; Sundelin et al.1983). CRABP is a 
cytosolic protein thought to function as a storage or transport protein delivering RA to the 
nucleus (Chytil, 1985). It shows relatively specific affinity for RA - retinol, retinal and 
various analogues will compete only in molar excess (Maden, and Summerbell, 1986; 
Keeble, and Maden, 1986). In general, CRABP distribution correlates with tissue 
requirement for retinoids (Chytil, 1986; Eriksson et al.1987). For example, CRABP is 
present in the developing limb bud at all stages susceptible to the morphogenetic effect of 
RA (Maden, and Summerbell, 1986; Maden et al.1988). Expression in the dividing cells 
of the progress zone is highest in the posterior limb bud decreasing anteriorly - i.e.anti- 
parallel to the RA gradient (Thaller, and Eichele, 1987). The authors propose CRABP 
distribution accentuates and stabilizes the RA gradient (see also Eichele, 1989). 
Similarly, blastemal tissue of the axolotl limb expresses high levels of CRABP which 
declines with regeneration (Keeble, and Maden, 1986).
Retinoids as inducers of differentiation
Historically, studies of vitamin A concentrated on its effects on epithelial tissues 
(Bertram et al.1987). Retinoids, by their ability to inhibit keratinization, are required for 
the differentiation and maintenance of the mucus secreting phenotype (Lotan, 1980a). 
Their role as therapeutic agents for disorders characterized by excessive keratinization is
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well established (Goodman, 1984). In vivo administration of natural or synthetic 
retinoids can prevent chemical induced carcinogenesis of epithelial tissues (Sporn et 
al.1976; Bertram et al. 1987).
More recently, attention has focussed on the in vitro activity of retinoids - particularly 
retinoic acid - on various tumor cell lines. Inhibition of cell division and induction of 
various indices of differentiation have been described for melanoma (Lotan et al. 1983; 
Meyskens, and Fuller, 1980), breast carcinoma (Lacroix, and Lippman, 1980), cervical 
carcinoma (He La cells; Lotan et al. 1980b) and promyelocytic leukemia cells (Breitman et 
al.1980). Mouse teratocarcinoma derived stem cells or embryonal carcinoma (EC) cells 
have, in particular, provided a useful model for investigation of early determining events, 
although it is apparent that response to retinoic acid varies with both cell line and method 
of RA administration. F9 cells exposed to RA for several days differentiate into 
endodermal like cells (Strickland, and Mahdavi, 1978). DNA synthesis is inhibited and 
the expression of both cytosolic and secreted proteins is altered (Linder et al. 1981). The 
P19 (EC) cell line exhibits concentration dependent differentiation in response to RA 
(Edwards, and McBurney, 1983). Low concentrations of RA (1-3 x 10'9M) result in the 
development of cardiac muscle cells. Increasing the concentration of retinoic acid to 3-30 
x 10'9M induces the formation of skeletal myoblasts or myotubes. At 10'7M neurons and 
astroglia differentiate from the stem cell line. A detailed study of the neuronal phenotype 
has revealed striking neuronal characteristics (Jones-Villeneuve et al.1982). Neuronal 
specific distribution of tubulin and neurofilaments, varicose processes and induction of 
acetylcholine esterase and CAT activity were reported. In addition, a population of cells 
expressing GFAP developed in RA treated cultures. The observation further supports the 
contention that RA functions in vivo as a diffusable, and therefore, concentration 
dependent morphogenetic agent.
RA exerts similar differentiating action on neuroblastoma cells (Haskell et a l l 987; Sidell 
et al. 1983; Pahlman et al.1984; Sided et al.1986). Responsive lines exhibit striking 
morphological changes; the normally pleiomorphic cells round up, cluster and extend 
neuntes which form dense fascicles connecting the in vitro pseudoganglia. Growth 
cones, filopodia, and varicosities characteristic of mature sympathetic neurons are seen 
on nerve processes (Haussier et al. 1983; Sided et al. 1983; Robson, and Sided, 1985). 
Inhibition of proliferation by RA of several primary human glioma lines has also been 
reported although no morphological differentiation was seen (Yung et al.1989).
Thus the role of vitamin A and its derivatives exceeds that of a simple vitamin 
requirement. They have been characterized to date as potent morphogens with several
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specific nuclear receptors of a class known to activate and depress gene activity. 
Although at the time of writing only one RA responsive element has been identified 
(Umesono et al. 1988), by analogy to the steroid/thyroid family it is proposed (see 
Evans, 1988) that the interaction of RA with its receptor will induce a cascade of genetic 
activity which in turn control the events of cellular determination.
Given the probable morphogenetic role of RA it became of interest to investigate possible 
effects of the molecule using standard neuronal bioassay techniques. The aims were to 
determine (i) whether the molecule possesses neurotrophic action and (ii) possible 
interactions between several neurotrophic factors, retinoic acid, and responsive cell 
types, both neuronal and non-neuronal. The neurotrophic molecules include the class 1 
HBGFs purified from bovine heart and bovine brain, the class 2 HBGF from bovine 
brain, and NGF. All-trans -retinoic acid was employed throughout the study.
Materials and methods
Neuronal and 3T3 cultures were set up as described in chapter 2. Neonatal rat 
sympathetic neurons were cultured as described for the embryonic chick derived neurons 
except that ganglia were dissociated in a mixture of trypsin and collagenase. Retinoic acid 
(Sigma, St. Louis) was dissolved in ethanol as a 10*2 stock solution such that the highest 
concentration of ethanol in cultures was 0.1% at 10*5M retinoic acid. HBGFs were 
purified from bovine heart and brain as described in chapter 2. Nerve growth factor was 
purified from the mouse submaxillary glands as the ß subunit (Mobley et al.1976).
Results
Effects o f retinoic acid on ciliary neuronal survival
Retinoic acid alone had no effect on ciliary neuronal survival over the concentration range 
10'5 to 10*^M . However, retinoic acid potentiated the survival promoting properties of 
subsaturating concentrations (25 ng/ml) of beef heart derived HBGF-1 (figure 6.1). The 
maximal enhancing effect was seen at 3xlO*7M retinoic acid. Retinoic acid at 10*7M was 
further shown to increase neuronal survival induced by all active concentrations of 
HBGF-1 purified from either bovine heart (figure 6.2A) or bovine brain (figure 6.2B). 
However, little or no effect was seen on HBGF-2 induced ciliary neuronal survival 
(figure 6.2C).
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Figure 6.1. Effect of retinoic acid on HBGF-1 induced neuronal survival. Neurons 
were cultured as described in Methods (chapter 2) in the presence (filled squares) or 
absence (open squares) of HBGF-1 (25 ng/ml) and the dose response to retinoic acid was 
determined Values represent means and standard errors (vertical bars) of 6 experiments.
AFigure 6.2. Effect of retinoic acid on HBGF-1 and HBGF-2 induced ciliary neuronal 
survival. Neurons were grown in varying concentrations of: A. HBGF-1 purified from 
bovine heart; B. HBGF-1 purified from bovine brain; C. HBGF-2 purified from bovine 
brain in the presence (filled squares) or absence (open squares) of 10'7 retinoic acid. 
Values represent means and standard errors (vertical bars) of 4 to 6 experiments.
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Retinoic acid effects on sympathetic neuronal survival
Neither HBGF-1 or HBGF-2 promote the in vitro survival of embryonic chick or 
neonatal rat sympathetic neurons (see also chapter 2); retinoic acid has no additional 
survival effect. NGF induced survival of rat sympathetic neurons is unaffected by the 
additional presence of retinoic acid in the culture medium (figure 6.3A). Retinoic acid did 
however induce morphological changes in long term cultures of sympathetic neurons. 
Over a period of several weeks neurons exposed to retinoic acid were observed to 
cluster; in extreme cases all neurons in a given well were grouped into one or two clumps 
projecting extensive fasciculated neuntes.
Effect o f retinoic acid on sensory neuronal survival
NGF, HBGF-1 and HBGF-2 promote the survival of sensory neurons in dissociated cell 
culture. Over the concentration range tested, retinoic acid did not effect NGF mediated 
neuronal survival (figure 6.3B). However, retinoic acid did augment the effect of 
HBGF-1 purified from both beef heart (figure 6.4A) and brain (figure 6.4B) on sensory 
neuronal survival, with maximal stimulation at 10*7M. As observed with dissociated 
ciliary neurons (figure 6.2C), retinoic acid did not enhace HBGF-2 induced sensory 
neuronal survival (figure 6.4C).
Effect o f retinoic acid on Balblc3T3 cell proliferation
Both HBGF-1 and HBGF-2 promote division of quiescent Balb/c3T3 cells. Retinoic 
acid over the concentration range tested did not affect the mitogenic activity of either 
protein on this fibroblast cell line (figure 6.5).
Discussion
The major result reported here is the potentiation by retinoic acid of in vitro neuronal 
survival in response to the class 1 heparin-binding growth factors. The effect was seen 
using dissociated cultures of both chick ciliary and sensory neurons and occurred 
regardless of the source of the factor. RA conferred similar activity to cultures supported 
by HBGF-1 purified from either bovine heart or brain and is thus in agreement with the 
previous contention that N-terminal modification does not affect biological activity. RA 
did not affect either NGF or HBGF-2 induced neuronal survival for any neuronal 
population. Similarly, mitogenic activity of HBGFs for quiescent 3T3 fibroblasts was
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Figure 6.3. Effect of retinoic acid on NGF induced survival'of A. sympathetic and B. 
sensory neurons. Neurons were cultured in the presence (filled squares) or absence (open 
squares) of NGF (lng/ml) and a dose response to retinoic acid performed. Values shown 
represent means and standard errors (vertical bars) of 4 to 6 experiments.
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Figure 6.4. Effect of retinoic acid on HBGF induced sensory neuronal survival. 
Neurons were grown in the presence (filled squares) or absence (open squares) of A. 
HBGF-1 purified from bovine heart (25ng/ml); B. HBGF-1 purified from bovine brain 
(lOn g/ml); C. HBGF-2 purified from bovine brain (1 ng/ml) and a dose response to 
retinoic acid performed. Values represent means and standard errors (vertical bars) of 4 to 
6 experiments.
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Figure 6.5. Effect of retinoic acid on HBGF induced proliferation of quiescent 
Balb/c3T3 fibroblasts. Balb/c3T3 cells were cultured as described (chapter 2) in the 
presence (filled squares) or absence (open squares) of A. HBGF-1 or B. HBGF-2 
purified from bovine brain, and a dose response to retinoic acid was performed. Values 
shown are means and standard errors (vertical bars) from 4 to 6 experiments.
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unaffected by the additional presence of RA in the culture medium. Over the 
concentrations tested, RA alone did not possess any biological activity for any bioassays 
employed in the current study.
A previous report has described neurite outgrowth by explanted E9 chick DRG in 
response to RA (Haskell et al.1987). Interestingly, in serum-free media this effect was 
dependent on the presence of insulin; i.e. in agreement with the present results RA 
potentiated the neurotrophic activity of a growth factor.
The concentration over which RA is active in potentiating HBGF-1 neurotrophic activity 
is consistent with reported potency in other bioassay systems. RA induced differentiation 
of neuroblastoma (Haussier et al. 1983; Sidell et al. 1983; Pahlman et al.1984), F9 
(Strickland, and Mahdavi, 1978), P19 (Edwards, and McBurney, 1983; Jones- 
Villeneuve et al.1982), HL-60 leukemia (Breitman et al.1980), and melanoma cells 
(Meyskens, and Fuller, 1980) occurs over a similar concentration range. Estimated in 
vivo concentration of RA varies from 20nm (anterior chick limb bud) to 50nm (posterior 
limb bud; Thaller, and Eichele, 1987) to 1 .5 x l0 '7M (Xenopus embryo; Durston et 
al.1989). Moreover maximal transactivation of RA Ra and RARy was seen with RA 
concentrations between 10‘7-10‘8M (Petkovich et al.1987; Zelent et al.1989; Krust et 
al.1989). The affinity of RARß for RA was reported to be some 10-fold greater than 
RARa (Benbrook et al. 1988; Brand et al.1988).
Without further investigation, the mechanism by which RA exerts its potentiating effect 
can only be the subject of speculation. The large number of gene products known to be 
affected by the retinoids (see e.g. Chytil, 1986) and their possible interactive effects 
complicate such a discussion. However two possible actions of RA described in other 
bioassay systems warrant further consideration.
Modulation of receptor number or function by RA is well described. Differentiation of 
human neuroblastoma cells is associated with a marked increase in the number of NGF 
receptors; a 7-11 fold increase of high affinity and 3-8 fold increase of low affinity NGF 
receptors was seen in response to RA exposure over 4 days (Haskell et al.1987). The 
response of the EGF receptor to RA has received more attention. Treatment of several 
mouse-derived fibroblast cell lines (including 3T3 cells) with retinoic acid for 3 days 
increased the EGF receptor number 5-7 fold (Jetten, 1980; Jetten, 1982). No change in 
receptor affinity was seen. A similar effect has been described for CH3/2K cells (Saito et 
al.1982), differentiating EC cells (Rees et al.1979) and mammary gland explants 
(Komura et al.1986). With regard to the potentiation of insulin induced neurotrophic
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activity (Haskell et al. 1987 and above), RA induced differentiation of EC cells is 
associated with the expression of functional insulin receptors (Heath et al. 1981). 
Moreover, the differentiated cell line responds to insulin by synthesis of DNA and cell 
proliferation.
It seems unlikely, however, given the time course of the increase in receptor number - 
normally occurring over several days - that such a mechanism can account for the 
potentiation of FGF neurotrophic activity using a 24hr bioassay. Furthermore, there is 
not necessarily a correlation between the number of receptors and the biological activity 
of the relevant ligand. For example, despite inducing an increased number of EGF 
receptors, RA inhibits EGF induced 3T6 cell mitogenesis (Jetten, 1982) and RA 
potentiation of EGF activity for human skin fibroblasts is not associated with a change in 
EGF binding (Harper, 1988). On the other hand, RA induced potentiation of the 
mitogenic effect of EGF on mouse mammary gland explants is associated with an 
increase in the EGF receptor number (Komura et al.1986). Similarly, differentiated EC 
cells respond to EGF with increased cell division (Rees et al.1979).
More relevant may be reports of short term modulation of receptor affinity or activity by 
RA. CH/3K cells exposed to RA exhibit a short term (l-2hr) increase in EGF receptor 
affinity with no change in the number of binding sites (Saito et al.1982). Over the 
succeeding 24 hrs a cycloheximide sensitive increase in receptor number was observed. 
Negative modulation of EGF receptor activity has been reported following exposure of 
human glioma cells to RA (Yung et al. 1989). Cell lines responsive to RA showed a 
decrease in both receptor autophosphorylation and ability to phosphorylate an exogenous 
substrate. In addition an increase in the dissociation constant was seen.
Also relevant are observations on the rate of recovery of receptors after down regulation 
in response to high concentrations of agonist. RA treated 3T6 cells recover EGF binding 
capacity - presumably representing synthesis of new EGF receptors - some 3-fold faster 
than unexposed controls (Jetten, 1982); such recovery occurs over several hours. That 
such a mechanism is responsible for the potentiation of FGF activity for neurons was 
suggested by preliminary experiments where ganglia were dissociated under harsh 
conditions. For example, dissociation by high concentrations of trypsin in serum-free 
media - conditions that would be expected to inflict more damage on cell surface 
components - enhanced the relative potentiating action of RA on subsequent FGF 
induced neuronal survival. Indeed under such conditions a significant increase in HBGF- 
2 induced survival was seen. Thus it is possible that if the capacity to synthesize and 
replace damaged receptors is established at the time of dissociation, RA may 'up
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regulate' the rate of receptor replacement before irreversible cell loss as a result of 
neurotrophic factor deprivation occurs. This mechanism is distinct from the slower 
appearance of receptors associated with differentiation of tumor cell lines (see above). 
Formal receptor binding studies, currently in progress in the laboratory, should further 
elucidate this possibility.
Despite the observation that RA potentiated the neurotrophic action of FGF in preplated 
cultures grown under conditions that deter the the survival of non-neuronal cells, an 
indirect effect of RA via contaminating non-neuronal cells cannot be ruled out. For 
example, RA has been shown to promote the in vitro synthesis of nerve growth factor by 
mouse L cells (Wion et al. 1987). Similarly, induction of expression and secretion of cell 
surface glycoproteins and matrix molecules following retinoid exposure is well described 
(Lotan et al. 1983; Sasak et al.1980; Lotan et al. 1980b; King, and Tabiowo, 1981a; 
Linder et al. 1981; Jetten et al.1979; Patt et al.1978). Differentiation of F9 cells is 
associated with expression of the genes encoding laminin and type IV collagen (Wang et 
al. 1985). Laminin can be immunohistochemically detected on the cell surface of 
differentiated cultures (Knowles et al.1980; Carlin et al.1983) and the laminin/entactin 
complex immunoprecipitated from culture medium (Williams, and Napoli, 1985). 
Treatment of 3T3 or 3T6 fibroblasts causes increased secretion of sulfated GAGs 
including chondroitin sulfate and heparan sulfate (Jetten et al.1979). Although laminin 
and heparan sulfate are known to potentiate both neuronal survival and neurite outgrowth 
(see Introduction chapter 4), temporal considerations alluded to above apply. For 
example, laminin is not seen in differentiating F9 cultures before 3 days exposure to RA. 
The situation may however be different for primary cell lines. RA induced incorporation 
of ^H-glucosamine into extracellular proteoglycans occurs within 4 hours in organ 
cultured epidermis (King, and Tabiowo, 1981b). Some 80-90% of the newly 
synthesized proteoglycan was identified as hyaluronic acid - a GAG shown (see Chapter 
5) to potentiate the neurotrophic action of FfBGF-1. If such an indirect mechanism is 
operative it is specific for HBGF-1: neither NGF or HBGF-2 supported cultures 
responded to the additional presence of RA.
At least one neurotrophic factor - purpurin - is known to be a retinol-binding protein 
(Schubert et al. 1987a). The possibility that RA also binds HBGF-1 and - by analogy to 
heparin - potentiates biological activity, was considered. However HBGF-1 failed to 
bind to a retinoic acid affinity column prepared by methods previously used to identify 
steroid binding proteins (see e.g. Mickelson, and Petra, 1975; Mickelson et al.1978) and 
3H-retinoic acid did not bind western blots of HBGF-1 (results not shown). It is 
concluded that HBGF-1 does not bind retinoic acid.
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RA did not enhance the mitogenic potency of the HBGFs for quiescent 3T3 fibroblasts in 
the current study. In contrast, RA has been reported to potentiate EGF induced mitosis of 
human fibroblasts (Harper, and Savage, 1980), mammary gland explants (Komura et 
al. 1986) and Swiss and BALB/c3T3 fibroblasts (Dicker, and Rozengurt, 1979). The last 
study identified a range of factors including serum, insulin, vasopressin and a 
'fibroblast-derived growth factor' ( possibly HBGF-2) that respond to the addition of 
RA by an increase in biological activity. Harper, (1988) reported that RA potentiated the 
EGF, but not the bFGF, induced proliferation of adult human skin fibroblasts. 
Differences may relate to the intrinsic action of the various mitogens, variability of the 
target cell response to RA and the mitogenic assay used; in particular, addition of the 
growth factor to log phase or quiescent cultures and the subsequent time interval before 
cell harvesting. Studies alluded to above (Harper, and Savage, 1980; Komura et al. 1986; 
Dicker, and Rozengurt, 1979) allowed periods of one week or longer between addition 
of the mitogen and cell harvesting, which may have allowed longer term effects of RA to 
become apparent.
RA induced clumping of long term sympathetic cultures is an interesting in vitro 
morphological phenomenon that is analogous to the formation of the ganglionic anlagen 
of early development. Similar clumping in response to RA has been described for 
blastema cells (Stocum, and Crawford, 1987) and differentiating neuroblastoma cell lines 
(Haussier et al. 1983). Such behaviour may be the result of changes in expression of cell 
surface components (see above). For example, the in vitro morphological behaviour of 
PC I2 cells is responsive to the addition of the GAGs heparan and chondriotin sulfate 
(Schubert et al. 1987b).
Several lines of evidence have suggested that the retinoids are involved in development 
of the nervous system. RA induced differentiation of both neuroblastoma cells and EC 
cells has been alluded to above. Offspring of vitamin A deficient mammals suffer 
anophthalmia, microphthalmia, a variety of retinal malformations and hydrocephalus in 
addition to a variety of systemic malformations (Kalter, and W arkany, 1959). 
Hypervitaminosis A results in gross brain and skull abnormalities including anencephaly 
and exencephaly as well as a range of ocular defects. Failure of neural tube closure in 
response to high doses of retinoids appeared to be the result of the accumulation of 
dividing neuroepithelial cells and disruption of the internal limiting membrane (Langman, 
and Welch, 1966).
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RA has been shown to influence regional differentiation within the developing Xenopus 
CNS. Xenopus embryos exposed to RA develop microcephaly, lacking the anterior CNS 
and associated structures including the eyes and nasal pits (Durston et al. 1989). 
Moreover, RA inhibited the formation of anterior forebrain and associated sense organs 
by cultured ectodermal explants; development of the posterior neural structures including 
the ears were unaffected. The results would suggest RA specifies AP axis formation in 
the CNS. In this regard it is worth noting that expression of RARs has been detected in 
central nervous tissue (Zelent et al.1989; Rees et al.1989; Benbrook et al. 1988; Giguere 
et al. 1987).
Further evidence to support the the role of RA as a putative morphogen in CNS 
development has been provided by the immunohistochemical localization of CRABP to 
developing neuronal structures (if indeed the presence of CRABP reflects either RA 
content or requirement). In the stage 16 chick embryo CRABP immunoreactivity in the 
mantle layer of the neural tube is associated with early differentiating post mitotic 
neurons (Maden et al.1989). In addition, neural crest cells migrating through the anterior 
scleretome are CRABP positive. Later stage embryos show staining of the dorsal roof 
plate, commissural axons of the developing spinal cord and neural crest derivatives 
including a sub-population of DRG cells, presumptive prevertebral ganglia, and enteric 
ganglia. CRABP has also been detected by ELISA in the adult rat brain (Eriksson et 
al.1987).
In light of the results presented in this chapter, it is tempting to hypothesize that one 
function of RA is to modulate neuronal response to neurotrophic factors. For example, 
the signals that determine the expression of the NGF-receptor on neuronal processes 
(Davies et al.1987) and expression of NGF in the target tissue (Rohrer et al.1988) are 
unknown; it is posssible that RA, in regulating the level of neuronal response, fine tunes 
the mechanisms that normally determine neuronal survival.
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As noted in the introduction the approach to the identification of new neurotrophic 
molecules has recently seen some changes. The tedious and often unrewarding search for 
biologically relevant molecules in tissue extracts using traditional methods of protein 
purification are being replaced with DNA technology. Indeed, if neurotrophic activity is 
present in crude tissue extract in sufficient concentration to be detected by in vitro 
neuronal bioassay, it is unlikely to be relevant to the biology of the neuron as predicted 
by the neurotrophic hypothesis. For example, NGF cannot be detected in normal 
peripheral tissues using conventional bioassay procedures (see e.g. Harper et al. 1980), 
although it is worth noting that BDNF was initially detected in brain extract using similar 
techniques (Barde et al.1980). The role of the HBGFs as neurotrophic molecules 
remains to be firmly established; certainly the known biology of both HBGF-1 and 
HBGF-2 is not in keeping with that predicted by the NGF paradigm. Several points of 
departure with classical neurotrophic theory were discussed in chapter 2, although it is 
emphasized that the in vivo activity of the HBGFs, as well as the specific neurotoxic 
effect of a monoclonal antibody directed against HBGF-1, would suggest the HBGFs 
exert some control over neuronal development. It is possible that more than one class of 
neurotrophic molecules exist; in addition to the 'classical' neurotrophic factors present in 
in target tissues in limiting concentration, matrix-bound molecules may regulate neuronal 
survival directly or determine the level of responsiveness to other target tissue derived 
molecules. The possibility that any or all of the other HBGFs ( chapter 1; see also Milner 
et al.(1989); Vigney et al.(1989) for isolation of two further HBGFs) are neurotrophic 
factors represents an exciting prospect for the future of neurotrophic investigation. 
During the writing of this thesis, the discovery of a third member of the NGF/BDNF 
family - neurotrophin-3 - has been reported (Hohn et al.1990; Maisonpierre et al.1990). 
The newly described factor is 57 and 58% homologous to NGF and BNGF and 
possesses in vitro activity for nodose, mesencephalic, sensory and sympathetic ganglia.
The last three chapters were concerned with the interaction of HBGF-1 with two distinct 
classes of molecules; the glycosaminoglycans and retinoids.Two points are emphasized; 
the observation that the ability of a given GAG to bind HBGF-1 does not directly 
correlate with its potentiating activity led to the suggestion that these polysaccharides are 
capable of exerting direct effects on target cells. The ability of some of the plant-derived 
GAGs and synthetic polysulfates to induce mitogenesis in quiescent 3T3 cultures would 
support this contention. Secondly, specific potentiation of the neurotrophic activity of 
HBGF-1 by retinoic acid would suggest mechanisms for regulating neuronal response to 
neurotrophic factors may exist in vivo.
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